Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

Study Counts

Type	Study_count
Total_Studies	3622
interventional	3171
Observational	425
Registry	26

Studies over Time

```

Interventional Trials

Intervention Type

intervention_type	Study_Count
Drug	1672
Biological	274
Drug\|Other	183
Biological\|Drug	173
Drug\|Procedure	100
Biological\|Drug\|Other	79
Biological\|Drug\|Procedure\|Radiation	66
Biological\|Drug\|Procedure	61
Other	59
Drug\|Procedure\|Radiation	58
Drug\|placebo	48
Procedure	45
Drug\|Radiation	33
Biological\|Drug\|Other\|Procedure\|Radiation	27
Behavioral	26
Drug\|Other\|Procedure\|Radiation	26
Biological\|Drug\|Radiation	22
Biological\|Other	20
Drug\|Other\|Procedure	17
Biological\|Drug\|Other\|Procedure	13
Device	11
Biological\|Procedure	10
Combination Product	9
Dietary Supplement	9
Drug\|Genetic\|Other	9
Device\|Drug\|Procedure	7
Other\|Procedure	7
Drug\|Genetic	6
Drug\|Other\|Radiation	6
Behavioral\|Other	5
Biological\|Drug\|Genetic\|Other\|Procedure	5
Biological\|Device\|Drug	4
Dietary Supplement\|Drug	4
Dietary Supplement\|placebo	4
Drug\|Genetic\|Other\|Procedure	4
Genetic	4
Radiation	4
Biological\|Other\|Procedure	3
Biological\|Procedure\|Radiation	3
Device\|Drug	3
Biological\|Combination Product	2
Biological\|Drug\|Other\|Radiation	2
Biological\|Drug\|placebo	2
Biological\|Genetic\|Other	2
Biological\|Other\|placebo	2
Device\|Drug\|Other	2
Device\|Other	2
Diagnostic Test\|Drug\|Genetic\|Procedure\|Radiation	2
Dietary Supplement\|Other	2
Drug\|placebo\|Procedure	2
Genetic\|Other	2
Genetic\|Procedure	2
Behavioral\|Dietary Supplement\|Other	1
Behavioral\|Dietary Supplement\|Other\|Procedure	1
Behavioral\|Drug	1
Behavioral\|Drug\|Other\|Procedure	1
Behavioral\|Other\|Procedure	1
Biological\|Combination Product\|Drug	1
Biological\|Device	1
Biological\|Device\|Drug\|Other	1
Biological\|Device\|Drug\|Other\|Procedure	1
Biological\|Device\|Drug\|Procedure\|Radiation	1
Biological\|Device\|Drug\|Radiation	1
Biological\|Dietary Supplement\|Drug\|placebo	1
Biological\|Dietary Supplement\|Drug\|Procedure	1
Biological\|Drug\|Genetic\|Other	1
Biological\|Drug\|placebo\|Procedure	1
Biological\|Genetic\|Other\|Procedure	1
Biological\|placebo	1
Combination Product\|Dietary Supplement	1
Device\|Drug\|Other\|Procedure\|Radiation	1
Device\|Drug\|Procedure\|Radiation	1
Device\|Other\|Procedure	1
Diagnostic Test\|Drug	1
Dietary Supplement\|Drug\|Other	1
Drug\|Genetic\|Other\|Procedure\|Radiation	1
Drug\|Genetic\|Procedure\|Radiation	1
Drug\|Other\|placebo\|Procedure	1
Other\|placebo\|Procedure	1
Procedure\|Radiation	1

Count of Studies by Intervention (normalized and mapped)

Intervention_type	intervention	Study_count	Date of First Study
Drug	cytarabine	431	2014
Drug	cyclophosphamide	424	2014
Other	laboratory biomarker analysis	329	2014
Drug	methotrexate	236	2014
Drug	fludarabine phosphate	192	2018
Drug	rituximab	192	2013
Drug	fludarabine	178	2014
Drug	etoposide	169	2014
Procedure	peripheral blood stem cell transplantation	155	2017
Drug	busulfan	147	2014
Drug	dexamethasone	145	2011
Biological	filgrastim	138	2016
Other	pharmacological study	130	2014
Drug	mycophenolate mofetil	117	2014
Drug	azacitidine	116	2016
Drug	tacrolimus	112	2014
Drug	idarubicin	107	2014
Drug	cyclosporine	105	2010
Drug	decitabine	100	2014
Drug	venetoclax	99	2014
Procedure	allogeneic hematopoietic stem cell transplantation	98	2014
Drug	vincristine sulfate	94	2010
Procedure	allogeneic bone marrow transplantation	91	2010
Drug	daunorubicin hydrochloride	89	2014
Radiation	radiotherapy	84	2018
Drug	mercaptopurine	82	2018
Radiation	total-body irradiation	82	2017
Drug	dasatinib	80	2009
Drug	prednisone	80	2010
Drug	melphalan	76	2017
Drug	clofarabine	74	2010
Drug	ibrutinib	70	2013
Drug	lenalidomide	69	2014
Drug	vincristine	69	2018
Drug	daunorubicin	64	2016
Biological	anti-thymocyte globulin	59	2010
Drug	leucovorin calcium	58	2014
Drug	mitoxantrone hydrochloride	58	2016
Drug	pegaspargase	54	2018
placebo	placebo	54	2017
Drug	imatinib mesylate	53	2018
Drug	asparaginase	52	2009
Drug	doxorubicin hydrochloride	52	2014
Drug	gemtuzumab ozogamicin	48	2008
Biological	alemtuzumab	47	2009
Drug	g-csf	47	2014
Drug	nilotinib	47	2015
Other	quality-of-life assessment	46	2009
Drug	thioguanine	45	2010
Drug	methylprednisolone	44	2010
Drug	mitoxantrone	44	2014
Drug	bortezomib	43	2018
Drug	obinutuzumab	43	2014
Biological	sargramostim	42	2011
Drug	doxorubicin	41	2018
Drug	bendamustine	38	2014
Drug	ofatumumab	37	2010
Other	questionnaire administration	37	2009
Drug	thiotepa	37	2019
Drug	imatinib	35	2014
Drug	sirolimus	34	2017
Biological	blinatumomab	32	2017
Biological	therapeutic allogeneic lymphocytes	32	2013
Drug	cladribine	31	2016
Procedure	umbilical cord blood transplantation	31	2012
Drug	vorinostat	31	2014
Biological	aldesleukin	29	2014
Drug	therapeutic hydrocortisone	29	2010
Drug	arsenic trioxide	28	2011
Drug	ara-c	26	2008
Procedure	nonmyeloablative allogeneic hematopoietic stem cell transplantation	26	2009
Drug	ifosfamide	25	2011
Radiation	total body irradiation	23	2018
Drug	mesna	22	2011
Drug	prednisolone	21	2018
Drug	chemotherapy	20	2018
Drug	chlorambucil	20	2014
Other	flow cytometry	20	2010
Drug	pentostatin	19	2010
Drug	midostaurin	18	2018
Drug	ruxolitinib	18	2018
Drug	tipifarnib	18	2011
Biological	nivolumab	17	2014
Drug	sorafenib	17	2009
Drug	gilteritinib	16	2014
Drug	nelarabine	16	2019
Biological	recombinant interferon alfa	16	2005
Drug	topotecan hydrochloride	16	2007
Drug	alvocidib	15	2018
Biological	inotuzumab ozogamicin	15	2018
Drug	ponatinib	15	2019
Procedure	autologous bone marrow transplantation	14	2006
Drug	carboplatin	14	2014
Drug	idelalisib	14	2014
Biological	pegfilgrastim	14	2018
Drug	pevonedistat	14	2018
Drug	quizartinib	14	2019
Drug	tretinoin	14	2011
Drug	acalabrutinib	13	2014
Procedure	autologous hematopoietic stem cell transplantation	13	2018
Drug	hydrocortisone	13	2017
Procedure	stem cell transplantation	13	2009
Procedure	bone marrow ablation with stem cell support	12	2006
Drug	bosutinib	12	2016
Drug	carmustine	12	2009
Drug	cpx-351	12	2014
Drug	pembrolizumab	12	2018
Radiation	total body irradiation (tbi)	12	2018
Drug	allopurinol	11	2012
Drug	everolimus	11	2009
Drug	liposome-encapsulated daunorubicin-cytarabine	11	2014
Drug	panobinostat	11	2009
Drug	peg-asparaginase	11	2017
Drug	plerixafor	11	2010
Genetic	polymerase chain reaction	11	2008
Drug	6-mercaptopurine	10	2018
Procedure	allogeneic stem cell transplantation	10	2013
Procedure	biopsy	10	2011
Procedure	bone marrow transplantation	10	2007
Genetic	cytogenetic analysis	10	2010
Biological	ipilimumab	10	2019
Drug	selinexor	10	2014
Drug	sorafenib tosylate	10	2011
Drug	thymoglobulin	10	2011
Drug	bendamustine hydrochloride	9	2010
Biological	bevacizumab	9	2008
Procedure	bone marrow aspiration	9	2018
Procedure	in vitro-treated bone marrow transplantation	9	2005
Procedure	in vitro-treated peripheral blood stem cell transplantation	9	2010
Drug	leucovorin	9	2019
Radiation	low-let photon therapy	9	1999
Procedure	stem cell transplant	9	2017
Drug	treosulfan	9	2014
Drug	vindesine	9	2018
Drug	bryostatin 1	8	2004
Other	educational intervention	8	2017
Genetic	fluorescence in situ hybridization	8	2010
Genetic	gene expression analysis	8	2008
Drug	hydroxyurea	8	2016
Drug	l-asparaginase	8	2009
Procedure	leukapheresis	8	2015
Genetic	mutation analysis	8	2008
Drug	romidepsin	8	2009
Drug	ruxolitinib phosphate	8	2014
Drug	thalidomide	8	2006
Drug	adriamycin	7	2018
Drug	all-trans retinoic acid	7	2016
Drug	atg	7	2016
Drug	brentuximab vedotin	7	2012
Drug	carfilzomib	7	2014
Device	clinimacs	7	2018
Drug	cytosine arabinoside	7	2013
Procedure	donor lymphocyte infusion	7	2017
Other	exercise	7	2014
Biological	granulocyte colony-stimulating factor	7	2017
Procedure	hematopoietic cell transplantation	7	2019
Drug	il-2	7	2016
Drug	laromustine	7	2009
Radiation	low-let cobalt-60 gamma ray therapy	7	1999
Biological	nk cells	7	2014
Drug	pci-32765	7	2009
Biological	stem cell infusion	7	2011
Drug	tanespimycin	7	2005
Radiation	tbi	7	2019
Drug	temozolomide	7	2014
Radiation	total marrow irradiation	7	2014
Drug	valproic acid	7	2019
Drug	abt-199	6	2013
Drug	ac220	6	2011
Drug	all-trans retinoic acid (atra)	6	2010
Drug	amsacrine	6	2009
Drug	atezolizumab	6	2015
Drug	atra	6	2009
Drug	azacytidine	6	2019
Drug	belinostat	6	2018
Procedure	care	6	2008
Biological	daratumumab	6	2017
Biological	donor lymphocytes	6	2016
Drug	eltrombopag	6	2010
Drug	entinostat	6	2010
Biological	graft-versus-tumor induction therapy	6	2007
Drug	guadecitabine	6	2016
Radiation	iodine i 131 monoclonal antibody bc8	6	2008
Drug	kg	6	2016
Biological	oblimersen sodium	6	2004
Drug	omacetaxine mepesuccinate	6	2007
Biological	palifermin	6	2010
Procedure	psychosocial assessment	6	2008
Procedure	psychosocial assessment/care	6	2008
Other	questionnaire	6	2016
Procedure	standard follow-up care	6	2010
Drug	temsirolimus	6	2011
Drug	ublituximab	6	2019
Drug	vosaroxin	6	2016
Biological	NA	5	2019
Drug	alisertib	5	2009
Drug	asparaginase erwinia chrysanthemi	5	2019
Drug	azd1152	5	2009
Other	blood sample	5	2014
Biological	cart-19	5	2012
Drug	clofarabine (iv formulation)	5	2006
Drug	dexrazoxane hydrochloride	5	2010
Biological	dli	5	2014
Drug	duvelisib	5	2018
Drug	enasidenib	5	2018
Drug	epoetin alfa	5	2006
Drug	erwinase	5	2014
Drug	etoposide phosphate	5	2010
Behavioral	exercise intervention	5	2013
Drug	gleevec	5	2010
Drug	graspa	5	2017
Procedure	hematopoietic stem cell transplantation	5	2016
Drug	hydrocortisone sodium succinate	5	2016
Other	immunologic technique	5	2007
Radiation	intensity-modulated radiation therapy	5	2020
Drug	isotretinoin	5	2009
Biological	lintuzumab	5	2006
Radiation	low-let electron therapy	5	1999
Drug	mycophenolate mofetil (mmf)	5	2018
Biological	natural killer cell therapy	5	2014
Drug	palbociclib	5	2014
Other	pharmacogenomic studies	5	2010
Drug	posaconazole	5	2018
Drug	rapamycin	5	2008
Biological	therapeutic autologous lymphocytes	5	2005
Drug	tocilizumab	5	2018
Drug	topotecan	5	2019
Drug	triapine	5	2006
Drug	valspodar	5	2000
Drug	velcade	5	2014
Drug	veliparib	5	2011
Drug	vp16	5	2013
Drug	5-azacitidine	4	2018
Drug	5-azacytidine	4	2010
Drug	7-hydroxystaurosporine	4	2006
Drug	abt-263	4	2009
Drug	ag-221	4	2019
Drug	akt inhibitor mk2206	4	2011
Drug	antibodies	4	2005
Drug	antithymocyte globulin	4	2015
Drug	ap1903	4	2017
Drug	astx727	4	2017
Procedure	autologous stem cell transplantation	4	2013
Drug	busulfan (bu)	4	2018
Drug	campath-1h	4	2007
Biological	cd19 car-t cells	4	2020
Drug	chidamide	4	2018
Biological	chimeric antigen receptor t-cell therapy	4	2018
Other	clinical observation	4	2014
Procedure	cord blood infusion	4	2011
Drug	cyclophosphamide (cy)	4	2018
Drug	cytarabine (ara-c)	4	2006
Drug	dinaciclib	4	2018
Biological	donor lymphocyte infusion (dli)	4	2019
Procedure	double-unit umbilical cord blood transplantation	4	2010
Drug	enasidenib mesylate	4	2019
Biological	filgrastim-sndz	4	2008
Drug	gemcitabine hydrochloride	4	2006
Drug	glasdegib	4	2017
Biological	gm-csf	4	2009
Biological	gvhd prophylaxis	4	2009
Drug	hqp1351	4	2019
Procedure	hsct	4	2017
Drug	low dose cytarabine	4	2013
Drug	mgcd0103	4	2007
Drug	mylotarg	4	2011
Biological	nk cell infusion	4	2016
Drug	oxaliplatin	4	2019
Drug	paclitaxel	4	1999
Drug	perifosine	4	2009
Procedure	peripheral blood stem cell transplant	4	2019
Other	pharmacokinetic study	4	2018
Genetic	polymorphism analysis	4	2008
Drug	ponatinib hydrochloride	4	2018
Drug	rasburicase	4	2007
Drug	sapacitabine	4	2011
Drug	sl-401	4	2014
Drug	sunitinib malate	4	2016
Drug	tgr-1202	4	2017
Drug	umbralisib	4	2019
Drug	vm26	4	2005
Drug	volasertib	4	2014
Drug	zanubrutinib	4	2017
Drug	6-thioguanine	3	2005
Drug	abl001	3	2014
Drug	acetaminophen	3	2019
Drug	ag-120	3	2019
Biological	alt-803	3	2013
Drug	amifostine trihydrate	3	1999
Biological	anti-cd19	3	2019
Drug	apr-246	3	2019
Drug	aprepitant	3	2009
Drug	arac	3	2014
Device	arm1	3	2019
Procedure	assessment of therapy complications	3	2008
Drug	azacitadine	3	2014
Other	best supportive care	3	2011
Drug	bexarotene	3	2009
Drug	bl-8040	3	2015
Procedure	blood draw	3	2013
Procedure	bone marrow biopsy	3	2015
Drug	campath	3	2007
Drug	caspofungin acetate	3	2011
Drug	cc-486	3	2014
Biological	cd123 car-t cells	3	2019
Biological	cd19	3	2018
Other	cd34	3	2012
Biological	cd8	3	2017
Drug	cediranib maleate	3	2007
Procedure	cns irradiation	3	2005
Procedure	computed tomography	3	2017
Biological	control	3	2016
Other	counseling intervention	3	2008
Drug	cpi-613	3	2013
Drug	crenolanib besylate	3	2015
Drug	cusatuzumab	3	2019
Drug	cy	3	2018
Drug	cyclosporine a	3	2013
Biological	daclizumab	3	2000
Drug	darbepoetin alfa	3	2008
Drug	daunomycin	3	2005
Drug	decitabine (5-aza-2’deoxycytidine)	3	2002
Drug	dexamethasone / prednisolone	3	2005
Drug	dexrazoxane	3	2017
Other	diagnostic laboratory biomarker analysis	3	2010
Genetic	dna methylation analysis	3	2009
Drug	eltrombopag olamine	3	2009
Drug	erwinia asparaginase	3	2017
Biological	etanercept	3	2006
Drug	fcr	3	2009
Drug	fludarabine monophosphate	3	2014
Drug	forodesine hydrochloride (bcx-1777)	3	2006
Drug	gemcitabine	3	2017
Drug	glivec	3	2013
Drug	granulocyte colony-stimulating factor (g-csf)	3	2018
Biological	gti-2040	3	2007
Drug	idasanutlin	3	2016
Drug	imatinib mesylate (gleevec)	3	2004
Drug	interleukin-2	3	2011
Procedure	intrathecal injection	3	2018
Biological	kte-x19	3	2018
Biological	kw-0761	3	2010
Drug	lbh589	3	2007
Drug	lenalidomide/dexamethasone	3	2010
Drug	m^2	3	2015
Procedure	management of therapy complications	3	2008
Drug	mbg453	3	2017
Drug	melphalan hydrochloride	3	2017
Drug	methotrexate (mtx)	3	2009
Drug	milademetan	3	2014
Device	miltenyi biotec clinimacs	3	2005
Drug	mtx	3	2014
Biological	multi-peptide cmv-modified vaccinia ankara vaccine	3	2018
Drug	ocv-501	3	2013
Drug	ondansetron	3	2009
Drug	oral azacitidine	3	2012
Biological	peripheral blood lymphocyte therapy	3	2006
Drug	pf-04449913	3	2013
Drug	pioglitazone	3	2016
Drug	poly iclc	3	2012
Procedure	positron emission tomography	3	2015
Genetic	protein expression analysis	3	2008
Drug	radotinib	3	2018
Genetic	reverse transcriptase-polymerase chain reaction	3	2009
Drug	revlimid	3	2010
Drug	ribavirin	3	2010
Drug	rimiducid	3	2018
Drug	rituxan]	3	2013
Drug	rituximab [mabthera	3	2013
Drug	rituximab [mabthera/rituxan]	3	2013
Drug	sodium phenylbutyrate	3	2000
Drug	standard chemotherapy	3	2017
Drug	trametinib	3	2013
Drug	vemurafenib	3	2018
Drug	vidaza	3	2014
Dietary Supplement	vitamin c	3	2018
Dietary Supplement	vitamin d	3	2017
Drug	voriconazole	3	2015
Drug	vp-16	3	2014
Genetic	western blotting	3	2010
Drug	15)	2	2008
Biological	20 mg	2	2010
Radiation	3-dimensional conformal radiation therapy	2	2005
Drug	6,8-bis(benzylthio)octanoic acid	2	2014
Procedure	ablative allogeneic hematopoietic cell transplantation	2	2005
Drug	aclarubicin	2	2017
Biological	allogeneic hematopoietic stem cell transplant	2	2012
Drug	amd3100	2	2007
Dietary Supplement	american ginseng	2	2008
Drug	aminopterin	2	1999
Biological	anti-cd19 car-t	2	2017
Biological	anti-cd22-car-transduced t cells	2	2016
Drug	anti-thymocyte globulin (rabbit)	2	2016
Biological	apolizumab	2	2004
Drug	at-101	2	2006
Biological	atir101	2	2016
Drug	atorvastatin	2	2011
Procedure	autologous-allogeneic tandem hematopoietic stem cell transplantation	2	2009
Other	autologous transplantation	2	2012
Drug	avelumab	2	2016
Drug	aza	2	2014
Biological	basiliximab	2	2009
Drug	beclomethasone dipropionate	2	2007
Behavioral	behavioral techniques	2	2016
Drug	bi 836826	2	2016
Drug	bi 836858	2	2015
Biological	bind19	2	2017
Other	biological samples	2	2016
Biological	biological therapy	2	2013
Procedure	biospecimen collection	2	2017
Biological	bl22 immunotoxin	2	2005
Behavioral	body composition	2	2007
Procedure	bone marrow aspiration/biopsy	2	2016
Biological	bpx-501 t cells	2	2017
Drug	br	2	2009
Other	buccal swab	2	2014
Drug	cabozantinib	2	2019
Drug	calaspargase pegol	2	2018
Drug	cc-292	2	2012
Biological	cd19 car t cells	2	2013
Biological	cd20	2	2018
Biological	cd22 car-t cells	2	2018
Biological	cd38	2	2019
Biological	cd56	2	2011
Procedure	chemotherapy, intrathecal chemotherapy, steroid therapy	2	2005
Drug	chemotherapy/antibodies	2	2005
Drug	chlorambucil, tablets	2	2013
Dietary Supplement	cholecalciferol	2	2014
Drug	cirmtuzumab	2	2016
Drug	copanlisib	2	2019
Other	cord blood transplantation	2	2005
Other	correlative studies	2	2013
Procedure	cranial irradiation	2	2013
Drug	crenolanib	2	2015
Device	ct-scan	2	2014
Biological	ctl019	2	2017
Drug	cwp232291	2	2017
Drug	cx-01	2	2016
Drug	cyclophosphamide (ctx)	2	2009
Drug	cyclophosphamide 50mg	2	2020
Drug	cyclosporin a	2	2015
Drug	cytarabine hydrochloride	2	2019
Drug	cytoxan	2	2019
Drug	dasatinib (bms-354825)	2	2006
Other	database	2	2007
Biological	dc vaccine	2	2015
Biological	dcp-001	2	2018
Biological	dec-205	2	2017
Biological	dec-205/ny-eso-1 fusion protein cdx-1401	2	2017
Drug	decitabine (dacogen)	2	2008
Drug	dfp-10917	2	2019
Behavioral	dietary intervention	2	2016
Drug	diphenhydramine	2	2019
Drug	docetaxel	2	1999
Drug	dolastatin 10	2	1999
Biological	donor natural killer cell infusion	2	2013
Biological	dose level 1	2	2004
Biological	dose level 2	2	2004
Drug	doxil	2	2012
Biological	dt2219arl	2	2009
Drug	dtrm-555	2	2020
Biological	durvalumab	2	2016
Drug	elacytarabine	2	2010
Drug	entospletinib	2	2016
Other	enzyme-linked immunosorbent assay	2	2011
Biological	epratuzumab	2	2009
Drug	epz-5676	2	2012
Drug	erlotinib	2	2010
Biological	ex vivo-expanded cord blood progenitor cell infusion	2	2012
Procedure	fatigue assessment	2	2008
Procedure	fatigue assessment/management	2	2008
Drug	fenretinide	2	2010
Diagnostic Test	fish	2	2018
Diagnostic Test	flow-mrd	2	2018
Diagnostic Test	flow immunophenotyping	2	2018
Drug	fluconazole	2	2019
Drug	fluorouracil	2	2019
Drug	ga101	2	2014
Drug	ganciclovir	2	2008
Drug	gemtuzumab ozogamicin (go)	2	2017
Genetic	gene rearrangement analysis	2	2007
Drug	gleevecâ®	2	2009
Drug	gm-csf (sargramostim)	2	2009
Biological	gm-k562 cell vaccine	2	2006
Biological	graft versus host disease prophylaxis	2	2005
Biological	graft versus host disease prophylaxis/therapy	2	2005
Biological	haploidentical stem cell transplantation	2	2017
Procedure	hematopoietic stem cell transplant	2	2005
Procedure	high dose chemotherapy then autologous hematopoietic cell transplant	2	2005
Drug	high dose cytarabine	2	2018
Drug	histamine dihydrochloride	2	1999
Combination Product	hma	2	2013
Drug	homoharringtonine	2	2020
Biological	hsc835	2	2013
Biological	hucart19	2	2019
Biological	human myeloid progenitor cells	2	2009
Drug	idarubicine	2	2011
Biological	il-15	2	2015
Drug	imatinib mesylate 400 mg	2	2005
Drug	imgn632	2	2017
Drug	imtox-25	2	2011
Biological	indium in 111 anti-cd45 monoclonal antibody bc8	2	2011
Other	informational intervention	2	2008
Drug	interferon	2	2006
Other	internet-based intervention	2	2008
Drug	intrathecal chemotherapy	2	2011
Drug	intrathecal triple therapy	2	2017
Drug	ipi-145	2	2013
Drug	irinotecan hydrochloride	2	2003
Drug	isavuconazole	2	2017
Biological	isf35	2	2008
Drug	itacitinib	2	2018
Combination Product	itmha	2	2017
Drug	ivosidenib	2	2018
Drug	ixabepilone	2	2003
Drug	ixazomib	2	2014
Diagnostic Test	karyotyping	2	2018
Biological	kg tru-016	2	2010
Drug	ldac	2	2009
Drug	lde225	2	2013
Drug	lestaurtinib	2	2007
Drug	liposomal annamycin	2	2017
Drug	liposomal cytarabine-daunorubicin cpx-351	2	2013
Drug	liposomal daunorubicin	2	2019
Drug	liposomal daunorubicin citrate	2	2000
Drug	lithium carbonate	2	2013
Drug	lmb-2	2	2009
Biological	lmb-2 immunotoxin	2	2004
Drug	lodac (low dose cytarabine)	2	2015
Drug	low dose ara-c (ldac)	2	2012
Radiation	lymphoid irradiation	2	2017
Drug	m2	2	2011
Procedure	management	2	2008
Other	mass spectrometry	2	2012
Drug	mbu	2	2018
Drug	mbu/cy	2	2018
Drug	mbu/cy/atg	2	2018
Drug	mec (mitoxantrone, etoposide, cytarabine)	2	2015
Other	medical chart review	2	2009
Biological	mem-enriched t-lymphocytes	2	2014
Biological	membrane-bound interleukin-21-expanded haploidentical natural killer cells	2	2019
Drug	mercaptopurine tablet	2	2008
Drug	metformin	2	2011
Drug	micafungin	2	2010
Genetic	microarray analysis	2	2007
Drug	mln4924	2	2013
Drug	mln9708	2	2014
Drug	mmf	2	2016
Biological	modified t cells	2	2011
Drug	montanide isa 51 vg	2	2012
Drug	motexafin gadolinium	2	2006
Drug	mycofenolate mofetil	2	2009
Biological	natural killer cell infusion	2	2012
Drug	navitoclax	2	2017
Genetic	ngs	2	2018
Drug	nicordâ®	2	2010
Drug	nintedanib	2	2018
Biological	ny-eso-1 fusion protein cdx-1401	2	2017
Other	observation	2	2018
Drug	on 01910.na	2	2009
Drug	onc201	2	2019
Other	palliative care	2	2017
Drug	peg-l-asparaginase	2	2009
Biological	peripheral blood stem cell	2	2019
Other	peripheral blood stem cell infusion	2	2007
Other	pharmacodynamic studies	2	2010
Other	pharmacogenomic study	2	2014
Drug	pinometostat	2	2018
Drug	pkc412	2	2010
placebo	placebo to match idelalisib	2	2012
Drug	plx3397	2	2011
Biological	pneumococcal 13-valent conjugate vaccine	2	2014
Drug	pomalidomide	2	2014
Drug	pracinostat	2	2013
Drug	pravastatin	2	2015
Drug	pravastatin sodium	2	2013
Drug	preparative regimen	2	2011
Biological	pretargeted radioimmunotherapy	2	2017
Biological	rabbit atg	2	2016
Drug	rasburicase (sr29142)	2	2005
Drug	recombinant asparaginase	2	2009
Biological	recombinant flt3 ligand	2	2000
Biological	recombinant interleukin-12	2	1999
Drug	rhil-15	2	2018
Drug	sargramostim (gm-csf)	2	2006
Drug	selumetinib	2	2007
Drug	sgn-cd33a	2	2013
Drug	sitagliptin	2	2009
Other	skin biopsy	2	2014
Drug	solu-medrol	2	2011
Other	standard care	2	2017
Other	standard leukemia care	2	2017
Drug	supportive care	2	2013
Genetic	t-cell infusion	2	2012
Biological	t cell-depleted hematopoietic stem cell transplantation	2	2009
Drug	talazoparib	2	2014
Behavioral	telephone-based intervention	2	2019
Drug	teniposide	2	2009
Biological	therapeutic immune globulin	2	2008
Biological	therapy	2	2005
Drug	tirabrutinib	2	2016
Radiation	tomotherapy	2	2007
Drug	tosedostat	2	2012
Radiation	total-body irradiation (tbi)	2	2009
Radiation	total marrow	2	2017
Radiation	total marrow/lymphoid irradiation	2	2017
Drug	tranylcypromine	2	2016
Drug	treatment choice	2	2016
Biological	trivalent influenza vaccine	2	2015
Biological	ucart19	2	2016
Biological	umbilical cord blood	2	2013
Drug	uproleselan	2	2018
Drug	valganciclovir	2	2010
Drug	vincristine liposomal	2	2018
Drug	vyxeos	2	2019
Procedure	white blood cell transfusion	2	2009
Biological	wt1 peptide vaccine	2	2010
Radiation	yttrium y 90 anti-cd45 monoclonal antibody bc8	2	2011
Radiation	yttrium y 90 epratuzumab	2	1999
Drug	zosuquidar	2	2005
Drug	- rituximab	1	2014
Drug	-1	1	2016
Drug	-4	1	2016
Drug	-5	1	2016
Biological	-enriched	1	2019
Drug	“prophylactic” delayed activated donor lymphocyte infusion	1	2006
Drug	“prophylactic” delayed adli	1	2006
Procedure	(clinimacs) t-cell depleted pbsc transplant	1	2010
Drug	)xk469	1	2004
Biological	10 mg	1	2012
Biological	10 mg/kg tru-016 / rituximab	1	2012
Drug	111in ibritumomab	1	2011
Drug	15 mg	1	2010
Drug	15 mg/kg tru-016/bendamustine	1	2010
Drug	17-n-allylamino-17-demethoxygeldanamycin	1	2006
Drug	17-n-allylamino-17-demethoxygeldanamycin/bortezomib	1	2006
Drug	18f flt	1	2011
Drug	2’-f-ara-deoxyuridine	1	2008
Drug	2-chlorodeoxyadenosine (cda) daily	1	1999
Drug	2-chlorodeoxyadenosine weekly	1	1999
Biological	20-car vector-transduced t cells	1	2017
Biological	20 mg/kg tru-016 / rituximab	1	2012
Drug	20 mg/kg tru-016/bendamustine	1	2010
Biological	22	1	2018
Biological	22-car vector-transduced t cells	1	2017
Biological	22 car t cells	1	2017
Drug	2cda	1	2014
Drug	2cda //- rituximab	1	2014
Device	3’-deoxy-3’-[18f]fluorothymidine	1	2009
Drug	3 day thiarabine	1	2010
Drug	3 scheme): daunorubicin, cytarabine	1	2009
Drug	3,	1	2016
Drug	300 mg oral azacitidine	1	2012
Drug	4	1	2016
Biological	4scar-cd22	1	2019
Biological	4scar-cd22/cd123/cd38/cd10/cd20/tslpr	1	2019
Drug	5-azacytidine (5-aza)	1	2006
Drug	5-fluoro-2-deoxycytidine	1	2009
Drug	5 azacytidine	1	2009
Drug	5 azacytidine - valproic acid- retinoic acid	1	2006
Drug	5 day thiarabine	1	2010
Drug	5ac	1	2011
Drug	6-mercaptopurine (6-mp)	1	2005
Drug	6-mercaptopurine.	1	2018
Drug	6-mp	1	2009
Drug	6-mp (6-mercaptopurine)	1	2013
Drug	6 mercaptopurine	1	2009
Drug	6mp	1	2014
Drug	6mpfixed	1	2008
Drug	6mpindividualized	1	2008
Drug	7-hydroxystaurosporine (ucn-01)	1	2000
Drug	8-chloro-adenosine	1	2008
Drug	8-chloroadenosine	1	2015
Drug	8-matched unrelated donors	1	2012
Drug	800 mg	1	2007
Drug	9-aminocamptothecin (9-ac)	1	2005
Drug	90y ibritumomabtiuxetan	1	2011
Biological	ab-110	1	2018
Drug	abatacept	1	2009
Drug	abbv-744	1	2017
Drug	abiraterone	1	2019
Drug	abl001 / nilotinib	1	2014
Drug	abl001/dasatinib	1	2014
Drug	abl001/imatinib	1	2014
Procedure	ablative allogeneic hematopoietic cell transplant	1	2005
Drug	abt-348	1	2010
Drug	abt-348/azacitidine	1	2010
Drug	acadesine	1	2007
Drug	acalabrutinib (acp-196)	1	2016
Drug	acalabrutinib 100 mg oral capsule	1	2019
Biological	acellular pertussis vaccine adsorbed	1	2015
Drug	aclacinomycin, cytarabine	1	2017
Drug	acp-196	1	2015
Drug	acp-319	1	2014
Biological	activated	1	2014
Biological	activated/expanded natural killer cells (nkaes)	1	2014
Other	active comparator	1	2016
Drug	active comparator (no fludarabine)	1	2009
Device	active tdcs	1	2019
Behavioral	activity	1	2016
Other	activity monitor	1	2019
Behavioral	activity/exercise intervention	1	2016
Drug	actonel (risedronate)	1	2007
Other	acute lymphobastic leukemia (all) treatment options	1	2015
Drug	acy-1215	1	2016
Drug	acyclovir	1	2003
Biological	adct-602	1	2018
Behavioral	adherence-encouraging interventions - group meeting	1	2013
Behavioral	adherence-encouraging interventions - individual meetings	1	2013
Behavioral	adherence-encouraging interventions - monthly phone calls	1	2013
Behavioral	adherence aids	1	2017
Procedure	adjuvant therapy	1	2005
Drug	administration of azd6738	1	2013
Device	administration of hyperbaric oxygen	1	2014
Biological	adult differentiated autologous t-cells	1	2017
Other	aerobic capacity	1	2008
Behavioral	aerobic exercises	1	2017
Drug	afatinib	1	2019
Drug	ag-013736 (axitinib)	1	2003
Drug	ag-120 (baml-16-001-s16)	1	2016
Drug	ag-120 (ivosidenib) with azacitidine	1	2017
Drug	ag-221 (baml-16-001-s3)	1	2016
Drug	aida	1	2007
Drug	alemtuzumab (campath 1h) associated to g-csf	1	2008
Drug	alemtuzumab (mabcampath)	1	2005
Biological	alemtuzumab i.v.	1	2008
Biological	alemtuzumab s.c.	1	2008
Drug	alemtuzumab/fludarabine	1	2005
Drug	alentuzumab	1	2006
Drug	all-trans-retinoid acid	1	2005
Drug	all-trans retinoid acid	1	2005
Drug	all-transretinoic acid	1	2017
Drug	all trans retinoic acid (vesanoid)	1	2009
Biological	allodepleted t cells	1	2008
Procedure	allogeneic blood	1	2005
Procedure	allogeneic blood stem cell transplant	1	2009
Procedure	allogeneic blood/bone marrow transplantation	1	2005
Procedure	allogeneic bone marrow	1	2002
Procedure	allogeneic bone marrow transplant	1	1999
Biological	allogeneic cart-19	1	2016
Biological	allogeneic cd123car-cd28-cd3zeta-egfrt-expressing t-lymphocytes	1	2014
Biological	allogeneic cd34	1	2019
Biological	allogeneic cd34-positive enriched peripheral blood stem cells	1	2019
Biological	allogeneic cd34/-enriched/cd45ra-depleted pbscs	1	2019
Biological	allogeneic cd56-positive cd3-negative natural killer cells	1	2013
Procedure	allogeneic cell transplantation	1	2003
Biological	allogeneic cytomegalovirus-specific cytotoxic t lymphocytes	1	2011
Biological	allogeneic epstein-barr virus-specific cytotoxic t lymphocytes	1	2000
Procedure	allogeneic hct	1	2002
Procedure	allogeneic hematopoietic stem-cell-transplantation	1	2009
Procedure	allogeneic hematopoietic stem cell transplant (allo-hsct)	1	2019
Procedure	allogeneic hematopoietic stem cell transplantation (hsct)	1	2013
Biological	allogeneic hematopoietic stem cell transplantation (naive t cell-depleted pbsc)	1	2018
Biological	allogeneic hematopoietic stem cell transplantation (unmanipulated t cell replete bm)	1	2018
Other	allogeneic hla-identical sibling transplantation	1	2012
Other	allogeneic matched related	1	2012
Other	allogeneic matched related/unrelated donor transplant.	1	2012
Biological	allogeneic natural killer cell line nk-92	1	2016
Procedure	allogeneic pbsct	1	2008
Procedure	allogeneic pbsct/bmt	1	2008
Procedure	allogeneic related stem cell transplant	1	2011
Procedure	allogeneic stem cell infusion	1	2012
Procedure	allogeneic stem cell transplant	1	2009
Other	allogeneic stem cell transplantation with a haplo-identical family donor graft	1	2019
Other	allogeneic stem cell transplantation with a matched unrelated donor graft	1	2019
Procedure	allogeneic transplant	1	2013
Procedure	allogeneic transplantation	1	2011
Drug	allogenic nk cells infusion	1	2013
Drug	allogenic stem cell transplant (asct)	1	2007
Procedure	allogenic transplantation	1	2007
Biological	alloreactive nk cell infusion	1	2019
Procedure	alloreactive nk infusion	1	2006
Biological	allostim	1	2007
Drug	alrn-6924	1	2016
Drug	alrn-6924 in combination with cytarabine	1	2016
Biological	alt803	1	2016
Drug	alternative anti-cancer treatment	1	2012
Drug	alternative anticancer treatment	1	2012
Procedure	alternative medicine procedure	1	2003
Drug	alvespimycin hydrochloride	1	2004
Drug	alvocidib (flavopiridol)	1	2019
Drug	alvocidib (flavopiridol)/cytarabine (ara-c)	1	2019
Drug	alvocidib hydrochloride	1	2008
Drug	ambisome	1	2006
Drug	amg 176	1	2015
Drug	amg 232	1	2013
Drug	amg 319	1	2011
Drug	amg 397	1	2018
Drug	amg 427	1	2018
Drug	amg 673	1	2017
Drug	aminolevulinic acid hydrochloride	1	2003
Drug	aml induction	1	2016
placebo	aml induction (placebo)	1	2016
Drug	amn107	1	2005
Drug	amonafide l-malate	1	2006
Drug	amp	1	2010
Drug	amufostine (ethyol)	1	2004
Biological	amv564	1	2017
Combination Product	amv564 in combination with pembrolizumab	1	2017
Drug	anidulafungin 200 mg q48h	1	2010
Drug	anidulafungin 300 mg q72h	1	2010
Other	ankle range of motion	1	2008
Device	anodal tdcs treatment	1	2019
Biological	anti-cd123-car-transduced t cells	1	2016
Biological	anti-cd19- car	1	2012
Biological	anti-cd19 car-t cells injection	1	2019
Combination Product	anti-cd19 car transduced t cells	1	2017
Biological	anti-cd19/20-car vector-transduced t cells	1	2017
Biological	anti-cd19/22-car vector-transduced t cells	1	2017
Biological	anti-cd19/cd22 car-t cells	1	2019
Biological	anti-cd20-car-transduced t cells	1	2015
Biological	anti-cd22 immunotoxins	1	2007
Drug	anti-cd45	1	2003
Biological	anti-endosialin	1	2012
Biological	anti-endosialin/tem1 monoclonal antibody morab-004	1	2012
Drug	anti-lymphocyte globulin	1	2015
Biological	anti-ox40 agonist monoclonal antibody pf-04518600	1	2017
Drug	anti-pr1	1	2015
Drug	anti-pr1/hla-a2 monoclonal antibody hu8f4	1	2015
Drug	anti-tac(fv)-pe38 (lmb-2) immunotoxin	1	2006
Drug	anti-thymocyte globulin (atg)	1	2018
Drug	anti-thymocyte globulin iv	1	2008
Drug	antibodies as follows:	1	2005
Procedure	antibody-drug conjugate therapy	1	2005
Other	antitumor drug screening assay	1	2013
Drug	antroquinonol	1	2019
Drug	aop2014	1	2017
Drug	aop2014 / pegylated-proline-interferon alpha-2b	1	2017
Drug	apixaban	1	2015
Drug	apo866	1	2007
Procedure	application of activated donor t cells	1	2007
Drug	apto-253	1	2014
Drug	apx001 with standard of care anti-fungal agent	1	2017
Drug	ar-42	1	2010
Drug	ara-c (cytarabine)	1	2009
Drug	ara-c (cytosine arabinoside)	1	2006
Drug	ara-c, mitoxantrone, daunorubicin, thioguanin	1	2011
Drug	arginine butyrate	1	2000
Drug	argx-110	1	2017
Device	arm 1	1	2019
Drug	arm 1- dose escalation	1	2011
Drug	arm 2- dose expansion	1	2011
Drug	arm a mylotarg	1	2014
Drug	arm a mylotarg/da versus cpx-351	1	2014
Drug	arm b vosaroxin	1	2014
Drug	arm b vosaroxin/decitabine	1	2014
Drug	arm c da v flag-ida v dac	1	2014
Drug	arm d small molecule	1	2014
Drug	arm d small molecule/not	1	2014
Drug	arm e cpx-351 (200 v 300)	1	2014
Drug	arm f da v idac	1	2014
Drug	arm ii	1	2007
Procedure	aromatherapy	1	2015
Procedure	aromatherapy/essential oils	1	2015
Drug	arq 531	1	2017
Drug	arry-520, ksp(eg5) inhibitor; intravenous	1	2008
Drug	arsenic	1	2012
Drug	arsenic trioxide (ato)	1	2006
Biological	as01b	1	2013
Drug	as1411	1	2007
Drug	ascentage pharma hqp1351 bioavailable inhibitor	1	2019
Drug	asciminib add-on	1	2018
Drug	aslan003	1	2018
Drug	asp	1	2009
Drug	asp1235	1	2016
Biological	asp7517	1	2019
Procedure	aspirate	1	2017
Drug	astarabine (bst-236)	1	2015
Biological	astatine at 211 anti-cd45 monoclonal antibody bc8-b10	1	2018
Drug	astx030 (cedazuridine	1	2020
Drug	astx030 (cedazuridine / azacitidine)	1	2020
Drug	astx660	1	2019
Drug	astx727 / day 2 food	1	2019
Drug	astx727 / day 4 food	1	2019
Drug	at7519m	1	2012
Biological	atg (rabbit)	1	2019
Drug	atg (thymoglobulin)	1	2009
Drug	atg fresenius (anti-lymphocyte-globulin)	1	2008
Drug	atg thymoglobulin	1	2013
Biological	atir	1	2013
Drug	ato	1	2014
Drug	atorvastatin calcium	1	2012
Drug	atovaquone	1	2018
Drug	atra/6-mp/mtx	1	2009
Drug	atra/arsenic	1	2012
Drug	atra/chemo	1	2012
Other	attention test	1	2019
Drug	atuveciclib, bay1143572	1	2015
Drug	auranofin	1	2011
Biological	auto-hsct	1	2018
Biological	auto1	1	2020
Biological	auto3 (cd19	1	2017
Biological	auto3 (cd19/22 car t cells	1	2017
Biological	autologous	1	2008
Procedure	autologous-autologous tandem hematopoietic stem cell transplantation	1	2007
Biological	autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes	1	2013
Biological	autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes	1	2014
Biological	autologous cd19-targeting car t cells	1	2019
Biological	autologous cd19 car	1	2012
Biological	autologous cd19 car/ egftt / t cells	1	2012
Biological	autologous cd19car-cd28-cd3zeta-egfrt-expressing tn	1	2014
Biological	autologous cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes	1	2014
Biological	autologous cik cell infusion	1	2008
Biological	autologous dendritic cells electroporated with wt1 mrna	1	2017
Biological	autologous epstein-barr virus-specific cytotoxic t lymphocytes	1	2000
Drug	autologous fecal microbiota transplantation	1	2016
Procedure	autologous hct	1	2002
Procedure	autologous hematopoietic cell transplantation	1	2010
Procedure	autologous hsct	1	2018
Biological	autologous human anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4	1	2017
Biological	autologous human anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4//cd8/ t-lymphocytes	1	2017
Biological	autologous humanized anti-cd22 chimeric antigen receptor t cells	1	2020
Biological	autologous multi-lineage potential cells (ampc)	1	2019
Other	autologous nk cells infusions	1	2014
Procedure	autologous pbsct	1	2005
Other	autologous peripheral blood stem cell transplantation.	1	2012
Biological	autologous tumor cells	1	2005
Biological	autologous wt1-tcrc4 gene-transduced cd8-positive tcm	1	2016
Biological	autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes	1	2016
Genetic	autologous wt1 tcr transduced t cells	1	2015
Biological	autologous/syngeneic pbtls/ebv-ctls	1	2008
Drug	avl-292	1	2011
Drug	avn-944 capsules for oral administration	1	2006
Drug	axitinib	1	2016
Drug	azacitidine (aza)	1	2011
Drug	azacitidine (baml-16-001-s16)	1	2016
Drug	azacitidine (baml-16-001-s2)	1	2016
Drug	azacitidine (baml-16-001-s3)	1	2016
Drug	azacitidine (baml-16-001-s4)	1	2016
Drug	azacitidine (baml-16-001-s9)	1	2016
Drug	azacitidine 75 mg	1	2016
Drug	azacitidine 75 mg/m^2	1	2016
Drug	azacitidine injection	1	2019
Drug	azacitidine)	1	2020
Drug	azacitidine/eltrombopag	1	2011
Drug	azacitidine/venetoclax	1	2018
Drug	azd2811	1	2017
Drug	azd4573	1	2017
Drug	azd5991	1	2017
Drug	azd5991 / venetoclax	1	2017
Drug	azd6738	1	2018
Drug	bactrim	1	2005
Drug	bafetinib	1	2010
Drug	bay1436032	1	2017
Drug	bay2402234	1	2017
Drug	bcl-2 inhibitor gdc-0199	1	2015
Biological	bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine	1	2007
Biological	bcr-abl peptide vaccine	1	1999
Drug	bcr-abl tyrosine kinase inhibitor (tki)	1	2018
Drug	bcx-1777	1	2002
Drug	becatecarin	1	2004
Other	bedside assessment	1	2016
Behavioral	behavioral intervention	1	2012
Other	behavioral, psychological	1	2019
Other	behavioral, psychological/informational intervention	1	2019
Drug	benadryl	1	2009
Drug	benadryl/tylenol	1	2009
Drug	bendamustine at a dose of 100 mg	1	2011
Drug	bendamustine at a dose of 100 mg/m2	1	2011
Drug	bendamustine at a dose of 120 mg	1	2011
Drug	bendamustine at a dose of 120 mg/m2	1	2011
Drug	bendamustine hydrochloride injection	1	2010
Drug	bendamustine, rituximab, lenalidomide	1	2011
Drug	bendamustine/lenalidomide	1	2009
Drug	best available care	1	2018
Drug	best available therapy	1	2020
Drug	beyond according to investigator choice.	1	2011
Biological	bi-1206 single agent dose escalation phase	1	2016
Biological	bi-1206 single agent expansion phase	1	2016
Drug	bi 2536	1	2008
Drug	bi 6727 (d1	1	2008
Drug	bi 6727 (d1/15)	1	2008
Drug	bi 811283 (d 1	1	2008
Drug	bi 811283 (d 1/15)	1	2008
Drug	bi 811283 (d1)	1	2008
Biological	bi 836858 (baml-16-001-s2)	1	2016
Drug	bicanorm	1	2020
Procedure	bioelectric impedance analysis	1	2013
Drug	bisantrene	1	2019
Radiation	bismuth bi213 monoclonal antibody m195	1	2001
Drug	biweekly-chop with g-csf	1	2005
Drug	biweekly-chop with g-csf/intrathecal prophylaxis	1	2005
Drug	bkm120	1	2011
Drug	bl-nhl	1	2009
Drug	bl22	1	2003
Biological	blinatumomab (mt103)	1	2007
Biological	blinatumomab expanded t-cells (bet)	1	2019
Drug	blinatumomab in combination with donor lymphocyte infusion	1	2019
Drug	blinatumomab injection	1	2018
Procedure	blood	1	2019
Procedure	blood cell transplantation	1	1999
Other	blood pressure	1	2014
Procedure	blood test	1	2007
Other	blood test, urine test,	1	2007
Other	blood test, urine test,/bone density x-ray.	1	2007
Procedure	blood/marrow transplant (bmt)	1	2019
Drug	blr-cll	1	2009
Drug	blr-nhl	1	2009
Drug	bmn 673	1	2011
Drug	bms-214662	1	2000
Drug	bms-833923	1	2010
Drug	bms-906024	1	2011
Drug	bms-936564 (anti-cxcr4)	1	2010
Procedure	bmt	1	2008
Drug	bnz132-1-40	1	2017
Other	body composition/vital signs	1	2008
Other	bone density x-ray.	1	2007
Other	bone marrow aspirate	1	2014
Procedure	bone marrow biopsy/aspirate	1	2017
Procedure	bone marrow for correlative studies	1	2013
Biological	bone marrow sample	1	2015
Other	bone marrow transplant (bmt)	1	2019
Drug	bortezomib 1.0mg	1	2006
Drug	bortezomib 1.0mg/m^2	1	2006
Drug	bortezomib 1.3mg	1	2006
Drug	bortezomib 1.3mg/m^2	1	2006
Drug	bortezomib injection	1	2020
Drug	bortezomib with mitoxantrone, etoposide	1	2006
Drug	bortezomib with mitoxantrone, etoposide/cytarabine	1	2006
Dietary Supplement	bovine colostrum	1	2013
Drug	bp1001	1	2010
Drug	bp1001 in combination with ldac	1	2010
Biological	bpx-501 dose 1	1	2012
Biological	bpx-501 dose 2	1	2012
Biological	bpx-501 dose 3	1	2012
Biological	bpx-501 dose 4	1	2012
Drug	br/ibrutinib	1	2019
Other	brain games stimulation	1	2014
Drug	brd4 inhibitor plx51107	1	2019
Drug	brequinar	1	2018
Drug	brequinar / ribavirin	1	2018
Other	bsc	1	2015
Behavioral	bsma	1	2015
Drug	bst-236	1	2018
Drug	btct4465a (mosunetuzumab) iv	1	2015
Drug	btct4465a (mosunetuzumab) sc	1	2015
Drug	btx-a51	1	2020
Drug	bucy vs buflu	1	2008
Drug	buparlisib	1	2015
Other	buschke selective reminding test	1	2019
Drug	busulfan-cyclophosphamide as conditioning regimen before allogeneic hematopoietic stem cell transplantation	1	2013
Procedure	busulfan pharmacokinetics	1	2005
Other	busulfan plasma level measurements	1	2015
Drug	busulfan plus	1	2011
Drug	busulfan x 4	1	2011
Drug	busulfan, fludarabine, cytoxan	1	2008
Drug	busulfan, melphalan, fludarabine, anti-thymocyte globulin, palifermin, stem cell transplant	1	2008
Drug	busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf	1	2007
Drug	busulphan	1	2019
Drug	bvd-523	1	2014
Procedure	c	1	2009
Biological	c-myb antisense oligonucleotide g4460	1	1999
Drug	c14 azd1152	1	2009
Drug	ca-4948	1	2020
Drug	cabazitaxel	1	2019
Drug	cag regimen (aclacinomycin, cytarabine, with	1	2015
Drug	cag regimen (aclacinomycin, cytarabine, with/w/o g-csf)	1	2015
Drug	cal-101	1	2008
Dietary Supplement	calcium	1	2007
Drug	calcium carbonate (tums), vitamin d	1	2005
Dietary Supplement	calcium citrate	1	2011
Drug	campath-1 h (alemtuzumab)	1	2002
Biological	campath]	1	2004
Drug	capecitabine	1	2010
Drug	capotenâ®	1	2017
Biological	car-t cell immunotherapy	1	2018
Biological	car-t cell therapy	1	2019
Biological	car-t cells	1	2019
Biological	car-t infusion	1	2019
Biological	car-t19	1	2019
Biological	car-t19/car-t22	1	2019
Biological	car-t22	1	2019
Biological	car t-cell therapy	1	2019
Biological	car.19	1	2017
Biological	carcik-cd19	1	2017
Behavioral	cardiorespiratory assessment	1	2007
Drug	care supports	1	2016
Biological	cart-19/22	1	2018
Biological	cart-38	1	2020
Biological	cart 19	1	2016
Biological	cart therapy in acute myeloid leukemia(aml)	1	2018
Biological	cart123 cells; cyclophosphamide; fludarabine	1	2018
Biological	cart19 cell	1	2018
Biological	cart19 cell/auto-hsct	1	2018
Biological	cart22-65s cells	1	2018
Biological	cart22 cells transduced with a lentiviral vector to express anti-cd22 scfv tcrz:41bb	1	2015
Drug	carvedilol	1	2010
Drug	caspofungin	1	2007
Drug	cat-8015 (moxetumomab pasudotox)	1	2008
Drug	cat-8015 20 mcg	1	2009
Drug	cat-8015 20 mcg/kg	1	2009
Drug	cat-8015 30 mcg	1	2009
Drug	cat-8015 30 mcg/kg	1	2009
Drug	cat-8015 40 mcg	1	2009
Drug	cat-8015 40 mcg/kg	1	2009
Drug	cat-8015 50 mcg	1	2009
Drug	cat-8015 50 mcg/kg	1	2009
Drug	cat-8015 60 mcg	1	2009
Drug	cat-8015 60 mcg/kg	1	2009
Drug	cat 8015 (moxetumomab pasudotox)	1	2007
Device	cathodal tdcs treatment	1	2019
Drug	cb-5339	1	2020
Drug	cb-839	1	2014
Drug	cb-aza	1	2014
Drug	cc-1088	1	2000
Drug	cc-122	1	2015
Drug	cc-90009	1	2016
Biological	cd10	1	2019
Biological	cd123	1	2019
Drug	cd123-car t	1	2020
Biological	cd123-cd33 ccar t cells	1	2019
Biological	cd123-specific gene-engineered t cells	1	2017
Biological	cd123car-41bb-cd3zeta-egfrt-expressing t cells	1	2017
Biological	cd19- specific car engineered autologous t-cells (sjcar19 product)	1	2018
Biological	cd19-car-t cells	1	2018
Biological	cd19-tricar-t	1	2019
Biological	cd19-tricar-t/silk	1	2019
Biological	cd19 car t-cells	1	2015
Combination Product	cd19 cart	1	2019
Biological	cd19 ucartcells	1	2019
Biological	cd19.car t cells	1	2018
Biological	cd19/	1	2019
Biological	cd19/cd22 car t-cells	1	2018
Genetic	cd19car	1	2009
Genetic	cd19car-28-zeta t cells	1	2007
Biological	cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t-lymphocytes	1	2014
Biological	cd19car-cd28-cd3zeta-egfrt-expressing tn	1	2014
Biological	cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes	1	2014
Genetic	cd19car/virus specific t cells	1	2009
Biological	cd19cat-41bbz car t-cells	1	2016
Drug	cd22 car-t cell immunotherapy	1	2019
Biological	cd22 car t-cells	1	2018
Biological	cd22 specific car	1	2017
Biological	cd25hi treg depleted dli	1	2019
Biological	cd28 stimulated t cells	1	2009
Biological	cd3-depleted	1	2011
Biological	cd3-depleted/cd56/ selected natural killer cells collected from apheresis products	1	2011
Biological	cd33	1	2017
Biological	cd33cart	1	2019
Other	cd34/ selection	1	2012
Biological	cd34/ selection with clinimacs device	1	2005
Other	cd34/ selection.	1	2012
Biological	cd4	1	2017
Other	cd4 dli	1	2010
Biological	cd40 ligand	1	2007
Biological	cd40 ligand/il-2-expressing tumor cells vaccine	1	2007
Biological	cd45ra-depleted dli	1	2019
Biological	cd45ra-depleted pbscs	1	2019
Biological	cd45ra-depleted peripheral blood mononuclear cells	1	2015
Device	cd45ra depleted peripheral stem cell addback	1	2019
Biological	cd4car	1	2018
Biological	cd7-specific car gene-engineered t cells	1	2019
Drug	cd7 car-t cells infusion	1	2019
Drug	cd8/ memory t cell selection	1	2019
Biological	cd8//cd4/ donor memory t-cells-expressing ha1-specific tcr	1	2017
Drug	cdiag regimen	1	2019
Drug	cedazuridine	1	2020
Drug	cediranib, azd2171, recentin	1	2006
Drug	cefepime hydrochloride	1	2011
Drug	cefepime injection	1	2019
Drug	ceftazidime injection	1	2019
Drug	celecoxib	1	2019
Drug	cellcept	1	2018
Drug	cenersen	1	2003
Radiation	central nervous system (cns) prophylaxis radiation	1	2005
Drug	cep-701	1	2004
Drug	cep-701 40mg	1	2002
Drug	cep-701 60mg	1	2002
Drug	cep-701 80mg	1	2002
Drug	cephalexin	1	2013
Drug	ceralasertib	1	2017
Drug	cerdulatinib (prt062070)	1	2013
Drug	cerubidine	1	2009
Drug	cfi-400945 fumarate	1	2017
Drug	chemo	1	2012
Drug	chemoimmunotherapy	1	2019
Other	chemosensitivity assay	1	2015
Drug	chemotherapy (aracytine	1	2009
Drug	chemotherapy (aracytine / daunorubicin)	1	2009
Drug	chemotherapy (daunorubicine-cytarabine)	1	2007
Drug	chemotherapy / blinatumomab	1	2017
Biological	chemotherapy starting	1	2016
Procedure	chemotherapy, intrathecal chemotherapy	1	2005
Drug	chep	1	2017
Biological	chimeric antigen receptor modified t cells targeting cd19	1	2015
Biological	chimeric antigen receptor t cell	1	2020
Biological	chimeric antigen receptor t cells	1	2017
Drug	chk1 inhibitor sch 900776	1	2013
Procedure	chlorhexidine gluconate skin cleanser	1	2013
Drug	choline magnesium trisalicylate	1	2014
Drug	chop-daclizumab	1	2011
Drug	chop regimen	1	2003
Drug	chr-2797 (tosedostat): aminopeptidase inhibitor	1	2008
Biological	chronic myeloid leukemia	1	2017
Biological	chronic myeloid leukemia / nk cell	1	2017
Drug	ciclophosphamide	1	2014
Drug	ciclopirox olamine	1	2009
Drug	cik-cells	1	2016
Drug	cilengitide	1	2000
Biological	ciml nk	1	2019
Drug	ciprofloxacin	1	2016
Drug	cisplatin	1	1999
Drug	cladribine s.c. injection, hcl treatment	1	2014
Drug	cladribine, cyclophosphamide, cytarabine, daunorubicin, dexamethasone	1	2005
Drug	cladribine, cytarabine,	1	2019
Drug	cladribine, cytarabine, mitoxantrone, g-csf (clag-m) regimen	1	2017
Drug	cladribine, cytarabine,/granulocyte-colony stimulating factor with fractionated gemtuzumab ozogamicin (clag-go)	1	2019
Drug	clag regimen	1	2009
Drug	clara	1	2009
Device	clinimacs cd34	1	2014
Device	clinimacs cd34 selection system	1	2014
Device	clinimacs cd34/ reagent system	1	2014
Device	clinimacs cell processing system for tcrî±î²	1	2019
Device	clinimacs cell processing system for tcrî±î² / t cell/cd45ra depleted peripheral stem cell addback	1	2019
Device	clinimacs system	1	2005
Device	clinimacs tcr alpha-beta-biotin system	1	2015
Biological	cll-1, cd33 and	1	2019
Biological	cll-1, cd33 and/or cd123-specific car gene-engineered t cells	1	2019
Biological	cll1	1	2017
Biological	cll1-cd33 ccar t cells	1	2019
Drug	clofarabine for remission induction	1	2009
Drug	clofarabine in conditioning before transplantation	1	2009
Drug	clofarabine incorporated into a 5-drug regimen	1	2009
Drug	clofarabine vp 16 ciclophospahamide	1	2011
Drug	clofarabine with busulfan	1	2009
Drug	clofarabine, cyclophosphamide	1	2011
Drug	clofarabine, methotrexate, mercaptopurine, dexamethasone, etoposide, dasatinib	1	2007
Drug	clofarabine/busulfan x 4	1	2011
Drug	clofarabine/cytarabine	1	2006
Biological	clt-008	1	2014
Biological	cm-cs1 t-cell infusion	1	2014
Drug	cmc-544 (inotuzumab ozogamycin)	1	2010
Biological	cmvpp65-a*0201 peptide vaccine	1	2015
Drug	co-argi-peg modified human arginase i	1	2016
Drug	cobimetinib	1	2016
Drug	cobomarsen	1	2015
Other	cognitive assessment	1	2014
Behavioral	cognitive behavior therapy	1	2018
Biological	collection of blood samples	1	2015
Other	collection of leukemia cells	1	2008
Procedure	collection of pbmcs	1	2013
Procedure	collection of treatment-stratefying prognostic factors	1	2005
Biological	combination of bi-1206 with rituximab	1	2016
Drug	combination therapy using decitabine	1	2010
Drug	combination therapy using decitabine/midostaurin	1	2010
Drug	combined use of azacitidine, valproic acid, hydroxurea	1	2011
Drug	combined use of azacitidine, valproic acid, hydroxurea/eventually donor leukocyte infusions.	1	2011
Procedure	complementary	1	2003
Procedure	complementary/alternative medicine procedure	1	2003
Behavioral	compliance monitoring	1	2012
Other	compliance supporting measures	1	2010
Drug	compound ac220	1	2009
Drug	conditioning chemotherapy	1	2007
Drug	conditioning treatment “thiotepa-treosulfan-fludarabine”	1	2018
Drug	consolidation chemotherapy	1	2013
Drug	conventional care	1	2016
Drug	conventional care regimen	1	2010
Drug	conventional chemotherapy (arac	1	2009
Drug	conventional chemotherapy (arac / daunorubicin),	1	2009
Procedure	conventional surgery	1	2001
Biological	conventional t cells (tcon)	1	2012
Biological	conventional t cells (tcon)/regulatory t cells (treg)	1	2012
Drug	cop, copadm8, cyve	1	2010
Drug	cop, copd m3, cym	1	2010
Drug	copad	1	2010
Drug	copanlisib hydrochloride	1	2019
Biological	cord blood	1	2011
Biological	cord blood stem cells	1	2019
Other	cord blood unit	1	2016
Drug	cordycepin	1	1999
Other	correlative laboratory samples	1	2012
Drug	corticosteroid	1	2009
Drug	corticosteroids	1	2011
Drug	cp-461	1	2002
Drug	cpg 7909	1	2005
Drug	cpi-613 / high dose cytarabine/mitoxantrone	1	2018
Radiation	cranial radiation	1	2005
Drug	crenolanib besylate (cp-868,596-26)	1	2012
Drug	csl360	1	2006
Biological	csl362	1	2012
Procedure	ct guided bone marrow sampling	1	2016
Device	ct/pet scans	1	2013
Drug	ct053ptsa	1	2017
Drug	ct53518	1	2003
Biological	cta101	1	2019
Biological	ctl019 t-cells	1	2014
Drug	ctx	1	2014
Drug	curcumin	1	2014
Drug	cxcr4 antagonist	1	2015
Biological	cyad-02	1	2019
Drug	cyc065	1	2018
Drug	cyc140	1	2018
Drug	cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic stem cell transplantation	1	2013
Drug	cyclophosphamide (non-imp)	1	2020
Drug	cyclophosphamide 14.5 mg	1	2016
Drug	cyclophosphamide 14.5 mg/kg/day iv on days -6, -5	1	2016
Drug	cyclophosphamide 50mg/kg/day iv on days -2,-1	1	2016
Drug	cyclophosphamide 50mg/kg/day iv on days -5,-4	1	2016
Drug	cyclophosphamide based chemotherapy regimens	1	2013
Drug	cyclophosphamide for remission induction	1	2009
Drug	cyclophosphamide)	1	2014
Drug	cyclophosphamide, fludarabine, clofarabine, etoposide, interleukin-2	1	2005
Drug	cyclosporin-a	1	2007
Drug	cyclosporine a (csa)	1	2007
Drug	cyclosporine ophthalmic emulsion	1	2008
Drug	cyclosporins	1	2009
Drug	cyproheptadine hydrochloride	1	2003
Drug	cytarabine (baml-16-001-s1)	1	2016
Drug	cytarabine (baml-16-001-s6)	1	2016
Drug	cytarabine arabinoside	1	2010
Drug	cytarabine dosage	1	2005
Drug	cytarabine induction	1	2019
Drug	cytarabine regimen	1	2019
Drug	cytarabine vs. cytarabine	1	2005
Drug	cytarabine vs. cytarabine/amsacrine/mitoxantrone	1	2005
Drug	cytarabine, all-trans retinoic acid, valproic acid	1	2009
Drug	cytarabine.	1	2002
Drug	cytarabine/mitoxantrone	1	2012
Drug	cytarabine/supportive care	1	2005
Biological	cytokine-induced killer cells	1	2013
Biological	cytokine-treated veto cells	1	2018
Other	cytokine assessment	1	2010
Other	cytology specimen collection procedure	1	2015
Biological	cytomegalovirus (cmv)-specific cytotoxic t cells (ctls)	1	2014
Drug	cytosar	1	2009
Drug	cytosin-arabinosid	1	2005
Drug	cytosine arabinoside (ara-c)	1	2005
Procedure	d-clag	1	2020
Drug	da versus cpx-351	1	2014
Drug	dacogen	1	2017
Drug	dacogen (decitabine) only	1	2005
Biological	dactinomycin	1	1999
Biological	darbopoetin	1	2006
Drug	dasatinib (sprycel)	1	2009
Drug	dasatinib (sprycelâ®)	1	2016
Drug	dasatinib / pegifn	1	2012
Drug	dasatinib, mitoxantrone, cytarabine	1	2009
Drug	daunorubicin (baml-16-001-s1)	1	2016
Drug	daunorubicin (baml-16-001-s6)	1	2016
Drug	daunorubicin (dnr)	1	2016
Drug	daunorubicin / cytarabine	1	2017
Drug	daunorubicin liposomal injection [daunoxome]	1	2018
Drug	daunorubicin)	1	2009
Drug	daunorubicin),	1	2009
Drug	daunorubicin, adriamycin	1	2005
Drug	daunorubicin, cytarabine	1	2017
Drug	daunorubicin, vincristine, prednisone, methotrexate, peg-asparaginase, 6-mercaptopurine, cytoxan, cytosine arabinoside, vm-26	1	2005
Drug	daunorubicin, vincristine, prednisone, methotrexate, peg-asparaginase, 6-mercaptopurine, cytoxan, cytosine arabinoside, vm-26/6-thioguanine	1	2005
Drug	daunorubicine	1	2018
Drug	daunoxome	1	2010
Drug	day	1	2011
Drug	day 2 food	1	2019
Drug	day 4 food	1	2019
Drug	day iv on days -2,-1	1	2016
Drug	day iv on days -5,-4	1	2016
Drug	day iv on days -6, -5	1	2016
Drug	day)	1	2007
Drug	day;	1	2007
Biological	dc vaccination for postremission therapy in aml	1	2012
Drug	dcc-2036	1	2009
Drug	dcdt2980s	1	2010
Drug	dcll9718s	1	2017
Drug	decadron	1	2009
Drug	decitabine (baml-16-001-s5)	1	2016
Drug	decitabine (baml-16-001-s8)	1	2016
Drug	decitabine (dac)	1	1999
Drug	decitabine (part 1 - completed)	1	2010
Drug	decitabine 15 mg	1	2009
Drug	decitabine 15 mg/m2 i.v.	1	2009
Drug	decitabine 20 mg	1	2015
Drug	decitabine 20 mg/m^2	1	2015
Drug	decitabine, homoharringtonine, aclarubicin, cytarabine	1	2019
Drug	decitabine, homoharringtonine, aclarubicin, cytarabine/g-csf	1	2019
Drug	decitabine/cytarabine	1	2013
Drug	decitabine/haag regimen	1	2019
Drug	decitabine/modified bucy	1	2017
Drug	deferasirox	1	2011
Biological	deglycosylated ricin a chain-conjugated anti-cd19	1	2007
Biological	deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins	1	2007
Other	demographic variables	1	2008
Biological	denileukin diftitox	1	2004
Drug	deoxycoformycin	1	1999
Drug	deoxycytidine	1	2000
Procedure	depleted haploidentical hsct	1	2015
Drug	dexametasone	1	2014
Drug	dexamethasona, idarubicine, ara-c, methotrexate	1	2011
Drug	dexamethasone acetate	1	2008
Drug	dexamethasone continuous	1	2017
Drug	dexamethasone intermittent	1	2017
Drug	dexamethasone/prednisolone	1	2005
Drug	dexamethosone	1	2004
Drug	dextromethorphan hydrobromide	1	1999
Drug	dhap	1	2012
Procedure	dhap rescue	1	2009
Procedure	dhap rescue/autologous stem cell transplantation	1	2009
Procedure	dhap rescue/f/c	1	2009
Other	diet	1	2017
Procedure	diffusion weighted imaging	1	2015
Biological	diphtheria toxoid	1	2015
Biological	diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed	1	2015
Other	dli of the 20 fraction of the ucbt	1	2014
Genetic	dna analysis	1	2012
Drug	dnr	1	2014
Biological	dnt cells	1	2017
Dietary Supplement	docosahexaenoic acid (dha)	1	2010
Biological	donor il-15 stimulated nk cells infusion	1	2018
Biological	donor leukocyte infusion (dli)	1	2011
Other	donor leukocytes	1	2017
Biological	donor lymphocyte infusions	1	2015
Biological	donor memory t-cells-expressing ha1-specific tcr	1	2017
Other	donor search prognosis score	1	2019
Biological	dose level 2- fixed dose	1	2004
Biological	dose level 3	1	2003
Biological	double umbilical cord blood transplant	1	2012
Biological	double umbilical cord blood unit transplant	1	2006
Dietary Supplement	doxercalciferol	1	2003
Drug	doxorubicin hydrochloride (hcl)	1	2013
Drug	doxorubicin, l-asparaginase, peg-l-asparaginase, erwinia asparaginase	1	2005
Drug	doxorubicine	1	2007
Drug	doxorubicine pegylated	1	2007
Other	drug withdrawn	1	2019
Combination Product	drugs	1	2017
Combination Product	drugs/anti-cd19 car transduced t cells	1	2017
Drug	ds-3201b	1	2017
Drug	dt388il3	1	2006
Biological	dtgm fusion protein	1	1999
Drug	dtrm-505	1	2016
Drug	dtrmwxhs-12	1	2016
Drug	dual specificity cd19	1	2019
Drug	dual specificity cd19/cd22 car-t cell immunotherapy	1	2019
Drug	during venetoclax	1	2019
Radiation	dynamic contrast-enhanced computed tomography	1	2014
Behavioral	dynamic muscular endurance	1	2007
Drug	e-coli l-asparaginase	1	2017
Drug	e. coli asparaginase	1	2005
Drug	e. coli asparaginase, peg-l-asparaginase	1	2005
Drug	e. coli l-asparaginase	1	2005
Drug	e.coli l-asparaginase	1	2013
Drug	e7070	1	2012
Drug	eagd t-cell infusion (expansion)	1	2018
Drug	eagd t-cell infusion (phase i)	1	2018
Procedure	early allogeneic pbsct within induction therapy	1	2005
Behavioral	ease	1	2015
Biological	ebv-ctls	1	2008
Biological	eculizumab	1	2005
Drug	edetate calcium disodium	1	2018
Drug	edicotinib	1	2018
Behavioral	education information system	1	2019
Other	education intervention	1	2015
Biological	egftt	1	2012
Drug	elacytarabine/idarubicin	1	2009
Other	electronic decision aid tool	1	2018
Drug	enalapril	1	2010
Drug	enalapril/carvedilol	1	2010
Drug	endotoxin	1	2009
Drug	endoxan	1	2019
Drug	entinostat days 10,17	1	2011
Drug	entinostat days 3, 10	1	2011
Drug	entospletinib (baml-16-001-s4)	1	2016
Drug	entospletinib (baml-16-001-s5)	1	2016
Drug	entospletinib (baml-16-001-s6)	1	2016
Drug	enzalutamide	1	2019
Drug	enzastaurin	1	2007
Drug	epirubicin	1	2017
Drug	epirubicin hydrochloride	1	2003
Drug	epoch-f	1	2007
Drug	erlotinib hydrochloride	1	2012
Drug	erwinaseâ®	1	2017
Drug	erythromycin	1	2015
Drug	erythropoetin	1	2010
Dietary Supplement	eskimo-3 pure fish oil	1	2019
Procedure	essential oils	1	2015
Drug	estramustine phosphate sodium	1	1999
Biological	et019003-t cells	1	2019
Biological	et190l1-artemisâ„¢ t cells - iv high dose	1	2019
Biological	et190l1-artemisâ„¢ t cells -iv low dose	1	2019
Biological	et190l1-artemisâ„¢ t cells -iv middle dose	1	2019
Drug	etoposid	1	2005
Drug	etoposide for remission induction	1	2009
Drug	etoposide, cytarabine, gemtuzumab, l-asparaginase, mercaptopurine, methotrexate, mitoxantrone, prednisone, vincristine	1	2005
Drug	etoposide, cytarabine, vincristine, dexamethasone	1	2005
Drug	etoposide, thioguanine, cyclophosphamide, busulfan, melphalan	1	2005
Drug	eventually donor leukocyte infusions.	1	2011
Drug	everolimus (rad001)	1	2009
Biological	ex-vivo expanded cord blood progenitor cell infusion	1	2009
Biological	ex-vivo expanded î³î´ t lymphocytes	1	2019
Other	ex-vivo umbilical cord blood expansion	1	2006
Biological	ex vivo-activated autologous lymph node lymphocytes	1	2015
Drug	exatecan mesylate	1	1999
Other	exercise based multimodal intervention	1	2011
Behavioral	exercise program	1	2007
Other	exercise therapy	1	2018
Behavioral	exergaming program	1	2014
Procedure	expanded allogeneic cord blood (cb)	1	2003
Procedure	expanded autologous t cells	1	2003
Biological	expanded haploidentical natural killer cells	1	2020
Biological	expanded natural killer cells (nkaes)	1	2014
Procedure	expansion of umbilical cord stem cells	1	2004
Drug	experimental (fludarabine)	1	2009
Drug	extracorporeal photopheresis	1	2010
Procedure	f	1	2009
Drug	fa	1	2011
Drug	fa/tbi/cy/vp-16	1	2011
Drug	farnesyl protein transferase inhibitor	1	2002
Other	fasting blood draw, measurement of height, weight	1	2014
Other	fasting blood draw, measurement of height, weight/waist circumference,/blood pressure	1	2014
Biological	fate-nk100	1	2017
Other	fatigue inventory	1	2010
Drug	fc infusion	1	2009
Drug	fccam	1	2005
Drug	fcr/ibrutinib	1	2019
Procedure	fdg-pet	1	2016
Procedure	fdg-pet/ct guided bone marrow sampling	1	2016
Dietary Supplement	ferrous sulfate	1	2008
Drug	ff-10101-01	1	2017
Drug	filanesib	1	2011
Drug	filgastrim	1	2014
Biological	filgrastim (g-csf)	1	1999
Procedure	first allogeneic bone marrow transplant (bmt)	1	2011
Behavioral	fit4life	1	2010
Drug	flag	1	2007
Drug	flag-ida (granulocyte-colony stimulating factor (g-csf), fludarabine, cytarabine, idarubicin)	1	2015
Drug	flag (fludarabine, cytarabine	1	2012
Drug	flag (fludarabine, cytarabine/g-csf)	1	2012
Drug	flag (granulocyte colony-stimulating factor (g-csf), fludarabine, cytarabine)	1	2017
Drug	flaimy - fluda, ida, ara-c, mylotarg	1	2009
Other	flexibility	1	2008
Biological	flotetuzumab	1	2019
Other	flt pet	1	2014
Other	flt pet/ct	1	2014
Drug	flu-mel	1	2008
Biological	flucam [fludara	1	2004
Biological	flucam [fludara / campath]	1	2004
Drug	fludara	1	2019
Drug	fludarabine-cladribine-busulfan conditioning regimen	1	2017
Drug	fludarabine (flu)	1	2018
Drug	fludarabine (non-imp)	1	2020
Drug	fludarabine from -5 to -3	1	2019
Drug	fludarabine mono	1	2006
Drug	fludarabine phosphate (fludara)	1	2005
Drug	fludarabine(flu)	1	2018
Other	fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft	1	2008
Drug	fludarabine, cytarabine, filgrastim	1	2018
Drug	fludarabine, cytarabine, liposomal daunorubicin (daunoxome)	1	2005
Drug	fludarabine, methotrexate, mercaptopurine	1	2005
Drug	fludarabine, mitoxantrone, cyclophosphamide	1	2010
Drug	fludarabine, mitoxantrone, cyclophosphamide/alemtuzumab	1	2010
Drug	fludarabine/ melphalan	1	2011
Drug	fludarabine/busulfan	1	2011
Drug	fludarabine/busulfan / low dose total body irradiation (ld tbi)	1	2011
Drug	fludarabine/busulfan plus/minus total body irradiation (low dose)	1	2011
Drug	fludarabine/cyclophosphamide	1	2006
Biological	fludarabine/darbopoetin	1	2006
Radiation	fludeoxyglucose f-18	1	2015
Drug	flumatinib	1	2020
Other	fluorothymidine f-18	1	2015
Biological	flysyn	1	2016
Drug	folinic acid	1	2019
Other	follow-up care	1	2013
Other	food safety guidelines	1	2008
Drug	forodesine hcl	1	2008
Dietary Supplement	fortini mf unflavoured (1.5kcal	1	2012
Radiation	fractionated total body irradiation	1	2016
Radiation	fractionated total body irradiation (ftbi)	1	2000
Drug	fragmin	1	2000
Drug	fresh frozen plasma	1	2012
Drug	ft-1101	1	2015
Drug	ft-2102 (olutasidenib)	1	2016
Drug	ft596	1	2020
Drug	fts	1	2009
Other	functional assessment of cancer therapy-bone marrow transplant (fact-bmt)	1	2018
Drug	g-csf (filgrastim)	1	2009
Drug	g-csf)	1	2012
Drug	g-scf	1	2018
Drug	gabapentin	1	2012
Drug	gadolinium	1	2015
Biological	galinpepimut-s	1	2020
Drug	gamma-secretase	1	2010
Drug	gamma-secretase/notch signalling pathway inhibitor ro4929097	1	2010
Drug	ganetespib	1	2010
Drug	gcs-100	1	2007
Drug	gdc-0853	1	2013
Drug	gefitinib	1	2005
Drug	gem333	1	2018
Drug	gemcitabine/oxaliplatin	1	2012
Drug	gemtuzumab	1	2009
Drug	gemtuzumab ozogamicin (mylotarg)	1	2009
Drug	gemtuzumab ozogamycin	1	2009
Biological	gene-modified t cells targeted	1	2010
Genetic	genetic variation analysis	1	2015
Biological	genetically engineered lymphocyte therapy	1	2008
Drug	gilteritinib (baml-16-001-s8)	1	2016
Drug	glasdegib maleate	1	2017
Drug	gleevec (imatinib mesylate)	1	2002
Drug	glivecâ®	1	2007
Drug	glivecâ®/gleevecâ®	1	2007
Drug	globulina antilinfocitaria	1	2006
Drug	glucarpidase	1	2011
Drug	glucocorticoid	1	2012
Drug	glutaminase inhibitor cb-839	1	2017
Drug	glutamine	1	2006
Drug	glycosylated g-csf	1	2019
Biological	gm-csf secreting leukemia vaccine	1	2007
Biological	gm-csf/g-csf	1	2016
Biological	gm-k562	1	2008
Biological	gm-k562 vaccine	1	2007
Biological	gm-k562/leukemia cell vaccine	1	2008
Drug	gmi-1271	1	2014
Drug	go-203-2c	1	2014
Drug	go-203-2c / decitabine	1	2014
Behavioral	go test (tgug).	1	2007
Drug	grafalon	1	2013
Device	graft manipulation (cd34	1	2013
Device	graft manipulation (cd34/ selection)	1	2013
Drug	granisetron hydrochloride	1	2006
Drug	granulocyte-colony stimulating factor	1	2016
Drug	granulocyte-colony stimulating factor (g-csf)	1	2017
Drug	granulocyte-colony stimulating factor with fractionated gemtuzumab ozogamicin (clag-go)	1	2019
Biological	grnvac1	1	2007
Other	grooved peg board test	1	2019
Other	gross motor function	1	2008
Drug	gs-4059	1	2012
Biological	gsk biologicals’ recombinant wt1 antigen-specific cancer immunotherapeutic (asci)	1	2008
Biological	gsk biologicals’ recombinant wt1 antigen-specific cancer immunotherapeutic (asci) gsk2130579a	1	2009
Drug	gsk1120212	1	2009
Drug	gsk3326595	1	2018
Drug	gtb-3550 trikeâ„¢ phase i	1	2017
Drug	gtb-3550 trikeâ„¢ phase ii	1	2017
Biological	gvax	1	2013
Biological	gvax leukemia vaccine (therapeutic cellular vaccine, gm-csf producing)	1	2005
Drug	gx15-070ms	1	2008
Drug	h3b-8800	1	2016
Drug	haag regimen	1	2019
Other	hand grip strength	1	2008
Behavioral	handgrip evaluation	1	2007
Biological	haplo-cord stem cell transplantation	1	2017
Biological	haplo-identical cells (donor)	1	2015
Procedure	haplo-identical hsct	1	2013
Biological	haplo bmt	1	2019
Biological	haplo bmt with nk cells	1	2019
Procedure	haploidentical bone marrow	1	2012
Biological	haploidentical bone marrow transplant	1	2012
Biological	haploidentical bone marrow transplantation	1	2009
Procedure	haploidentical bone marrow/kidney	1	2012
Procedure	haploidentical donor derived natural killer cell infusion	1	2008
Drug	haploidentical donors	1	2012
Procedure	haploidentical hematopoietic stem cell transplantation	1	2007
Procedure	haploidentical hematopoietic stem cell transplantation (hsct)	1	2015
Procedure	haploidentical transplantation of t-cell depleted graft	1	2009
Procedure	hct	1	2016
Drug	hdac	1	2009
Drug	hdac inhibitor ar-42	1	2013
Drug	hdm201	1	2019
Drug	hdmp	1	2010
Behavioral	health counseling	1	2012
Behavioral	health counseling/exercise	1	2012
Biological	heat shock protein 70 hsp70	1	2001
Other	heavy water (2h2o)	1	2012
Procedure	hematopoietic cell transplant	1	2015
Procedure	hematopoietic cell transplant (hct)	1	2014
Device	hematopoietic stem cell transplantation (hsct)	1	2011
Biological	hematopoietic umbilical cord blood stem cell transplantation	1	2009
Drug	hidac (high dose cytarabine)	1	2012
Drug	hidrocortisone	1	2014
Drug	high-dose anthracycline	1	2007
Drug	high-dose cytarabine	1	2004
Drug	high-dose ia regimen	1	2014
Drug	high-dose methotrexate	1	2013
Drug	high-dose trivalent inactivated influenza vaccine	1	2010
Drug	high dose cytarabine for consolidation	1	2014
Drug	high dose cytarabine/mitoxantrone	1	2018
Drug	high dose il-2	1	2019
Biological	high dose irradiation conditioning	1	2019
Biological	high dose irradiation conditioning / treg/tcon	1	2019
Drug	high dose methotrexate	1	2015
Drug	high dose methylprednisolone (hdmp)	1	2011
Drug	high dose mtx	1	2009
Other	high performance liquid chromatography	1	2007
Dietary Supplement	high phenolic evoo intake	1	2019
Device	high throughput screening	1	2017
Drug	hign dose daunorubicin	1	2018
Drug	histamine dihydrochloride/il-2	1	2011
Drug	hla-a2 monoclonal antibody hu8f4	1	2015
Biological	hla-matched related donor bone marrow	1	2008
Other	hla-mismatched micro-transplantation after induction chemotherapy	1	2018
Genetic	hla matched stem cell	1	2015
Genetic	hla mismatched stem cell	1	2015
Drug	hm43239	1	2019
Combination Product	hma/dli	1	2018
Drug	hmpl-306	1	2020
Behavioral	home-based exercise program	1	2008
Procedure	hpc(a) stem cell allograft	1	2018
Biological	hpc,a infusion	1	2016
Procedure	hsct from hrd	1	2015
Procedure	hsct from msd	1	2015
Procedure	hsct from mud	1	2015
Biological	hsct with non-tbi regimen	1	2017
Biological	hsct with tbi regimen	1	2017
Genetic	hsv-tk	1	2009
Biological	hu-mik-beta-1	1	2004
Drug	hu5f9-g4	1	2019
Biological	hucart19 cells	1	2018
Drug	hum-195	1	2002
Drug	hum-195/rgel	1	2002
Other	human activity profile	1	2018
Drug	human cd19 targeted t cells injection	1	2019
Drug	human growth hormone	1	2006
Drug	human placental derived stem cell	1	2012
Biological	humanized cd19 car-t cells	1	2017
Biological	humanized cd19 car-t cells with crs suppression technology	1	2017
Combination Product	hva regimens as salvage treatment	1	2020
Drug	hyaluronidase human	1	2018
Drug	hydroxyurea/interferon-based therapy	1	2019
Drug	hyper-cvad	1	2010
Radiation	hyperfractionated tbi	1	2019
Radiation	hyperfractionated total body irradiation	1	2018
Drug	ï»¿amphotericin b	1	2012
Biological	î²	1	2019
Drug	î³î´t cell infusion agent	1	2020
Drug	iac regimen	1	2014
Drug	ibrutinib (as subsequent therapy)	1	2018
Drug	ibrutinib (i	1	2019
Drug	ibrutinib / ofatumumab	1	2015
Drug	ibrutinib / venetoclax 15 cycles	1	2017
Drug	ibrutinib 140 mg oral capsule [imbruvica]	1	2017
Drug	ibrutinib 420 mg	1	2017
Drug	ibrutinib 560 mg	1	2017
Drug	ibrutinib until progression	1	2017
Drug	ibrutinib until progression/relapse	1	2017
Drug	ibrutinib/thalidomide	1	2019
Biological	ic9	1	2017
Biological	ic9-car19 cells	1	2017
Biological	ic9/car.19/il15-transduced cb-nk cells	1	2017
Biological	icar19 car-t cells	1	2017
Biological	icaspase9-transduced t cells	1	2011
Drug	idarubicin hydrochloride	1	2014
Drug	idarubicin, etoposide, cytarbine, teniposide	1	2005
Drug	idarubicin/cytarabine induction	1	2019
Drug	idarubicina	1	2006
Drug	idarubicine/cytarabine regimen	1	2019
Drug	idarubicinï¼ˆidaï¼‰	1	2016
Drug	idarubincin	1	2004
Drug	idarubincin/amufostine (ethyol)	1	2004
Drug	idec-152	1	2002
Drug	idec-c2b8	1	2014
Drug	ign523	1	2014
Biological	il-12	1	2015
Biological	il-15/alemtuzumab	1	2016
Biological	il-2-expressing tumor cells vaccine	1	2007
Drug	il-4	1	2009
Biological	il15-transduced cb-nk cells	1	2017
Drug	im jzp-458	1	2019
Drug	imatinib (gleevec)	1	2010
Drug	imatinib (sti571)	1	2007
Drug	imatinib 400 mg	1	2005
Drug	imatinib 400 mg / peg-interferon	1	2005
Other	imatinib discontinuation	1	2016
Behavioral	imatinib ending	1	2007
Drug	imatinib mesilate	1	2006
Drug	imatinib mesilate (glivec)	1	2007
Drug	imatinib mesylate 100 mg (glivec)	1	2009
Drug	imatinib mesylate 400 mg / cytarabine	1	2005
Drug	imatinib mesylate 600 mg	1	2005
Drug	imatinib mesylate tablets, 400 mg	1	2014
Drug	imatinib stop	1	2011
Drug	imatinib, dasatinib	1	2019
Drug	imatinib, dasatinib/nilotinib	1	2019
Drug	imatinib/acetaminophen	1	2007
Drug	imatinib/nilotinib	1	2012
Drug	imatinib/pegylated interferon	1	2010
Drug	imgn529	1	2012
Drug	imgn779	1	2016
Biological	imiquimod	1	2018
Procedure	immunoablative hematopoietic pbsc transplant	1	2005
Other	immunoenzyme technique	1	2006
Biological	immunotherapy	1	2008
Procedure	immunotoxin therapy	1	2005
Procedure	in vitro-treated peripheral blood stem cell transplantation (pbsct)	1	2000
Device	in vitro kinase inhibitor assay	1	2016
Drug	in vitro sensitivity-directed chemotherapy	1	2015
Procedure	in vitro treated peripheral blood stem cell transplantation	1	2006
Drug	ina03 administration	1	2019
Drug	incb018424	1	2008
Biological	incomplete freund’s adjuvant	1	2006
Radiation	indium in 111 ibritumomab tiuxetan	1	2007
Radiation	indium in 111 ll2 igg	1	1999
Radiation	indium in 111 monoclonal antibody mn-14	1	1999
Behavioral	individual diet	1	2014
Behavioral	individual diet/physical activity counselor/website through healthways at hopkins	1	2014
Biological	individual peptide vaccination with adjuvant gm-csf	1	2018
Biological	individual peptide vaccination with adjuvant gm-csf/imiquimod	1	2018
Behavioral	individualized yoga intervention group	1	2014
Drug	indoximod freebase	1	2016
Drug	indoximod hcl f1	1	2016
Drug	indoximod hcl f2	1	2016
Drug	induction chemotherapy	1	2013
Drug	induction chemotherapy (fludarabine, cytarabine, idarubicin)	1	2010
Procedure	infusion of activated	1	2003
Procedure	infusion of activated/expanded autologous t cells	1	2003
Biological	infusion of allogeneic cik cells	1	2007
Procedure	infusion of autologous cik cells	1	2006
Biological	infusion of cd3	1	2009
Biological	infusion of cd3/cd28 stimulated t cells	1	2009
Procedure	infusion of non-t-cell depleted bone marrow on day 0	1	2016
Biological	infusion of one mpc expanded cord unit	1	2013
Biological	infusion of one mpc expanded cord unit/one unexpanded cord unit	1	2013
Biological	infusion of two unexpanded cord blood units.	1	2013
Drug	injection mecobalamin	1	2018
Biological	injection of antigen-loaded cultured dendritic cells	1	2009
Biological	injection of il-2-secreting cd40l-expressing autologous b-cll cells	1	2003
Drug	inno-406	1	2006
Drug	inotuzumab ozogamicin-dose level 1	1	2018
Drug	inotuzumab ozogamicin-dose level 2	1	2018
Drug	inotuzumab ozogamicin (ino)	1	2017
Drug	inotuzumab ozogamicin (io)	1	2018
Drug	intensive chemo - ric preparation	1	2011
Drug	intensive salvage therapy	1	2009
Drug	interferon-alfa-2b	1	2016
Drug	interferon-alpha	1	2017
Drug	interferon-alpha (inf-a)	1	2006
Drug	interferon-based therapy	1	2019
Biological	interferon-î±-2b	1	2007
Biological	interferon alfa	1	2006
Drug	interferon alpha-2b (ifn-î±) 3 million units (mu) subcutaneous daily	1	2014
Drug	interferon alpha 2a	1	2007
Drug	interleukin-11 (il-11	1	2007
Drug	interleukin-11 (il-11/neumega)	1	2007
Drug	interleukin-2 (il-2)	1	2008
Drug	intermediate-dose cytarabine (idac)	1	2015
Drug	intermediate-dose ia regimen	1	2014
Other	intervention by caregiver	1	2010
Other	interview	1	2019
Biological	intranodal injection of ad-isf35	1	2009
Drug	intrathecal (it) methotrexate	1	2014
Drug	intrathecal (it) triple chemotherapy prophylaxis	1	2019
Drug	intrathecal methotrexate	1	2009
Drug	intrathecal prophylaxis	1	2005
Drug	intrathecal triple chemotherapy	1	2015
Drug	intrathecal triple therapy (intrathecal cytarabine, hydrocortisone,	1	2014
Drug	intrathecal triple therapy (intrathecal cytarabine, hydrocortisone,/methotrexate)	1	2014
Procedure	intrathecally treatment	1	2007
Drug	intravenous (iv)	1	2018
Drug	intravenous (iv)/oral vitamin c	1	2018
Drug	intravenous fluids	1	2019
Biological	intravenous recombinant human il-15 (rhil-15)	1	2011
Biological	invac-1	1	2017
Drug	investigator’s choice	1	2010
Combination Product	iodine i 131 tositumomab	1	2007
Drug	iomab-b	1	2016
Other	ionization time of flight mass spectrometry	1	2007
Biological	iov-2001	1	2019
Drug	ioversol	1	2014
Other	ipad activity control group	1	2014
Drug	iph2101	1	2010
Drug	iph2102 at 0.1 mg	1	2012
Drug	iph2102 at 0.1 mg/kg	1	2012
Drug	iph2102 at 1 mg	1	2012
Drug	iph2102 at 1 mg/kg	1	2012
Drug	ipi-145 (duvelisib)	1	2014
Drug	irinotecan	1	2000
Drug	irofulven	1	1999
Procedure	irradiation (in specific conditions)	1	2005
Drug	isatuximab	1	2019
Device	isolex 300i	1	1999
Device	isolex 300i stem cell selection	1	2003
Device	isolex 300i/moabs	1	1999
Drug	isolex system	1	2001
Other	isotonic solution	1	2010
Drug	ispinesib	1	2004
Device	ithermonitor	1	2015
Drug	itraconazole	1	2002
Biological	itreg	1	2012
Drug	iv bag protectant for moxetumomab pasudotox	1	2013
Drug	iv jzp-458	1	2019
Drug	ixazomib citrate	1	2015
Drug	jbh492	1	2020
Drug	jcar017	1	2018
Biological	jcar017 (lisocabtagene maraleucel)	1	2017
Biological	jcar017 (lisocabtagene maraleucel) / ibrutinib	1	2017
Drug	jnj-63709178	1	2016
Drug	jnj-67571244	1	2019
Drug	jnj-67856633	1	2019
Drug	jvrs-100	1	2009
Drug	k0706 capsules	1	2015
Biological	kappa cd28 t cells	1	2009
Drug	karonudib	1	2019
Drug	keppra	1	2012
Drug	kg iv on day	1	2016
Drug	kg)	1	2018
Procedure	kidney	1	2012
Drug	klh	1	2009
Other	knee extension strength	1	2008
Drug	kpt-330	1	2014
Drug	krt-232	1	2019
Drug	kw-2478	1	2007
Drug	kx2-391	1	2011
Drug	l-asparaginase, erwinia asparaginase	1	2005
Drug	l-phenylalanine mustard	1	2007
Other	laboratory procedure	1	2001
Drug	lansoprazole	1	2011
Drug	larotrectinib sulfate	1	2019
Drug	lbh589b	1	2010
Drug	lcv	1	2014
Drug	ldac (low dose cytosine arabinoside)	1	2009
Drug	lenalidomida	1	2009
Drug	lenalidomida/rituximab	1	2009
Drug	lenalidomide (revlimidâ®)	1	2009
Drug	lenalidomide / plerixafor (/ rituximab)	1	2011
Drug	lenalidomide, dexamethasone	1	2012
Drug	lenograstim	1	2014
Drug	lenvatinib	1	2019
Drug	lenzilumab	1	2015
Biological	leridistim	1	2000
Drug	letermovir	1	2019
Drug	leucomax	1	2007
Procedure	leukapheresis/collection of pbmcs	1	2013
Procedure	leukemia cell harvest	1	2007
Biological	leukemia cell vaccine	1	2008
Other	leukemic	1	1999
Other	leukemic/stroma cells	1	1999
Drug	leuprolide	1	2011
Dietary Supplement	levocarnitine	1	2018
Drug	levofloxacin	1	2011
Drug	lfb-r603	1	2010
Drug	lgh447	1	2014
Drug	lgh447 / midostaurin	1	2014
Drug	lintuzumab (sgn-33)	1	2007
Drug	lintuzumab ac 225	1	2018
Drug	liposomal amphotericine b	1	2006
Drug	liposomal arac	1	2014
Drug	liposomal cytarabine	1	1999
Drug	liposome-encapsulated cytarabine (depocyte)	1	2008
Drug	lirilumab	1	2015
Drug	lomustine	1	2007
Drug	lomustine, intermediate dose cytarabine	1	2007
Drug	lonafarnib (sch66336)	1	2002
Drug	lorvotuzumab mertansine (imgn901)	1	2015
Drug	low-dose cytarabine (ldac)	1	2015
Drug	low-dose methotrexate	1	2013
Drug	low dose 5’-azacitidine	1	2013
Drug	low dose il-2	1	2019
Drug	low dose total body irradiation (ld tbi)	1	2011
Behavioral	low glycemic index diet	1	2017
Drug	loxo-305	1	2018
Drug	luitpold azacitidine	1	2011
Biological	lumiliximab	1	2003
Drug	lumiliximab with fcr	1	2005
Drug	ly2090314	1	2010
Drug	ly2181308 sodium	1	2008
Drug	ly2510924	1	2016
Drug	ly2874455	1	2017
Drug	ly573636-sodium	1	2008
Procedure	lymph node biopsy	1	2008
Drug	lymphocyte injection of prophylactic donor (pdli)	1	2016
Drug	lymphodepleting	1	2018
Drug	lymphodepletion with cyclophosphamide	1	2015
Drug	lymphodepletion with fludarabine	1	2015
Drug	m2 i.v.	1	2009
Drug	m2 x 1	1	2016
Drug	m2 x 2	1	2016
Drug	mab 216	1	2006
Other	magnetic affinity cell sorting	1	2009
Procedure	magnetic resonance imaging	1	2015
Dietary Supplement	manuka honey	1	2018
Drug	maraviroc	1	2014
Drug	marqibo	1	2016
Drug	marqiboâ® (vincristine sulfate liposomes injection)	1	2007
Procedure	marrow transplant (bmt)	1	2019
Procedure	massage therapy	1	2010
placebo	matched placebo	1	2019
Other	matrix-assisted laser desorption	1	2007
Other	matrix-assisted laser desorption/ionization time of flight mass spectrometry	1	2007
Drug	max-40279	1	2018
Biological	mb-102	1	2019
Biological	mb-cart19.1	1	2019
Drug	mcla-117 bispecific antibody	1	2017
Drug	mdm2 inhibitor krt-232	1	2017
Biological	mdx-1342	1	2008
Drug	mec	1	2008
Drug	medi-551	1	2011
Procedure	mediastinal irradiation	1	2005
Procedure	mediastinal irradiation (if residual tu)	1	2005
Procedure	mediastinal irradiation (if residual tumor)	1	2005
Procedure	megadose of cd34 selected progenitor cells	1	2002
Drug	megestrol acetate	1	2003
Drug	mek 162	1	2014
Drug	melfalan in conditioning before transplantation	1	2009
Drug	melphalan, atg, fludarabine	1	2005
Drug	melphalan/bortezomib	1	2008
Drug	memory t cell selection	1	2019
Drug	men1112	1	2015
Drug	men1703	1	2016
Drug	mercaptopurine oral suspension	1	2019
Drug	mercaptopurine, imatinib	1	2005
Drug	merestinib	1	2017
Procedure	mesenchymal stem cell transplantation	1	2014
Biological	mesenchymal stem cells	1	2010
Drug	mesylate imatinib capsule	1	2013
Drug	metformin hydrochloride	1	2016
Drug	methotrexate (arm with bortezomib)	1	2014
Drug	methotrexate (arm with maraviroc)	1	2014
Drug	methotrexate (intrathecal administration)	1	2018
Drug	methotrexate (intravenous administration)	1	2018
Drug	methotrexate (low dose)	1	2013
Drug	methotrexate oral product	1	2018
Drug	methotrexate sodium	1	2014
Drug	methotrexate)	1	2014
Drug	methotrexate, cyclophosphamide, cytarabine, etoposide	1	2005
Drug	methotrexate, teniposide, peg-asparaginase	1	2005
Drug	methotrexate/hydrocortisone	1	2005
Drug	methotrexate/hydrocortisone/cytarabine	1	2014
Drug	methoxyamine	1	2012
Drug	methylprednisone	1	2009
Drug	metotrexate	1	2014
Drug	metronidazole, clarithromycin, ciprofloxacin	1	2011
Drug	metronidazole, clarithromycin, ciprofloxacin/lansoprazole	1	2011
Drug	mgta 456 infusion	1	2018
Other	microbiological analysis	1	2011
Biological	microtransplantation	1	2016
Drug	midazolam	1	2013
Drug	midostaurin (pkc412)	1	2008
placebo	midostaurin placebo	1	2018
Drug	milademetan tosylate	1	2018
Procedure	mild soap skin cleanser	1	2013
Device	miltenyi biotec clinimacs device	1	2008
Device	miltenyi clinimacs	1	2005
Device	miltenyi magnetic cell sorter for cd3	1	2009
Device	miltenyi reagent system	1	2006
Combination Product	miltenyi system	1	2007
Drug	minnelide	1	2018
Drug	minus total body irradiation (low dose)	1	2011
Drug	mitomycin c	1	1999
Drug	mitoxantrone / etoposide / gemtuzumab ozogamicin	1	2019
Drug	mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine	1	2005
Drug	mitoxantrone, cytarabine	1	2017
Drug	mitoxantrone, etoposide	1	2018
Drug	mitoxantrone, etoposide/cytarabine	1	2018
Drug	mitozantrone	1	2004
Drug	mitozantrone, etoposide, cytarabine (combination chemotherapy)	1	2004
Drug	mk-4827	1	2008
Drug	mk-8628	1	2012
Drug	mk0457	1	2005
Dietary Supplement	ml)	1	2012
Drug	mlm-car44.1 t-cells, cyclophosphamide	1	2019
Drug	mlm-car44.1 t-cells, cyclophosphamide/fludarabine from -5 to -3	1	2019
Drug	mln 9708	1	2014
Drug	mln518	1	2006
Device	moabs	1	1999
Procedure	mobilized peripheral blood stem cell graft with tacrolimus	1	2019
Procedure	mobilized peripheral blood stem cell graft with tacrolimus/methotrexate	1	2019
Procedure	mobilized peripheral blood stem cell graft with tacrolimus/mycophenolate mofetil/post-transplant cyclophosphamide	1	2019
Drug	modified bone marrow stem cell transplantation	1	1999
Drug	modified bucy	1	2017
Behavioral	modified geriatric assessment (mga)	1	2019
Behavioral	modified strength training	1	2017
Biological	mogamulizumab	1	2019
Biological	monoclonal antibody a27.15	1	1999
Biological	monoclonal antibody cd19	1	1999
Biological	monoclonal antibody cd20	1	1999
Biological	monoclonal antibody e2.3	1	1999
Biological	monoclonal antibody mik-beta-1	1	2001
Biological	montanide adjuvant	1	2007
Drug	montelukast	1	2019
Biological	mor00208	1	2013
Drug	morphine	1	2019
Drug	morphine sulfate	1	1999
Drug	moxetumomab pasudotox	1	2013
Drug	moxetumomab pasudotox-tdfk	1	2019
Drug	moxetumomab pasudotox (cat 8015)	1	2007
Combination Product	mrd-directed therapy	1	2016
Other	mri pelvic	1	2018
Drug	ms-533	1	2018
Drug	msc2490484a (m3814)	1	2014
Drug	mt-3724 phase 1	1	2015
Drug	mt-3724 phase 2	1	2015
Biological	muc1	1	2017
Biological	muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cells	1	2017
Drug	multikinase inhibitor at9283	1	2011
Other	multiplex respiratory viral pcr	1	2013
Biological	multistemâ®	1	2008
Dietary Supplement	multivitamin	1	2018
Biological	murine autologous anti-cd19 chimeric antigen receptor t cells	1	2020
Drug	muromonab	1	2007
Behavioral	music imagery	1	2004
Procedure	music therapy	1	2006
Drug	mvpd	1	2009
Drug	mvpdl	1	2011
Drug	mycophenolate	1	2011
Drug	mycophenylate mofetil	1	2013
Drug	myeloablative allogeneic hct with a non-tbi conditioning regimen	1	2018
Drug	myeloablative conditioning regimen	1	2015
Procedure	myeloablative haploidentical stem cell transplant	1	2012
Procedure	myeloid progenitor cell transplantation	1	2014
Drug	mylotarg (gemtuzumab ozogamicin) injection	1	2002
Drug	mylotarg associated with conventional chemotherapy (arac	1	2009
Drug	mylotarg associated with conventional chemotherapy (arac / daunorubicin),	1	2009
Other	mylotarg purging before autologous pbsc transplantation	1	2012
Drug	nalbuphine	1	2019
Drug	native l asparaginase	1	2008
Biological	natural killer (nk) cell infusion	1	2011
Procedure	natural killer (nk) cell transplant	1	2005
Biological	natural killer (nk) cells	1	2016
Drug	nedisertib	1	2019
Drug	nelarabine injection 1000mg	1	2006
Drug	nelarabine injection 1000mg/m2	1	2006
Drug	nelarabine injection 1500mg	1	2006
Drug	nelarabine injection 1500mg/m2	1	2006
Drug	nelarabine injection 400mg	1	2006
Drug	nelarabine injection 400mg/m2	1	2006
Drug	nelarabine injection 650mg	1	2006
Drug	nelarabine injection 650mg/m2	1	2006
Drug	nelfinavir mesylate	1	2010
Drug	nerofe	1	2017
Biological	neukoplastâ„¢ (nk-92)	1	2009
Drug	neumega)	1	2007
Other	neutropenic diet	1	2008
Drug	nexavar (sorafenib, bay43-9006)	1	2008
Diagnostic Test	ngs-mrd	1	2018
Drug	nicordâ® (omidubicel)	1	2016
Other	nih toolbox flanker inhibitory control	1	2019
Other	nih toolbox flanker inhibitory control/attention test	1	2019
Other	nih toolbox list sorting working memory test	1	2019
Drug	nilotinib / lde225	1	2011
Drug	nilotinib 400 mg bid	1	2015
Drug	nilotinib followed by treatment-free	1	2013
Drug	nilotinib, interferon-alfa	1	2010
Drug	nilotinib, pegylated interferon alpha-2b, imatinib	1	2013
Drug	nilotinib,novartis,300 mg twice a day	1	2011
Drug	nilotinib,novartis,300 mg twice a day /pegylated interferon 2a,roche, 45 microg weekly starting month 2-month 12/beyond according to investigator choice.	1	2011
Drug	nilotinib/mvpd	1	2009
Drug	nintedanib/aml induction	1	2016
Drug	nivolumab (.25 mg	1	2018
Drug	nivolumab (.25 mg/kg)	1	2018
Drug	nivolumab (.5 mg	1	2018
Drug	nivolumab (.5 mg/kg)	1	2018
Biological	nk cell	1	2017
Procedure	nk cell infusion:	1	2011
Biological	nk cells / chemotherapy starting	1	2016
Drug	nms-03592088	1	2019
Other	no dli	1	2010
Dietary Supplement	no high phenolic evoo intake	1	2019
Other	no systemic anticoagulant prophylaxis	1	2015
Drug	non-myeloablative allogeneic stem cell transplant with prophylactic activated dli	1	2006
Procedure	non-tbi regime	1	2015
Procedure	nonmyeloablative allogeneic hsct	1	2008
Drug	not	1	2014
Drug	notch signalling pathway inhibitor ro4929097	1	2010
Drug	nox-a12	1	2011
Biological	npmw-peptide vaccine	1	2016
Dietary Supplement	nutrinidrink	1	2012
Dietary Supplement	nutrinidrink/fortini mf unflavoured (1.5kcal/ml)	1	2012
Dietary Supplement	nutritional intervention	1	2013
Drug	o g-csf)	1	2015
Drug	oblimersen-rituximab-fludarabine	1	2004
Drug	oblimerson sodium, g3139	1	2001
Drug	odsh	1	2013
Drug	ofatumumab (gsk1841157) infusion	1	2012
Drug	ofatumumab / fresh frozen plasma	1	2012
Drug	ofatumumab 100 mg, 1000 mg	1	2010
Drug	ofatumumab 100 mg, 1000 mg / vial	1	2010
Drug	ofatumumab with gsk2110183	1	2012
Drug	ofatumumab/dexamethasone	1	2011
Drug	ofatumumab/hdmp	1	2010
Drug	ofc infusion	1	2009
Other	off therapy	1	2012
Drug	olaparib	1	2019
Dietary Supplement	olive oil	1	2018
Drug	omacetaxine	1	2011
Drug	omega-3 fatty acids	1	2015
Drug	omegaven	1	2013
Drug	on01910 na	1	2009
Drug	oncaspar	1	2012
Biological	oncoquest-cll vaccine	1	2013
Procedure	one expanded cord blood unit	1	2003
Biological	one unexpanded cord unit	1	2013
Procedure	one unmanipulated	1	2003
Procedure	one unmanipulated/one expanded cord blood unit	1	2003
Drug	ono	1	2012
Drug	ono-7475	1	2017
Drug	ono/gs-4059	1	2012
Drug	ontak	1	2003
Drug	ontak (denileukin diftitox)	1	2007
Drug	onvansertib	1	2017
Drug	opb-111077	1	2017
Drug	opb-51602	1	2011
Drug	open label lam-003	1	2018
Combination Product	optimal medical treatment	1	2018
Biological	or cd123-specific car gene-engineered t cells	1	2019
Drug	oral arsenic trioxide	1	2018
Drug	oral sodium phenylbutyrate	1	2000
Drug	oral vitamin c	1	2018
Biological	orcagraft	1	2019
Drug	osi-461	1	2003
Drug	ots167iv	1	2016
Drug	otx015	1	2012
Drug	otx015/mk-8628	1	2012
Behavioral	outpatient care model	1	2019
Drug	oxidative phosphorylation inhibitor iacs-010759	1	2016
Biological	p.dom-wt1-126 dna vaccine	1	2011
Biological	p.dom-wt1-37 dna vaccine	1	2011
Biological	p.dom-wt1-37 dna vaccine/p.dom-wt1-126 dna vaccine	1	2011
Drug	p1101	1	2013
Behavioral	pace call	1	2010
Behavioral	pace call/fit4life	1	2010
Drug	pacritinib	1	2014
Drug	pad-vcd	1	2016
Drug	palbociclib oral capsule	1	2018
Drug	palcociclib	1	2019
Other	palliative care intervention	1	2015
Drug	panobinostat (lbh589)	1	2009
Drug	panobinostat (lbh589)/5-azacytidine	1	2009
Drug	panobinostat/lbh589	1	2009
Drug	panobinostat/lbh589b	1	2010
Biological	patient-derived cd19-	1	2017
Biological	patient-derived cd19-/cd22 specific car	1	2017
Biological	patient-derived cd22-specific car t-cells also expressing an egfrt	1	2017
Biological	patient derived cd19 specific car t cells also expressing an egfrt	1	2014
Other	patient observation	1	2018
Drug	pazopanib	1	2011
Genetic	pbcar0191	1	2018
Genetic	pbcar20a	1	2019
Biological	pbsc	1	2000
Procedure	pbsc graft	1	2018
Procedure	pbsc transplant	1	2011
Procedure	pbsct	1	2006
Drug	pci 32765	1	2011
Combination Product	pd-l1, pd-l2 peptides with montanide isa51	1	2019
Drug	pdr001	1	2017
Biological	pediacelâ®	1	2015
Drug	peg-alpha interferon (peg-intron)	1	2002
Drug	peg-asp	1	2014
Drug	peg-g-csf	1	2017
Drug	peg-ifn-î±	1	2014
Drug	peg-interferon	1	2005
Drug	peg-interferon alpha2b	1	2013
Drug	peg-l-asparaginase cons	1	2013
Drug	peg-l-asparaginase ind	1	2013
Drug	peg asparaginase	1	2019
Drug	peg asparaginase at six weeks interval	1	2009
Drug	peg asparaginase at two weeks interval	1	2009
Drug	peg interferon alpha 2b (peg intron)	1	2006
Drug	pegaspargase 1250 iu	1	2016
Drug	pegaspargase 1250 iu/m2 x 2	1	2016
Drug	pegaspargase 2500 iu	1	2016
Drug	pegaspargase 2500 iu/m2 x 1	1	2016
Drug	pegifn	1	2012
Drug	peginterferon-î±-2a	1	2015
Drug	peginterferon alfa-2a	1	2016
Drug	peginterferon î±2b	1	2012
Drug	pegylated-proline-interferon alpha-2b	1	2017
Drug	pegylated asparaginase	1	2008
Drug	pegylated interferon	1	2010
Drug	pegylated interferon-alfa-2b	1	2016
Drug	pegylated interferon 2a,roche, 45 microg weekly starting month 2-month 12	1	2011
Drug	pegylated interferon alfa-2a	1	2016
Drug	pegylated l-asparaginase	1	2017
Drug	pegylated liposomal doxorubicin hydrochloride	1	1999
Drug	pembrolizumab,	1	2016
Drug	pemetrexed	1	2007
Drug	pentetic acid calcium	1	2001
Drug	pentoxifylline	1	2015
Drug	pentoxifylline/chemotherapy	1	2015
Biological	peptide specific dendritic cell	1	2017
Procedure	peripheral blood for correlative studies	1	2013
Procedure	peripheral blood hematopoietic cell transplantation (hct)	1	2017
Procedure	peripheral blood progenitor cell transplant	1	1999
Procedure	peripheral blood stem cell transplantation (pbsct)	1	2011
Biological	peripheral blood stem cells	1	2016
Procedure	peripheral blood transplant	1	2018
Drug	pertuzumab	1	2019
Diagnostic Test	pet-ct scan	1	2018
Device	pet scans	1	2013
Drug	pevonedistat (baml-16-001-s9)	1	2016
Drug	pevonedistat 10 mg	1	2016
Drug	pevonedistat 10 mg/m^2	1	2016
Drug	pevonedistat 20 mg	1	2016
Drug	pevonedistat 20 mg/m^2	1	2016
Drug	pevonedistat 25 mg	1	2016
Drug	pevonedistat 25 mg/m^2	1	2016
Drug	pevonedistat 44 mg	1	2016
Drug	pevonedistat 44 mg/m^2	1	2016
Drug	pf-03084014	1	2009
Drug	pf-04449913 (glasdegib)	1	2015
Drug	pf-114	1	2016
Drug	pgx-odsh-2013-aml-1	1	2014
Behavioral	pharmaceutical care	1	2017
Behavioral	pharmaceutical care/adherence aids	1	2017
Other	pharmacodynamic study	1	2013
Genetic	pharmacogenomics	1	2015
Drug	phenytoin	1	2005
Other	phosphate-buffered saline (pbs)	1	2006
Drug	photopheresis	1	2002
Other	physical activity adapted program	1	2019
Behavioral	physical activity counselor	1	2014
Behavioral	physical therapy	1	2009
Drug	physicians’ choice	1	2011
Drug	pioglitazone / tki	1	2016
Drug	piperacillin-tazobactam	1	1999
Drug	piperacillin sodium	1	1999
Drug	pixantrone iv infusion	1	2005
placebo	placebo (normal saline solution)	1	2012
Drug	placebo / cytarabine	1	2010
placebo	placebo for ag-120	1	2019
placebo	placebo for ag-221	1	2019
placebo	placebo to match ibrutinib	1	2016
placebo	placebo with azacitidine	1	2017
Drug	placebo/chemotherapy	1	2015
Procedure	planar scintigraphy imaging	1	2011
Drug	plerixafor (	1	2011
Drug	plerixafor dose escalation	1	2011
Drug	plx2853	1	2018
Drug	pm01183 1 mg powder for concentrate for solution for infusion	1	2011
Drug	pm01183 1 mg powder for concentrate for solution for infusion/pm01183 4 mg powder for concentrate for solution for infusion	1	2011
Drug	pm01183 4 mg powder for concentrate for solution for infusion	1	2011
Biological	pneumococcal polyvalent vaccine	1	2011
Biological	pneumococcal vaccine	1	2006
Drug	pneumovax	1	2013
Biological	pneumovaxâ® 23	1	2015
Drug	pol6326	1	2011
Drug	polatuzumab vedotin	1	2011
Biological	polyphenon e	1	2005
Drug	ponatinib - phase 1	1	2012
Drug	ponatinib - phase 2	1	2012
Drug	ponatinib 15 mg	1	2015
Drug	ponatinib 15 mg qd	1	2015
Drug	ponatinib 30 mg	1	2015
Drug	ponatinib 30 mg qd	1	2015
Drug	ponatinib 45 mg	1	2015
Drug	posaconazole oral suspensions	1	2019
Drug	posology dose modification	1	2016
Drug	possible reinitiation treatment: ibrutinib	1	2017
Drug	possible reinitiation treatment: ibrutinib / venetoclax 12 cycles	1	2017
Drug	post-chlorambucil therapy follow-up	1	2012
Drug	post-hct cyclophosphamide 50mg	1	2016
Drug	post-hct cyclophosphamide 50mg/kg iv on day/3, /4	1	2016
Drug	post-hct mesna	1	2016
Procedure	post-transplant cyclophosphamide	1	2019
Behavioral	postremission consolidation based on mrd status	1	2006
Biological	pr1 leukemia peptide vaccine	1	2000
Biological	pr1:169-177 peptide	1	2007
Drug	pralatraxate,	1	2018
Drug	pralatrexate	1	2012
Biological	prame vaccination	1	2015
Drug	pre-dli salvage chemotherapy	1	2011
Drug	pre-hct mesna on days -2	1	2016
Drug	pre-hct mesna on days -2/-1	1	2016
Drug	pre-hct mesna on days -5	1	2016
Drug	pre-hct mesna on days -5/-4	1	2016
Drug	pre-hct mesna on days -6	1	2016
Drug	pre-hct mesna on days -6/-5	1	2016
Drug	prednison, vincristine, cytarabine, methotrexate, etoposide, cyclophosphamide, doxorubicin	1	2005
Drug	prednisone pill	1	2019
Drug	prednisone, dexamethasone, vincristine, daunorubicin	1	2005
Drug	prednisone, vincristine, daunorubicin, peg-l-asparaginase, erwinia l-asparaginase, doxorubicin, cyclophosphamide, cytarabine, thioguanine	1	2007
Drug	prevenar 13	1	2013
Drug	prevention of gvhd	1	2016
Biological	prevnarâ®13	1	2015
Drug	prexasertib	1	2016
Drug	prgn-3006 t cells	1	2019
Drug	pri-724	1	2012
Drug	primary antifungal prophylaxis	1	2018
Drug	procrit	1	2008
Drug	procrit (epoetin alfa)	1	2010
Behavioral	promoting resilience in stress management (prism)	1	2015
Procedure	prophylactic gpbpci	1	2011
Biological	prophylactic platelet transfusion	1	2007
Drug	propofol-fentanyl	1	2005
Drug	propofol alone	1	2005
Other	proteosome inhibition assessment	1	2010
Biological	protmune	1	2016
Procedure	protocol ii-ida	1	2005
Drug	ps-341	1	2005
Drug	psc-833	1	1999
Drug	psoralen	1	2000
Other	psychological intervention	1	2017
Drug	ptc299	1	2018
Drug	ptk 787 (vatalanib)	1	2004
Drug	ptx-200	1	2016
Drug	pyrimethamine	1	2010
Drug	pyroxamide	1	2002
Drug	pz01 car-t cells	1	2017
Biological	qs21	1	1999
Other	quality-of-life	1	2016
Other	quality of life assessment	1	2012
Procedure	r-blocks	1	2005
Drug	r-chop	1	2018
Drug	r(	1	2004
Drug	r(/)xk469	1	2004
Drug	rabbit anti-human t-lymphocyte globulin	1	2017
Biological	rabbit anti-thymocyte globulin (atg)	1	2007
Device	rabbit antithymocyte globulin	1	2018
Drug	rad001	1	2004
Radiation	radiation	1	2015
Radiation	radiation therapy (rt)	1	2000
Radiation	radioimmunotherapy	1	1999
Drug	radotinib hcl	1	2018
Drug	raltegravir	1	2009
Drug	raltitrexed	1	1999
Drug	randomisation course 1 mitoxantrone versus daunoxome	1	2013
Drug	randomisation course 2 adxe versus fladx	1	2013
Drug	randomization between two established chemotherapies	1	2005
Drug	rapamycin / mec	1	2008
Drug	rapamycin, mitoxantrone, etoposide, cytarabine	1	2008
Dietary Supplement	rapeseed oil	1	2019
Drug	ravuconazole	1	2003
Device	reagent system	1	2014
Drug	realgar-indigo naturalis formula	1	2016
Biological	recombinant 70-kd heat-shock protein	1	2002
Biological	recombinant ephb4-hsa fusion protein	1	2018
Biological	recombinant human thrombopoietin	1	2000
Drug	recombinant interferon alfa 2a	1	2016
Biological	recombinant interleukin-3	1	2000
Biological	recwt1-a10	1	2013
Biological	recwt1-a10/as01b	1	2013
Biological	red blood cell transfusion	1	2014
Drug	reduced-intensity conditioning regimen	1	2015
Procedure	reduced intensity conditioning stem cell transplantation	1	2006
Procedure	reduced intensity haplodentical stem cell transplant	1	2012
Biological	regulatory t cells (treg)	1	2012
Drug	relapse	1	2017
Biological	related	1	2016
Biological	related/unrelated bone marrow cells	1	2016
Behavioral	relaxation education	1	2014
Other	respiratory training	1	2019
Behavioral	resting vitals	1	2007
Drug	rft5-smpt-dga	1	2001
Drug	rgel	1	2002
Drug	rhtpo	1	2019
Drug	ribociclib	1	2018
Drug	rif	1	2014
Drug	rigosertib	1	2010
Other	risk-adapted, mrd-directed therapy	1	2011
Behavioral	risk-oriented consolidation	1	2006
Drug	ritonavir	1	2016
Drug	rituxan	1	2003
Drug	rituxanâ„¢	1	2007
Drug	rituximab / idec-c2b8	1	2014
Drug	rituximab [mabthera]	1	2011
Drug	rituximab for patients with b-cell malignancies	1	2006
Drug	rituximab injection	1	2020
Drug	rituximab)	1	2011
Drug	rituximab, methylprednisolone	1	2007
Drug	rituximab, vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-c	1	2012
Drug	rituximab/hyaluronidase human	1	2018
Drug	rituximab/mvpdl	1	2011
Biological	rivogenlecleucel	1	2018
Genetic	rna analysis	1	2007
Drug	ro5045377	1	2012
Drug	ro5429083	1	2012
Drug	ro5503781	1	2011
Drug	ro5503781 mbp	1	2013
Drug	ro5503781 sdp	1	2013
Drug	ro6839921	1	2014
Drug	ro6870810	1	2014
Drug	roferon-a	1	1999
Drug	ropeginterferon	1	2019
Drug	routine reduction of immunosuppressive drugs(cyclosporine)	1	2017
Drug	s 055746	1	2016
Drug	s 55746	1	2016
Combination Product	s 64315 (also referred as mik665)	1	2018
Combination Product	s 64315 (also referred as mik665)/venetoclax	1	2018
Drug	s64315 once a week	1	2016
Drug	s64315 twice a week	1	2016
Drug	s65487	1	2018
Drug	saline	1	2018
Drug	salvage chemotherapy	1	2014
Dietary Supplement	salvia hispanica seed	1	2016
Biological	samalizumab (baml-16-001-s1)	1	2016
Drug	sapacitabine/decitabine (part 1 - completed)	1	2010
Drug	sapacitabine/venetoclax (part 2 - recruiting)	1	2010
Drug	sapanisertib	1	2015
Drug	sar103168	1	2009
Drug	sar245409	1	2011
Drug	sar440234	1	2018
Drug	sb1518	1	2008
Drug	sb939	1	2010
Drug	sc-peg	1	2012
Drug	sc-peg e. coli l-asparaginase	1	2010
Drug	sch66336	1	2002
Biological	scri-hucar19v1	1	2018
Procedure	sct	1	2012
Drug	second-line ibrutinib	1	2012
Procedure	second allogeneic bone marrow transplantation	1	2011
Drug	second phase of induction	1	2017
Drug	sel120	1	2019
Drug	sel24	1	2016
Drug	sel24/men1703	1	2016
Biological	selected natural killer cells collected from apheresis products	1	2011
Other	selection	1	2012
Biological	selection with clinimacs device	1	2005
Device	selection)	1	2013
Other	selection.	1	2012
Behavioral	self directed weight loss	1	2014
Drug	semaxanib	1	2000
Drug	sequential packaging (set)	1	2016
Drug	sertraline	1	2016
Drug	sgi-110	1	2014
Drug	sgi-110 (guadecitabine)	1	2015
Drug	sgi-110 administration	1	2014
Drug	sgn-40 (anti-hucd40 mab)	1	2006
Drug	sgn-cd19a	1	2013
Device	sham	1	2014
Device	sham tdcs	1	2019
Device	sham treatment	1	2019
Dietary Supplement	sheng-yu-tang	1	2015
Drug	shingrix vaccine	1	2018
Biological	silk	1	2019
Dietary Supplement	silymarin	1	2003
Biological	single dose of cnct19	1	2020
Biological	single dose of ctl019	1	2015
Radiation	single dose total body irradiation	1	2016
Biological	single ft1050 treated ucb unit	1	2012
Procedure	single photon emission computed tomography	1	2017
Biological	single umbilical cord blood unit transplant	1	2006
Drug	sirolimus (sir)	1	2017
Drug	sirolimus/methotrexate	1	2010
Drug	ski-606 (bosutinib)	1	2008
Drug	ski-g-801	1	2018
Behavioral	sleep hygiene	1	2014
Behavioral	sleep hygiene/relaxation education	1	2014
Drug	sndx-5613	1	2019
Drug	sodium chloride solution 0.9%	1	2012
Drug	sodium ferric gluconate complex in sucrose	1	2008
Drug	sodium salicylate	1	2000
Device	solex 300i stem cell selection	1	2006
Drug	solumedrol	1	2008
Drug	sonidegib	1	2014
Drug	sorafenib-vorinostat	1	2009
Drug	sorafenib, vorinostat	1	2012
Drug	sorafenib, vorinostat/bortezomib	1	2012
Drug	sotatercept	1	2012
Drug	spc2996	1	2005
Biological	specificity cd38 car-t cells	1	2018
Other	specimen collection	1	2018
Drug	spectrilaâ®	1	2017
Other	sport therapy	1	2019
Dietary Supplement	st. john’s wort	1	2000
Drug	sta-9090 (ganetespib)	1	2009
Other	staining method	1	2003
Drug	standard chemotherapy (7	1	2009
Drug	standard chemotherapy (7/3 scheme): daunorubicin, cytarabine	1	2009
Drug	standard chemotherapy / imatinib	1	2006
Drug	standard combination chemotherapy	1	2014
Drug	standard consolidation therapy	1	2017
Drug	standard dose cytarabine for induction	1	2014
Drug	standard dose trivalent inactivated influenza vaccine	1	2010
Drug	standard induction therapy	1	2017
Dietary Supplement	standard vitamin d3 supplementation	1	2017
Drug	stat inhibitor opb-111077	1	2017
Procedure	stem cell transfusion	1	2003
Procedure	stem cell transplantation (sct)	1	2020
Drug	stem cells	1	2008
Drug	stemexâ®	1	2007
Procedure	steroid therapy, hematopoietic stem cell transplantation	1	2005
Drug	sti571	1	2007
Drug	sti571 (400 mg	1	2007
Drug	sti571 (400 mg/day;/800 mg/day)	1	2007
Other	stopping treatment with tki	1	2012
Other	stroma cells	1	1999
Other	structured education dvd	1	2015
Other	structured education dvd / verbal teaching	1	2015
Other	study of socioeconomic	1	2008
Other	study of socioeconomic/demographic variables	1	2008
Drug	subcutaneous (sc) azacitidine	1	2007
Drug	succimer	1	2018
Drug	sunitinib	1	2019
Drug	supersaturated calcium phosphate rinse	1	2011
Behavioral	support	1	2009
Other	supportive	1	2015
Other	supportive /palliative care intervention	1	2015
Other	surface expression of functional biomarkers of the nk cell	1	2009
Other	surveillance	1	2017
Drug	sy-1425 (tamibarotene)	1	2016
Drug	syb l-0501	1	2013
Procedure	syngeneic bone marrow transplantation	1	1999
Biological	syngeneic pbtls	1	2008
Biological	synthetic tumor-specific breakpoint peptide vaccine	1	2005
Drug	systematic chemotherapy	1	2005
Drug	systematic chemotherapy/antibodies	1	2005
Drug	systemic chemotherapy	1	2005
Drug	systemic chemotherapy/antibodies	1	2005
Biological	t-allo10	1	2017
Biological	t-cell antigen presenting cells expressing truncated cd19 (t-apc)	1	2017
Other	t-cell depleted	1	2009
Procedure	t-cell depleted hsct from a related, haploidentical donor	1	2016
Other	t-cell depleted/t-cell replete strategies	1	2009
Procedure	t-cell replete hsct from a related, haploidentical donor	1	2016
Other	t-cell replete pbpc allograft	1	1999
Other	t-cell replete strategies	1	2009
Biological	t-lymphocytes	1	2017
Device	t cell	1	2019
Biological	t cell-depleted donor lymphocyte infusion	1	2015
Biological	t cells	1	2012
Drug	tablet pyridoxine hydrochlorid	1	2018
Drug	tacrolimus (arm with methotrexate)	1	2014
Drug	tacrolimus (arm with mmf	1	2014
Drug	tacrolimus (arm with mmf/cyclophosphamide)	1	2014
Drug	tacrolimus (tac)	1	2018
Biological	tafasitamab	1	2015
Drug	tak-659	1	2014
Drug	tak-901	1	2008
Drug	talabostat mesylate (pt-100) tablets	1	2004
Drug	talacotuzumab 9 mg	1	2015
Drug	talacotuzumab 9 mg/kg	1	2015
Drug	tamibarotene	1	2007
Radiation	targeted radiotherapy	1	2012
Drug	tasigna	1	2011
Drug	tazobactam sodium	1	1999
Biological	tbi-1501	1	2017
Procedure	tbi regime	1	2015
Drug	tbi, systemic chemotherapy	1	2005
Drug	tbi, systemic chemotherapy/antibodies as follows:	1	2005
Drug	tbi/cy/vp-16	1	2011
Drug	tc-110 t cells	1	2020
Biological	tcon	1	2019
Biological	tcr alfa beta t cell depletion	1	2012
Biological	tcrî±	1	2019
Biological	tcrî±/î²/	1	2019
Procedure	tcrî±î²	1	2015
Procedure	tcrî±î²//cd19/ depleted haploidentical hsct	1	2015
Biological	tem1 monoclonal antibody morab-004	1	2012
Drug	tenalisib	1	2019
Biological	tetanus	1	2012
Biological	tetanus-cmv fusion peptide vaccine	1	2012
Biological	tetanus toxoid	1	2015
Drug	tetrahydrouridine	1	2009
Drug	tevagastrim	1	2012
Biological	tg-1501	1	2015
Drug	tg02 citrate	1	2012
Drug	tgr-1202 / obinutuzumab / chlorambucil	1	2014
Drug	tgr-1202 / ublituximab	1	2017
Drug	th-302	1	2010
Drug	th2 cells	1	1999
Drug	th2 cells in allo hsctt	1	1999
Drug	theophyllin	1	2005
Drug	theophylline	1	1999
Biological	therapeutic autologous dendritic cells	1	2009
Biological	therapeutic platelet transfusion	1	2007
Procedure	therapeutic touch	1	2006
Drug	thio tepa	1	2019
Drug	thioguanine (oral)	1	2016
Drug	thioplexâ®	1	2007
Drug	thioridazine	1	2014
Drug	thiotepa in conditioning before transplantation	1	2009
Biological	third-generation anti-cd123 car-t cells	1	2019
Procedure	three-dimensional spoiled gradient mri	1	2015
Drug	thymoglobulin (atg)	1	2009
Biological	thymoglobulin [anti-thymocyte globulin (rabbit)]	1	2004
Drug	tigecycline	1	2011
Behavioral	timed get-up	1	2007
Behavioral	timed get-up/go test (tgug).	1	2007
Drug	tioguanin	1	2018
Drug	tipifarnib (r115777)	1	2006
Drug	tipifarnib;zarnestra; r115777	1	2004
Biological	tisagenlecleucel	1	2015
Other	titrated pain management	1	2008
Drug	tj011133	1	2019
Drug	tki	1	2016
Other	tki discontinuation	1	2016
Drug	tm123 (imp)	1	2020
Drug	tms	1	2007
Biological	tn lymphocytes	1	2016
Drug	topotecan, dexamethasone, vincristine	1	2005
Combination Product	tositumomab	1	2007
Combination Product	tositumomab/iodine i 131 tositumomab	1	2007
Radiation	total body irradiation (8gy)	1	2019
Radiation	total body irradiation (tbi) 200cgy on day -1	1	2016
Radiation	total body irradiation (tbi) 200cgy twice a day on days -3, -2, -1	1	2016
Radiation	total body irradiation 1200 cgy	1	2016
Radiation	total body irradiation 200 cgy	1	2016
Radiation	total body radiation	1	2011
Radiation	total lymphoid irradiation	1	2007
Radiation	total lymphoid irradiation (tli)	1	2018
Radiation	total marrow irradiation (tmi)	1	2018
Radiation	total nodal irradiation	1	2015
Device	transcranial direct current stimulation (tdcs)	1	2014
Drug	transfusion graft	1	2016
Procedure	transplant	1	2007
Drug	transplants from 8	1	2012
Drug	transplants from 8/8-matched unrelated donors	1	2012
Drug	transplants from family-mismatched	1	2012
Drug	transplants from family-mismatched/haploidentical donors	1	2012
Drug	traumeel s	1	2004
Drug	treatment choice (tc)	1	2016
Biological	trebananib	1	2012
Biological	treg	1	2019
Biological	treg infusion	1	2008
Biological	treggraft	1	2019
Drug	tretinoin/arsenic trioxide	1	2011
Drug	triciribine	1	2008
Drug	trimethoprim-sulfamethoxazole	1	2003
Drug	trimetrexate glucuronate	1	1999
Drug	triple intrathecal therapy	1	2013
Drug	triple intrathecal therapy (mtx, cytarabine, hydrocortisone)	1	2005
Drug	triple intrathecal therapy (tit)	1	2008
Drug	triple it therapy	1	2007
Drug	troxacitabine	1	2001
Drug	tru-016	1	2010
Drug	tru-016 (anti-cd37 protein therapeutic)	1	2008
Biological	tru-016 10-20 mg	1	2012
Biological	tru-016 10-20 mg/kg / bendamustine	1	2012
Biological	tru-016 10-20 mg/kg / ibrutinib	1	2012
Biological	tru-016 20 mg	1	2012
Biological	tru-016 20 mg/kg / obinutuzumab	1	2012
Biological	tru-016 6-20 mg	1	2012
Biological	tru-016 6-20 mg/kg / idelalisib / rituximab	1	2012
Drug	tru-016/bendamustine	1	2010
Biological	tslpr	1	2019
Behavioral	two-step remission induction	1	2006
Behavioral	two-step remission induction/risk-oriented consolidation	1	2006
Drug	txa127 1000 mcg	1	2011
Drug	txa127 1000 mcg/kg/day	1	2011
Drug	txa127 300 mcg	1	2011
Drug	txa127 300 mcg/kg/day	1	2011
Drug	tylenol	1	2009
Drug	tyrosine kinase inhibitor	1	2019
Drug	tyrosine kinase inhibitor (tki)	1	2011
Drug	tyrosine kinase inhibitor (tkis)	1	2018
Biological	ucart019	1	2017
Biological	ucart123	1	2017
Biological	ucart22	1	2019
Biological	uld il-2	1	2014
Genetic	umbilical cord blood (ucb)	1	2013
Biological	umbilical cord blood cell infusion	1	2016
Procedure	umbilical cord blood transfusion	1	2013
Biological	umbilical cord blood unit (cbu)	1	2015
Drug	unicar02-t (imp)	1	2020
Biological	universal dual specificity cd19	1	2018
Biological	universal dual specificity cd19/cd20/cd22 car-t cells	1	2018
Biological	unmanipulated umbilical cord blood (ucb)	1	2018
Biological	unrelated bone marrow cells	1	2016
Biological	unrelated cord blood	1	2019
Other	unrelated donor transplant.	1	2012
Drug	up-front allogeneic hematopoietic stem cell transplantation (hsct)	1	2019
Biological	us-atg-f	1	2011
Combination Product	usual clinical practice	1	2018
Procedure	uv light therapy	1	2003
Drug	valacyclovir	1	2007
Drug	valemetostat tosylate	1	2019
Drug	valproate	1	2014
Drug	valproic acid (vpa)	1	2006
Drug	vancomycin	1	1999
Drug	vay736	1	2018
Drug	vcap	1	2010
Drug	vcap-amp-vecp with g-csf	1	2005
Drug	vcap-amp-vecp with g-csf/intrathecal prophylaxis	1	2005
Drug	vcap/amp/vecp(mlsg15)	1	2010
Biological	vcl-cb01	1	2006
Drug	vcr	1	2014
Drug	vecp(mlsg15)	1	2010
Biological	veltuzumab	1	2007
Drug	ven)	1	2019
Drug	venetoclax (part 2 - recruiting)	1	2010
Drug	venetoclax 12 cycles	1	2017
Drug	venetoclax 15 cycles	1	2017
Drug	venetoclax/ibrutinib (i/ven)	1	2019
Other	verbal teaching	1	2015
Drug	vial	1	2010
Drug	vidaza/valproic acid	1	2014
Drug	vidazaâ®	1	2011
Drug	vinblastine	1	2012
Drug	vincristine / vindesine	1	2005
Drug	vincristine sulfate liposome	1	2017
Drug	vincristine sulfate liposomes injection	1	2005
Drug	vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-c	1	2012
Drug	vincristine/vindesine	1	2005
Drug	vinorelbine ditartrate	1	1999
Drug	vinorelbine tartrate	1	2007
Other	virtual reality	1	2019
Genetic	virus specific t cells	1	2009
Other	vital signs	1	2008
Drug	vitamin b complex	1	2018
Dietary Supplement	vitamin d/calcium citrate	1	2011
Dietary Supplement	vitamin e	1	1999
Drug	vls-101 schedule 1	1	2019
Drug	vls-101 schedule 2	1	2019
Drug	vls-101 schedule 3	1	2019
Drug	voreloxin injection	1	2007
Drug	voreloxin injection/cytarabine	1	2007
Drug	voruciclib	1	2018
Drug	vosaroxin / cytarabine	1	2010
Drug	vpa	1	2009
Drug	vsli	1	2011
Drug	w	1	2015
Other	waist circumference,	1	2014
Behavioral	wait list	1	2008
Behavioral	website through healthways at hopkins	1	2014
Drug	wee1 inhibitor azd1775	1	2016
Genetic	welgenaleucel	1	2019
Radiation	whole-brain radiation therapy	1	2010
Other	withdrawal of immunosuppression	1	2009
Other	withdrawal of immunosuppression/donor lymphocyte infusion	1	2009
Behavioral	writing a (experimental informative writing)	1	2008
Behavioral	writing b (experimental noninformative writing)	1	2008
Behavioral	writing c (control informative writing)	1	2008
Behavioral	writing d (control noninformative writing)	1	2008
Biological	wt-1 analog peptide vaccine	1	2006
Procedure	wt 1 testing	1	2005
Biological	wt1	1	2015
Biological	wt1-sensitized allogeneic t-lymphocytes	1	2011
Biological	wt1-sensitized t cells	1	2008
Biological	wt1 126-134 peptide vaccine	1	2012
Drug	wt1 peptide-pulsed dendritic cells	1	2009
Drug	wt1 peptides	1	2009
Genetic	wt1 tcr-transduced t cells	1	2012
Biological	wt1/prame vaccination	1	2015
Biological	wt1:126-134	1	2007
Biological	xmab13676	1	2016
Biological	xmab14045	1	2016
Biological	xmab5574	1	2010
Genetic	xyf19 car-t cell	1	2019
Other	yttrium-90 labelled monoclonal antibody against cd66	1	2019
Drug	yttrium-90 radiolabeled anti-tac antibody	1	1999
Radiation	yttrium y 90 daclizumab	1	2001
Radiation	yttrium y 90 ibritumomab tiuxetan	1	2007
Radiation	yttrium y 90 monoclonal antibody m195	1	2000
Drug	zarnestra (r115777)	1	2002
Drug	zarnestra, tipifarnib, r115777	1	2002
Drug	zavedos	1	2009
Drug	zevalin radioimmunotherapy	1	2002
Drug	zidovudine	1	2016
Drug	zinc sulfate 50 mg tab	1	2020
Drug	zio-101 (darinaparsin)	1	2007
Drug	zoledronate	1	2015
Drug	zolinza	1	2011
Drug	zolinza/vorinostat	1	2011
Drug	zosuquidar trihydrochloride	1	2002

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country	Study_Count
United States	1833
China	147
France	89
Germany	83
United States\|Canada	64
NA	60
Italy	58
Japan	50
Spain	45
United Kingdom	39
Canada	31
Korea, Republic of	25
United States\|Australia\|Canada	22
Austria\|Germany	13
Israel	11
Denmark	10
Switzerland	10
United States\|France	9
United States\|Germany	9
Austria	8
Russian Federation	8
United States\|Germany\|Italy	8
Brazil	7
Mexico	7
Sweden	7
United States\|Australia	7
United States\|Italy	7
Australia	6
United States\|Canada\|Puerto Rico	6
United States\|Israel	6
Belgium	5
Egypt	5
Hong Kong	5
Netherlands	5
United States\|Australia\|Canada\|Netherlands\|New Zealand\|Puerto Rico\|Switzerland	5
United States\|Australia\|Canada\|Netherlands\|Puerto Rico\|Switzerland	5
United States\|United Kingdom	5
Norway	4
Singapore	4
Turkey	4
United States\|Australia\|Canada\|New Zealand\|Puerto Rico	4
United States\|Australia\|Canada\|New Zealand\|Switzerland	4
United States\|Australia\|Canada\|Puerto Rico	4
Denmark\|Finland\|Iceland\|Norway\|Sweden	3
Germany\|Netherlands	3
Germany\|Switzerland	3
Iran, Islamic Republic of	3
Malaysia	3
United States\|Australia\|Canada\|New Zealand	3
United States\|Australia\|Canada\|New Zealand\|Puerto Rico\|Saudi Arabia	3
United States\|Canada\|Puerto Rico\|Switzerland	3
United States\|France\|Germany	3
United States\|Korea, Republic of	3
United States\|Puerto Rico\|South Africa	3
Austria\|France\|Germany	2
Austria\|France\|Germany\|Italy\|Netherlands\|United Kingdom	2
Canada\|France	2
Finland\|Norway\|Sweden	2
France\|Germany	2
France\|United Kingdom	2
Germany\|Austria	2
India	2
Japan\|Korea, Republic of\|Taiwan	2
Lebanon	2
Lithuania	2
Poland	2
United States\|Australia\|Austria\|Belgium\|France\|Germany\|Hungary\|Italy\|New Zealand\|Spain\|United Kingdom	2
United States\|Australia\|Belgium\|Canada\|China\|Czechia\|Ireland\|Israel\|Italy\|New Zealand\|Poland\|Russian Federation\|Spain\|Turkey\|Ukraine\|United Kingdom	2
United States\|Australia\|Canada\|Ireland\|New Zealand\|Puerto Rico\|Switzerland	2
United States\|Australia\|Canada\|Switzerland	2
United States\|Australia\|France\|Poland	2
United States\|Belgium	2
United States\|Canada\|France\|Germany\|Hungary\|India\|Italy\|Poland\|Singapore\|United Kingdom	2
United States\|Canada\|France\|Germany\|Italy\|Spain	2
United States\|Canada\|France\|Netherlands	2
United States\|Canada\|Netherlands\|Puerto Rico\|Switzerland	2
United States\|Denmark\|Germany	2
United States\|France\|Germany\|Italy\|United Kingdom	2
United States\|Georgia	2
United States\|Germany\|Italy\|Spain	2
United States\|Germany\|Netherlands	2
United States\|Germany\|Spain	2
United States\|Poland	2
United States\|Puerto Rico	2
United States\|Spain	2
United States\|Switzerland	2
Algeria\|Argentina\|Australia\|Brazil\|Canada\|Egypt\|India\|Israel\|Lebanon\|Malaysia\|Mexico\|Oman\|Russian Federation\|Saudi Arabia\|South Africa\|Taiwan\|Thailand\|Tunisia\|United Arab Emirates	1
Argentina\|Australia\|Austria\|Belarus\|Belgium\|Canada\|Chile\|Croatia\|Czechia\|Denmark\|Finland\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Malaysia\|Mexico\|Netherlands\|New Zealand\|Norway\|Poland\|Romania\|Saudi Arabia\|Slovakia\|Slovenia\|Spain\|Sweden\|Switzerland\|Turkey	1
Argentina\|Australia\|Brazil\|Canada\|Chile\|Croatia\|Czechia\|France\|Germany\|Greece\|Italy\|Mexico\|New Zealand\|Poland\|Portugal\|Russian Federation\|Slovakia\|Spain\|Turkey	1
Argentina\|Australia\|Brazil\|Canada\|France\|Spain	1
Argentina\|Australia\|Bulgaria\|Hong Kong\|Hungary\|Mexico\|New Zealand\|Poland\|Russian Federation\|Taiwan	1
Argentina\|Austria\|Belgium\|Chile\|Czech Republic\|Germany\|Hungary\|Italy	1
Argentina\|Belgium\|Bosnia and Herzegovina\|Brazil\|Canada\|Egypt\|Estonia\|Finland\|France\|Germany\|Greece\|Ireland\|Israel\|Italy\|Korea, Republic of\|Latvia\|Lithuania\|Mexico\|North Macedonia\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|Slovakia\|Slovenia\|Spain\|Sweden\|Switzerland\|Thailand\|Turkey	1
Argentina\|Brazil\|China\|Colombia\|Germany\|Guatemala\|India\|Mexico\|Panama\|Poland\|Russian Federation\|Venezuela	1
Argentina\|Canada\|Denmark\|Finland\|France\|Italy\|Netherlands\|Norway\|Sweden	1
Argentina\|Croatia\|Greece\|Ireland\|Italy\|New Zealand\|Russian Federation\|United Kingdom	1
Argentina\|Venezuela	1
Armenia\|Belarus\|Kyrgyzstan\|Russian Federation\|Uzbekistan	1
Australia\|Austria\|Belgium\|Czech Republic\|Denmark\|France\|Germany\|Israel\|Italy\|New Zealand\|Spain	1
Australia\|Austria\|Czechia\|Germany\|Israel\|Italy\|Slovakia\|Switzerland	1
Australia\|Austria\|Czechia\|Germany\|Israel\|Italy\|Switzerland	1
Australia\|Belgium\|France\|Germany\|Italy\|Korea, Republic of\|Netherlands\|Singapore\|Spain\|Sweden\|United Kingdom	1
Australia\|Brazil\|France\|Israel\|Italy\|Russian Federation\|Spain\|Switzerland\|Turkey	1
Australia\|Canada\|Estonia\|Finland\|Germany\|Greece\|New Zealand\|Norway\|Sweden	1
Australia\|Canada\|France\|Korea, Republic of\|Netherlands	1
Australia\|China\|Malaysia\|Taiwan	1
Australia\|China\|New Zealand\|Taiwan	1
Australia\|France	1
Australia\|France\|Germany\|Hungary\|Korea, Republic of\|Poland\|Singapore\|United Kingdom	1
Australia\|France\|Spain\|United Kingdom	1
Australia\|United Kingdom	1
Austria\|Belgium\|Bulgaria\|Czechia\|France\|Germany\|Hungary\|Ireland\|Israel\|Italy\|Poland\|Russian Federation\|Singapore\|Slovakia\|Sweden\|Ukraine\|United Kingdom	1
Austria\|Belgium\|Canada\|France\|Germany\|Italy\|Japan\|Norway\|Spain	1
Austria\|Belgium\|Canada\|France\|Germany\|Italy\|Norway	1
Austria\|Belgium\|Croatia\|France\|Germany\|Italy\|Netherlands	1
Austria\|Belgium\|Croatia\|France\|Italy\|Netherlands	1
Austria\|Belgium\|France\|Germany\|Italy\|Netherlands\|Poland\|Romania\|Russian Federation\|Spain\|United Kingdom	1
Austria\|Belgium\|France\|Germany\|Italy\|Netherlands\|Portugal	1
Austria\|Belgium\|France\|Italy	1
Austria\|Canada\|Finland\|Norway\|Russian Federation\|Sweden	1
Austria\|Czechia\|Germany\|Italy\|Poland\|United Kingdom	1
Austria\|Czechia\|Slovakia	1
Austria\|Finland\|Germany\|Russian Federation	1
Austria\|Germany\|Italy	1
Austria\|Germany\|Switzerland	1
Austria\|United States\|Australia\|Belgium\|Brazil\|Canada\|China\|Czechia\|Denmark\|France\|Germany\|Italy\|Korea, Republic of\|Russian Federation\|Spain\|Taiwan\|Turkey\|United Kingdom	1
Austria\|United States\|Canada\|France\|Germany\|Italy\|Netherlands	1
Bangladesh	1
Belarus	1
Belarus\|Poland	1
Belarus\|Russian Federation\|Uzbekistan	1
Belgium\|Bulgaria\|Croatia\|France\|Germany\|Italy\|Lithuania\|Netherlands\|Portugal	1
Belgium\|Canada\|China\|France\|Hungary\|Italy\|Netherlands\|Poland\|Spain\|United Kingdom	1
Belgium\|Canada\|Croatia\|Germany\|Portugal\|United Kingdom	1
Belgium\|Canada\|Germany\|United Kingdom	1
Belgium\|Croatia\|Czech Republic\|France\|Germany\|Italy\|Netherlands\|Portugal\|Slovakia\|Turkey	1
Belgium\|Czechia\|France\|Germany\|Italy	1
Belgium\|Czechia\|France\|Germany\|Netherlands\|Slovakia	1
Belgium\|Denmark\|Estonia\|Finland\|Hong Kong\|Iceland\|Netherlands\|Norway\|Sweden	1
Belgium\|Denmark\|France\|Germany\|Italy\|Netherlands\|Spain\|Sweden\|United Kingdom	1
Belgium\|Denmark\|Netherlands	1
Belgium\|France	1
Belgium\|France\|Germany	1
Belgium\|France\|Germany\|Italy	1
Belgium\|France\|Germany\|Italy\|Spain	1
Belgium\|France\|Spain	1
Belgium\|Germany	1
Belgium\|Germany\|Italy\|Netherlands\|Turkey	1
Belgium\|Germany\|Netherlands\|Switzerland	1
Belgium\|Germany\|United Kingdom	1
Belgium\|Switzerland	1
Bulgaria\|Austria\|Brazil\|United States\|Argentina\|Australia\|Canada\|Croatia\|Czechia\|Denmark\|Egypt\|Estonia\|France\|Germany\|Hong Kong\|Italy\|Mexico\|Netherlands\|New Zealand\|Romania\|Russian Federation\|Slovakia\|Spain\|Switzerland\|Thailand\|United Kingdom	1
Bulgaria\|Canada\|India\|Russian Federation\|Slovakia\|South Africa\|Spain	1
Bulgaria\|Croatia\|Czechia\|Estonia\|Finland\|France\|Greece\|Hungary\|Italy\|Lithuania\|Norway\|Romania\|Serbia\|Slovakia\|Spain\|Sweden	1
Bulgaria\|Georgia\|Poland	1
Canada\|France\|Germany\|Italy\|Spain	1
Canada\|Germany	1
Canada\|Russian Federation\|Spain	1
China\|Malaysia\|Russian Federation\|Singapore\|Thailand	1
China\|Philippines\|Taiwan\|Thailand\|Vietnam	1
Colombia\|Venezuela	1
Czech Republic	1
Czech Republic\|United States\|Australia\|Brazil\|France\|Israel\|Italy\|Poland\|Puerto Rico\|Russian Federation\|Ukraine\|United Kingdom	1
Czechia\|Austria\|Belgium\|Denmark\|France\|Germany\|Ireland\|Italy\|Netherlands\|Spain\|Sweden\|Switzerland\|United Kingdom	1
Czechia\|Denmark\|Finland\|France\|Germany\|Greece\|Netherlands\|Norway\|Portugal\|Sweden	1
Czechia\|France\|Israel\|Japan\|Spain	1
Czechia\|Germany\|Switzerland	1
Denmark\|Estonia\|Finland\|Lithuania\|Norway\|Sweden	1
Denmark\|Finland\|Norway\|Sweden	1
Denmark\|Germany\|Netherlands	1
Denmark\|Norway\|Sweden	1
Denmark\|Sweden	1
Denmark\|United Kingdom	1
Finland	1
Finland\|Germany\|Netherlands\|Norway\|Sweden	1
France\|Belgium\|Portugal	1
France\|Germany\|Italy	1
France\|Germany\|Italy\|Netherlands\|Spain	1
France\|Germany\|Italy\|United Kingdom	1
France\|Germany\|Spain	1
France\|Switzerland	1
France\|United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Bulgaria\|Czechia\|Germany\|Israel\|Italy\|Japan\|Norway\|Poland\|Portugal\|Spain\|Switzerland\|Taiwan\|Turkey	1
France\|United States\|Argentina\|Austria\|Belgium\|Brazil\|Canada\|Colombia\|Czechia\|Denmark\|Egypt\|Finland\|Germany\|Hong Kong\|Hungary\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Mexico\|Netherlands\|Norway\|Poland\|Portugal\|Russian Federation\|Singapore\|Slovakia\|South Africa\|Spain\|Sweden\|Switzerland\|Taiwan\|Thailand\|Turkey\|United Kingdom\|Venezuela	1
France\|United States\|Australia\|Austria\|Belgium\|Canada\|Denmark\|Finland\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Netherlands\|New Zealand\|Norway\|Poland\|Singapore\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
France\|United States\|Australia\|Italy\|Spain	1
France\|United States\|Belgium\|Canada\|Germany\|Greece\|Netherlands\|Poland\|Serbia\|United Kingdom	1
France\|United States\|Germany\|Italy	1
Germany\|Austria\|Belgium\|Denmark\|Finland\|Ireland\|Israel\|Netherlands\|Sweden\|Switzerland	1
Germany\|Netherlands\|United Kingdom	1
Germany\|United States\|Argentina\|Australia\|Austria\|Brazil\|Bulgaria\|Canada\|Croatia\|Czechia\|Denmark\|Egypt\|Estonia\|France\|Hong Kong\|Italy\|Mexico\|Netherlands\|New Zealand\|Romania\|Russian Federation\|Slovakia\|Spain\|Switzerland\|Thailand\|United Kingdom	1
Germany\|United States\|France\|Italy\|United Kingdom	1
Greece	1
Hong Kong\|Japan\|Korea, Republic of\|Russian Federation\|Taiwan\|Thailand\|Vietnam	1
Hong Kong\|Japan\|Malaysia\|Singapore\|Taiwan	1
India\|Korea, Republic of\|Thailand	1
Indonesia	1
Indonesia\|Korea, Republic of\|Philippines\|Thailand	1
Ireland	1
Ireland\|Italy\|United Kingdom	1
Ireland\|United States\|Germany\|Israel	1
Israel\|United States	1
Italy\|Saudi Arabia\|United Kingdom	1
Italy\|United Kingdom	1
Japan\|Korea, Republic of	1
Jordan\|Lebanon\|Saudi Arabia\|Tunisia	1
Korea, Republic of\|Turkey\|Ukraine	1
Mexico\|United States\|Argentina\|Belgium\|Brazil\|Canada\|Czechia\|Germany\|Greece\|Hong Kong\|Hungary\|Ireland\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Poland\|Puerto Rico\|Russian Federation\|Spain\|Taiwan\|Thailand	1
Netherlands\|United Kingdom	1
Netherlands\|United States\|Belgium\|Canada\|Czechia\|Denmark\|France\|Israel\|Poland\|Russian Federation\|Spain\|Sweden\|Turkey\|United Kingdom	1
Poland\|Spain\|Uruguay	1
Poland\|United Kingdom	1
Portugal\|Spain	1
Saudi Arabia	1
South Africa\|United States\|Canada\|Puerto Rico	1
Spain\|Finland\|France\|Portugal\|Sweden\|Tunisia\|Turkey\|United Kingdom	1
Spain\|Sweden\|United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Czech Republic\|Denmark\|Finland\|France\|Germany\|Greece\|Hungary\|Ireland\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Peru\|Philippines\|Poland\|Russian Federation\|Singapore\|South Africa\|Switzerland\|Taiwan\|Thailand\|United Kingdom	1
Spain\|United States\|Australia\|Austria\|Belgium\|Canada\|Colombia\|Czechia\|Denmark\|France\|Germany\|Hungary\|Ireland\|Israel\|Italy\|Mexico\|Netherlands\|New Zealand\|Poland\|Portugal\|Romania\|Russian Federation\|South Africa\|Sweden\|United Kingdom	1
Spain\|United States\|Australia\|Canada\|Croatia\|Czechia\|France\|Hungary\|Mexico\|Poland\|Romania\|Russian Federation\|Serbia\|Taiwan\|United Kingdom	1
Switzerland\|Australia\|United States\|Argentina\|Austria\|Brazil\|Bulgaria\|Canada\|Croatia\|Czechia\|Denmark\|Egypt\|Estonia\|France\|Germany\|Hong Kong\|Italy\|Mexico\|Netherlands\|New Zealand\|Romania\|Russian Federation\|Slovakia\|Spain\|Thailand\|United Kingdom	1
Taiwan	1
Thailand	1
United States\|Argentina\|Australia\|Austria\|Belarus\|Brazil\|Bulgaria\|Canada\|Finland\|France\|Greece\|Italy\|Korea, Republic of\|Poland\|Russian Federation\|Spain\|Taiwan\|Turkey	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|China\|Denmark\|Estonia\|Finland\|France\|Germany\|Hungary\|Ireland\|Israel\|Italy\|Korea, Republic of\|Norway\|Peru\|Philippines\|Poland\|Puerto Rico\|Russian Federation\|Singapore\|South Africa\|Spain\|Sweden\|Switzerland\|Taiwan\|Thailand\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Czech Republic\|Denmark\|Finland\|France\|Germany\|Hungary\|Ireland\|Israel\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Norway\|Peru\|Philippines\|Poland\|Russian Federation\|Singapore\|South Africa\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Denmark\|Finland\|France\|Germany\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Peru\|Sweden\|Switzerland\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Belgium\|Brazil\|Chile\|China\|Colombia\|Czech Republic\|Denmark\|France\|Germany\|Greece\|Hungary\|India\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Peru\|Poland\|Russian Federation\|Singapore\|Spain\|Turkey	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Bulgaria\|Canada\|Croatia\|Denmark\|Estonia\|France\|Germany\|Italy\|Mexico\|New Zealand\|Poland\|Romania\|Russian Federation\|Spain\|Switzerland\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Bulgaria\|Canada\|Czechia\|Denmark\|France\|Germany\|Hungary\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Poland\|Russian Federation\|Saudi Arabia\|Slovakia\|South Africa\|Spain\|Sweden\|Taiwan\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Canada\|Chile\|China\|Colombia\|Finland\|Germany\|Hong Kong\|Hungary\|India\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Norway\|Peru\|Russian Federation\|Singapore\|South Africa\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Austria\|Brazil\|Czechia\|France\|Germany\|Hungary\|Italy\|Korea, Republic of\|Poland\|Romania\|Spain\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Bulgaria\|Canada\|China\|Croatia\|Czechia\|France\|Germany\|Hong Kong\|Hungary\|Israel\|Italy\|Taiwan\|Japan\|Korea, Republic of\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|Singapore\|Spain\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Chile\|China\|Colombia\|Finland\|France\|Hong Kong\|Hungary\|India\|Italy\|Japan\|Korea, Republic of\|Latvia\|Netherlands\|Peru\|Poland\|Russian Federation\|Singapore\|South Africa\|Spain\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Greece\|Hungary\|Ireland\|Japan\|Korea, Republic of\|Mexico\|New Zealand\|Norway\|Puerto Rico\|Russian Federation\|South Africa\|Spain\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Denmark\|Finland\|France\|Germany\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Peru\|Philippines\|Singapore\|Sweden\|Switzerland\|Taiwan\|Thailand\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|Finland\|France\|Germany\|Hungary\|Ireland\|Israel\|Italy\|Korea, Republic of\|Norway\|Peru\|Poland\|Russian Federation\|South Africa\|Spain\|Sweden\|Switzerland\|Thailand\|United Kingdom	1
United States\|Argentina\|Australia\|Belgium\|Brazil\|Canada\|France\|Germany\|Greece\|Israel\|Japan\|Korea, Republic of\|Mexico\|Poland\|Russian Federation\|Singapore\|Spain\|Tunisia\|United Kingdom	1
United States\|Argentina\|Australia\|Brazil\|Bulgaria\|Canada\|Czechia\|France\|Germany\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Lebanon\|Mexico\|Netherlands\|Romania\|Russian Federation\|Saudi Arabia\|Serbia\|Spain\|Switzerland\|Turkey\|United Kingdom	1
United States\|Argentina\|Australia\|Brazil\|Canada	1
United States\|Argentina\|Australia\|Brazil\|Canada\|France\|Germany\|India\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Romania\|Russian Federation\|Singapore\|South Africa\|Spain\|United Kingdom	1
United States\|Argentina\|Australia\|Canada\|Chile\|Czechia\|Denmark\|France\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Poland\|Portugal\|Russian Federation\|Singapore\|Spain\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Argentina\|Australia\|Canada\|China\|Czechia\|Finland\|France\|Germany\|Hungary\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Singapore\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Argentina\|Austria\|Belgium\|Brazil\|Canada\|China\|Czechia\|France\|Hungary\|Italy\|Korea, Republic of\|Poland\|Spain\|Thailand	1
United States\|Argentina\|Austria\|Belgium\|Brazil\|Canada\|Czechia\|Finland\|France\|Germany\|Greece\|Hungary\|India\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Norway\|Poland\|Portugal\|Russian Federation\|South Africa\|Spain\|Taiwan	1
United States\|Argentina\|Austria\|Belgium\|Bulgaria\|Colombia\|Denmark\|France\|Germany\|Greece\|Hungary\|Ireland\|Italy\|Japan\|Netherlands\|Poland\|Spain\|Sweden\|United Kingdom	1
United States\|Argentina\|Belgium\|Brazil\|Canada\|Chile\|China\|Colombia\|France\|Germany\|Hong Kong\|Hungary\|India\|Italy\|Japan\|Korea, Republic of\|Latvia\|Lithuania\|Mexico\|Poland\|Russian Federation\|Singapore\|South Africa\|Spain\|Taiwan\|Thailand\|Turkey\|Ukraine\|United Kingdom	1
United States\|Argentina\|Belgium\|Brazil\|Canada\|Colombia\|Czechia\|France\|Germany\|Greece\|Israel\|Korea, Republic of\|Mexico\|Poland\|Portugal\|Russian Federation\|Spain\|Sweden\|Turkey\|Ukraine\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Brazil\|Bulgaria\|Canada\|Chile\|Colombia\|Croatia\|Czechia\|Denmark\|France\|Hungary\|Israel\|Italy\|Netherlands\|New Zealand\|Poland\|Portugal\|Romania\|Russian Federation\|Serbia\|Slovakia\|South Africa\|Spain\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Brazil\|Canada\|China\|Croatia\|Czechia\|Denmark\|Finland\|France\|Germany\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Norway\|Poland\|Portugal\|Puerto Rico\|Russian Federation\|South Africa\|Spain\|Sweden\|Taiwan\|Turkey\|Ukraine	1
United States\|Australia\|Austria\|Belgium\|Brazil\|Canada\|Czechia\|Finland\|France\|Germany\|Ireland\|Israel\|Italy\|Korea, Republic of\|Lithuania\|Mexico\|Poland\|Portugal\|Russian Federation\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Bulgaria\|Canada\|Croatia\|Czechia\|France\|Germany\|Hong Kong\|Hungary\|Israel\|Italy\|Korea, Republic of\|New Zealand\|Poland\|Russian Federation\|Singapore\|Slovakia\|Spain\|Sweden\|Taiwan\|Ukraine\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Bulgaria\|Canada\|Czechia\|Denmark\|Finland\|France\|Germany\|Hungary\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Poland\|Romania\|Russian Federation\|Serbia\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|China\|Czechia\|France\|Germany\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Poland\|Russian Federation\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Czechia\|Denmark\|France\|Germany\|Hungary\|Italy\|Korea, Republic of\|Netherlands\|New Zealand\|Poland\|Russian Federation\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Czechia\|France\|Germany\|Hungary\|Italy\|Korea, Republic of\|New Zealand\|Poland\|Spain\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Czechia\|France\|Israel\|Italy\|New Zealand\|Poland\|Russian Federation\|Spain\|Sweden\|Turkey\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Denmark\|Finland\|France\|Germany\|Ireland\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Peru\|Singapore\|South Africa\|Spain\|Sweden\|Switzerland\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Denmark\|Finland\|France\|Germany\|Israel\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Philippines\|Singapore\|Sweden\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Denmark\|France\|Germany\|Italy\|Netherlands\|New Zealand\|Norway\|Spain\|Sweden\|Switzerland\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|France\|Germany\|Italy\|Japan\|Norway\|Spain	1
United States\|Australia\|Austria\|Belgium\|Canada\|France\|Germany\|Netherlands\|Norway\|Poland\|Turkey\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Canada\|Germany\|Hungary\|Netherlands\|Norway\|Spain\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|Czechia\|France\|Italy\|New Zealand\|Poland\|Russian Federation\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Belgium\|France\|Germany\|Korea, Republic of\|Poland\|Spain	1
United States\|Australia\|Austria\|Belgium\|France\|Ireland\|Italy\|Poland\|Spain\|United Kingdom	1
United States\|Australia\|Austria\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Netherlands\|Poland\|Russian Federation\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Canada\|Chile\|Czechia\|Denmark\|France\|Germany\|Hong Kong\|Italy\|Japan\|Korea, Republic of\|Poland\|Portugal\|Russian Federation\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Austria\|Canada\|Denmark\|France\|Israel\|Italy\|Netherlands\|Spain\|Switzerland\|United Kingdom	1
United States\|Australia\|Austria\|Finland\|France\|Germany\|Italy\|Netherlands\|United Kingdom	1
United States\|Australia\|Belarus\|Brazil\|Canada\|Israel\|Korea, Republic of\|Mexico\|New Zealand\|Poland\|Russian Federation\|Singapore	1
United States\|Australia\|Belgium\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Greece\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Poland\|Russian Federation\|Spain\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|Brazil\|Canada\|Czechia\|Korea, Republic of\|Mexico\|New Zealand\|Poland\|Puerto Rico\|Russian Federation	1
United States\|Australia\|Belgium\|Canada\|Croatia\|Czechia\|France\|Germany\|Hong Kong\|Hungary\|Italy\|Korea, Republic of\|Netherlands\|Poland\|Serbia\|Singapore\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Croatia\|Czechia\|France\|Greece\|Hungary\|Ireland\|Italy\|Poland\|Portugal\|Romania\|Russian Federation\|Spain\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Denmark\|France\|Germany\|Greece\|Italy\|Japan\|Korea, Republic of\|New Zealand\|Poland\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Denmark\|France\|Hungary\|Italy\|Netherlands\|New Zealand\|Norway\|Poland\|Romania\|Russian Federation\|Spain\|Sweden\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|France\|Germany\|Ireland\|Italy\|Norway\|Poland\|Romania\|Spain\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|France\|Germany\|Italy\|Japan\|Korea, Republic of\|Poland\|Spain\|Taiwan\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Germany\|New Zealand\|Sweden\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|Canada\|Greece\|Hungary\|Israel\|Korea, Republic of\|Poland\|Russian Federation	1
United States\|Australia\|Belgium\|China\|Czechia\|France\|Germany\|Italy\|Netherlands\|New Zealand\|Poland\|Spain\|Sweden\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|France\|Germany\|Israel\|Korea, Republic of\|Poland\|Russian Federation\|Spain\|Sweden\|Taiwan\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|France\|Germany\|Italy\|Korea, Republic of\|Peru\|Spain\|Switzerland\|Turkey\|United Kingdom	1
United States\|Australia\|Belgium\|France\|Germany\|Italy\|Netherlands\|Puerto Rico\|United Kingdom	1
United States\|Australia\|Belgium\|Hungary\|India\|Poland\|Singapore\|Spain\|Taiwan\|Turkey	1
United States\|Australia\|Brazil\|Canada	1
United States\|Australia\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Greece\|Hungary\|Italy\|Japan\|Korea, Republic of\|Puerto Rico\|Russian Federation\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Australia\|Brazil\|Canada\|China\|Czechia\|France\|Germany\|Israel\|Italy\|Japan\|Korea, Republic of\|Russian Federation\|Spain\|Switzerland\|Taiwan\|United Kingdom	1
United States\|Australia\|Brazil\|Canada\|Denmark\|Finland\|France\|Germany\|Italy\|Korea, Republic of\|Netherlands\|Norway\|Russian Federation\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Australia\|Canada\|Denmark\|Estonia\|Finland\|France\|Germany\|Israel\|New Zealand\|Sweden\|United Kingdom	1
United States\|Australia\|Canada\|France\|Germany\|Italy\|Korea, Republic of\|Netherlands\|Portugal\|Spain\|Switzerland\|United Kingdom	1
United States\|Australia\|Canada\|France\|Germany\|Italy\|Korea, Republic of\|Spain\|United Kingdom	1
United States\|Australia\|Canada\|France\|Germany\|Italy\|Spain	1
United States\|Australia\|Canada\|France\|Germany\|Korea, Republic of\|Spain\|United Kingdom	1
United States\|Australia\|Canada\|France\|Germany\|Netherlands\|Switzerland\|United Kingdom	1
United States\|Australia\|Canada\|France\|Germany\|Poland\|United Kingdom	1
United States\|Australia\|Canada\|France\|Italy\|Korea, Republic of\|United Kingdom	1
United States\|Australia\|Canada\|Germany\|Israel\|Italy\|New Zealand\|Poland\|Romania\|Russian Federation\|Spain\|Sweden\|Ukraine	1
United States\|Australia\|Canada\|Germany\|Japan	1
United States\|Australia\|Canada\|Ireland\|Italy\|Netherlands\|Spain	1
United States\|Australia\|Canada\|Israel	1
United States\|Australia\|Canada\|Italy\|Puerto Rico\|United Kingdom	1
United States\|Australia\|Canada\|New Zealand\|Puerto Rico\|Switzerland	1
United States\|Australia\|Canada\|New Zealand\|Saudi Arabia	1
United States\|Australia\|Canada\|Puerto Rico\|Switzerland	1
United States\|Australia\|Finland\|France\|Germany\|Netherlands\|Spain\|United Kingdom	1
United States\|Australia\|Finland\|Italy\|Singapore\|Spain\|Switzerland	1
United States\|Australia\|France	1
United States\|Australia\|France\|Germany	1
United States\|Australia\|France\|Germany\|Israel\|Korea, Republic of\|Spain	1
United States\|Australia\|France\|Germany\|Italy\|Japan\|Korea, Republic of\|Netherlands\|Singapore\|Spain	1
United States\|Australia\|France\|Germany\|Italy\|Japan\|Netherlands	1
United States\|Australia\|France\|Germany\|Italy\|Japan\|Romania\|Spain\|United Kingdom	1
United States\|Australia\|France\|Greece\|Italy\|Japan	1
United States\|Australia\|France\|Italy\|Spain	1
United States\|Australia\|France\|Spain	1
United States\|Australia\|Germany	1
United States\|Australia\|Germany\|Italy	1
United States\|Australia\|Germany\|United Kingdom	1
United States\|Australia\|Ireland	1
United States\|Australia\|Israel\|Poland\|Ukraine	1
United States\|Australia\|Italy\|New Zealand\|Spain	1
United States\|Australia\|New Zealand	1
United States\|Australia\|Singapore	1
United States\|Australia\|Spain	1
United States\|Austria	1
United States\|Austria\|Belgium\|Canada\|Denmark\|Finland\|France\|Germany\|Greece\|Ireland\|Israel\|Italy\|Netherlands\|Norway\|Portugal\|Puerto Rico\|Spain\|Sweden\|Switzerland\|Turkey\|United Kingdom	1
United States\|Austria\|Belgium\|Canada\|France\|Germany\|Hungary\|Italy\|Korea, Republic of\|Spain\|Sweden\|Switzerland\|Thailand\|United Kingdom	1
United States\|Austria\|Belgium\|Canada\|France\|Germany\|Italy\|Netherlands\|Poland\|Portugal\|Spain\|United Kingdom	1
United States\|Austria\|Belgium\|Czech Republic\|France\|Germany\|Ireland\|Italy\|Netherlands\|Sweden\|United Kingdom	1
United States\|Austria\|Belgium\|Czechia\|France\|Germany\|Italy\|Netherlands\|United Kingdom	1
United States\|Austria\|Belgium\|France\|Germany\|Hungary\|Italy\|Poland\|Spain\|Sweden\|Switzerland\|United Kingdom	1
United States\|Austria\|Bulgaria\|Canada\|Croatia\|France\|Germany\|Greece\|Italy\|Poland\|Portugal\|Romania\|Russian Federation\|Sweden\|Ukraine	1
United States\|Austria\|France\|Germany\|Italy\|Norway\|Spain\|Sweden	1
United States\|Austria\|Germany\|Italy\|Poland\|United Kingdom	1
United States\|Austria\|Germany\|Italy\|Spain	1
United States\|Austria\|Germany\|Poland\|Spain	1
United States\|Belgium\|Brazil\|France\|Peru\|United Kingdom	1
United States\|Belgium\|Bulgaria\|Canada\|Czechia\|France\|Germany\|Ireland\|Israel\|Italy\|Netherlands\|Spain	1
United States\|Belgium\|Canada\|Croatia\|France\|Germany\|Israel\|Italy\|Netherlands\|Portugal\|Spain\|Sweden\|United Kingdom	1
United States\|Belgium\|Canada\|Czech Republic\|Finland\|France\|Germany\|Greece\|Israel\|Slovakia\|Switzerland\|Turkey\|United Kingdom	1
United States\|Belgium\|Canada\|Czechia\|Denmark\|France\|Germany\|Italy\|Japan\|Korea, Republic of\|Poland\|Spain\|Sweden\|United Kingdom	1
United States\|Belgium\|Canada\|Czechia\|France\|Germany\|Ireland\|Israel\|Italy\|Norway\|Poland\|Serbia\|Spain\|United Kingdom	1
United States\|Belgium\|Canada\|Denmark\|Finland\|France\|Germany\|Italy\|Netherlands\|Norway\|Spain\|United Kingdom	1
United States\|Belgium\|Canada\|Denmark\|France\|Germany\|Hungary\|Italy\|Japan\|Korea, Republic of\|Poland\|Spain\|Sweden\|Ukraine\|United Kingdom	1
United States\|Belgium\|Canada\|France\|Germany\|Israel\|Italy\|Japan\|Korea, Republic of\|Poland\|Spain\|Taiwan\|Turkey\|United Kingdom	1
United States\|Belgium\|Canada\|France\|Germany\|Israel\|Italy\|Poland	1
United States\|Belgium\|Canada\|France\|Germany\|United Kingdom	1
United States\|Belgium\|Czech Republic\|France\|Serbia\|United Kingdom	1
United States\|Belgium\|Czech Republic\|Greece\|Italy\|Poland\|Russian Federation\|Spain	1
United States\|Belgium\|Czechia\|France\|Hungary\|India\|Italy\|Korea, Republic of\|Romania\|Spain\|United Kingdom	1
United States\|Belgium\|Denmark\|France\|Israel\|Italy\|Netherlands\|Spain\|Sweden	1
United States\|Belgium\|France\|Germany	1
United States\|Belgium\|France\|Germany\|Greece\|Israel\|Italy\|Lithuania\|Portugal\|Spain	1
United States\|Belgium\|France\|Germany\|Israel\|Italy\|Netherlands\|Spain\|Sweden\|United Kingdom	1
United States\|Belgium\|France\|Italy\|Netherlands	1
United States\|Belgium\|France\|Italy\|Netherlands\|Spain	1
United States\|Brazil\|Bulgaria\|Canada\|Germany\|Greece\|India\|Italy\|Mexico\|Netherlands\|Poland\|Romania\|Russian Federation\|Spain\|Taiwan\|Thailand\|Ukraine\|United Kingdom	1
United States\|Brazil\|Canada\|Czechia\|Denmark\|France\|Germany\|Greece\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Poland\|Portugal\|Romania\|Serbia\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|Brazil\|Denmark\|France\|Germany\|Hong Kong\|Italy\|Korea, Republic of\|Puerto Rico\|Taiwan\|United Kingdom	1
United States\|Brazil\|France\|Israel\|Italy\|Netherlands\|Portugal\|Singapore\|Spain\|United Kingdom	1
United States\|Brazil\|France\|Italy\|Korea, Republic of\|Netherlands\|Russian Federation\|United Kingdom	1
United States\|Canada\|Denmark\|France\|Germany\|Israel\|Italy\|Netherlands\|Poland\|Spain\|United Kingdom	1
United States\|Canada\|Finland\|France\|Germany\|Italy\|United Kingdom	1
United States\|Canada\|France\|Germany\|Italy	1
United States\|Canada\|France\|Germany\|Italy\|Netherlands\|Poland\|Spain\|United Kingdom	1
United States\|Canada\|France\|Germany\|Italy\|Spain\|Sweden\|United Kingdom	1
United States\|Canada\|France\|Germany\|Netherlands	1
United States\|Canada\|France\|Italy	1
United States\|Canada\|France\|Italy\|Norway\|Spain\|United Kingdom	1
United States\|Canada\|France\|Italy\|United Kingdom	1
United States\|Canada\|France\|Netherlands\|Spain\|United Kingdom	1
United States\|Canada\|France\|Poland	1
United States\|Canada\|France\|Spain	1
United States\|Canada\|Georgia\|Moldova, Republic of\|Poland\|Spain\|Ukraine	1
United States\|Canada\|Germany\|Israel\|United Kingdom	1
United States\|Canada\|Germany\|Italy\|Poland\|Spain	1
United States\|Canada\|Germany\|Italy\|Spain\|Sweden\|United Kingdom	1
United States\|Canada\|Germany\|Poland\|Switzerland	1
United States\|Canada\|Israel\|Puerto Rico	1
United States\|Canada\|Netherlands	1
United States\|Canada\|New Zealand	1
United States\|Canada\|Sweden	1
United States\|Denmark	1
United States\|Denmark\|France\|United Kingdom	1
United States\|Denmark\|Italy	1
United States\|Egypt\|India	1
United States\|Egypt\|Singapore	1
United States\|France\|Australia\|Austria\|Belgium\|Canada\|China\|Czechia\|Germany\|Hungary\|Israel\|Italy\|Japan\|Korea, Republic of\|Mexico\|Poland\|Romania\|Russian Federation\|Spain\|Sweden\|Taiwan\|United Kingdom	1
United States\|France\|Germany\|Italy\|Japan\|Netherlands\|United Kingdom	1
United States\|France\|Germany\|Italy\|Korea, Republic of	1
United States\|France\|Germany\|Italy\|Spain\|United Kingdom	1
United States\|France\|Germany\|Italy\|Switzerland\|United Kingdom	1
United States\|France\|Germany\|Norway	1
United States\|France\|Germany\|Spain	1
United States\|France\|Hungary\|Italy\|Japan\|Korea, Republic of\|Malaysia\|Netherlands\|Russian Federation\|Spain\|Thailand\|Turkey\|United Kingdom	1
United States\|France\|Italy\|Netherlands	1
United States\|France\|Italy\|Spain	1
United States\|France\|Italy\|United Kingdom	1
United States\|France\|Japan\|United Kingdom	1
United States\|France\|Spain\|United Kingdom	1
United States\|France\|United Kingdom	1
United States\|Germany\|Israel	1
United States\|Germany\|United Kingdom	1
United States\|Hungary\|Israel\|Italy\|Spain	1
United States\|India\|Israel	1
United States\|Israel\|Italy\|Poland\|Russian Federation\|Spain\|United Kingdom	1
United States\|Israel\|Peru	1
United States\|Italy\|Netherlands\|Singapore\|Spain	1
United States\|Italy\|United Kingdom	1
United States\|Japan	1
United States\|New Zealand	1
United States\|Singapore	1
United States\|Singapore\|Australia\|Belgium\|Canada\|Czechia\|Denmark\|Finland\|France\|Germany\|Hungary\|Israel\|Italy\|Korea, Republic of\|Mexico\|Netherlands\|Norway\|Poland\|Slovakia\|South Africa\|Spain\|Sweden\|Taiwan\|Thailand\|Ukraine\|United Kingdom	1
United States\|Spain\|Australia\|Belgium\|Denmark\|France\|Germany\|Hungary\|Israel\|Italy\|Netherlands\|New Zealand\|Poland\|Turkey\|United Kingdom	1
United States\|Spain\|United Kingdom	1
United States\|Sweden	1

Sites per Study

Site_count	Study_Count
1	1619
2	219
3	143
4	96
5	93
6	75
7	50
8	54
9	50
10	42
11	42
12	31
13	28
14	19
15	23
16	14
17	21
18	17
19	15
20	18
21	20
22	21
23	17
24	16
25	11
26	8
27	11
28	10
29	5
30	8
31	8
32	8
33	12
34	13
35	7
36	7
37	1
38	9
39	4
40	3
41	3
42	6
43	6
44	4
45	3
46	5
47	2
48	2
49	1
50	11
51	4
52	5
53	6
54	5
55	4
56	3
57	4
58	3
59	2
60	2
61	4
62	4
63	1
64	1
65	4
66	4
67	1
69	3
70	2
71	3
72	2
73	3
75	1
76	4
78	3
79	2
80	2
81	5
82	2
83	1
84	2
85	5
86	2
87	3
88	3
90	1
91	3
92	2
94	1
95	1
96	2
97	3
98	1
99	4
100	1
101	2
102	1
103	1
105	1
106	2
107	2
108	3
109	2
110	1
111	2
112	2
113	2
115	1
117	2
118	2
119	4
120	1
122	2
123	2
124	1
125	1
127	2
128	1
130	2
131	2
132	1
134	1
135	3
137	1
139	2
140	1
143	1
144	1
145	1
148	1
149	1
150	2
151	1
153	2
157	1
160	3
161	1
162	1
163	1
165	1
166	1
169	1
170	1
171	2
172	1
173	2
174	2
176	1
177	1
178	1
179	1
185	2
186	1
187	1
188	1
192	2
196	1
198	2
199	1
201	1
209	1
210	1
212	1
215	1
216	1
218	1
220	2
224	1
225	1
228	1
233	1
234	1
235	2
237	1
239	1
241	1
242	1
244	2
262	3
269	1
279	1
298	1
299	1
326	1
341	2
364	1
447	1
454	1
551	1
739	1
796	1
835	1
955	1

Phase

Phase	Study_Count
Phase 2	1198
Phase 1	819
Phase 1/Phase 2	466
Phase 3	338
N/A	193
Phase 4	70
Phase 2/Phase 3	60
Early Phase 1	27

Number of Arms

Number_of_Arms	Count_of_Studies
1	1620
2	689
3	161
4	93
5	30
6	31
7	14
8	5
9	7
10	8
11	2
12	3
13	1
16	1
17	1
21	1
NA	504

Number of Updates

Count of Versions	Count of Studies
1	104
2	154
3	151
4	170
5	145
6	142
7	137
8	121
9	138
10	126
11	130
12	137
13	121
14	106
15	92
16	69
17	76
18	78
19	55
20	52
21	51
22	44
23	42
24	45
25	40
26	47
27	33
28	36
29	23
30	29
31	22
32	27
33	21
34	14
35	13
36	17
37	13
38	15
39	6
40	17
41	14
42	11
43	5
44	10
45	9
46	8
47	6
48	5
49	5
50	5
51	9
52	6
53	5
54	1
55	5
56	2
57	3
58	2
59	5
60	3
61	3
62	6
63	2
64	2
65	6
66	3
67	7
68	1
69	4
70	3
71	4
72	8
73	2
74	2
75	3
76	1
77	3
78	3
79	3
80	1
81	4
82	2
83	4
84	1
85	4
86	5
88	1
91	3
92	1
93	1
94	3
96	3
97	1
98	2
101	1
103	1
105	1
106	1
107	2
109	2
111	1
112	1
113	1
114	1
115	1
116	1
117	1
118	2
119	1
124	2
125	2
127	3
129	2
130	1
132	1
133	1
134	2
136	1
137	1
139	2
141	1
148	1
149	1
153	1
154	1
156	2
157	2
158	1
162	2
164	1
170	2
174	1
178	1
183	1
185	1
188	1
192	1
204	1
205	1
208	1
213	1
223	1
232	1
237	1
239	1
241	1
243	1
281	1
284	1
292	1
304	2
320	1
326	1
346	1
347	1
349	2
376	1
397	1
418	1
428	1
439	1
444	1
455	1
482	1
510	1
556	1
630	1
870	1
883	1

Update History Change Type

Change Type	Count_of_Changes	Count_of_Studies	ratio
Study Status	66970	3067	21.835670
Contacts/Locations	30875	2803	11.014984
Arms	6909	2149	3.214984
Interventions	6909	2149	3.214984
Recruitment Status	5952	2721	2.187431
Eligibility	5887	2152	2.735595
Study Design	5707	2308	2.472704
Study Description	5630	1842	3.056460
Study Identification	5259	2054	2.560370
Outcome Measures	4605	1931	2.384775
Conditions	4092	1462	2.798906
Sponsor/Collaborators	3625	1864	1.944743
None (earliest Version on record)	3171	3171	1.000000
Oversight	2770	1822	1.520307
References	1682	810	2.076543
More Information	1543	413	3.736077
Results	604	604	1.000000
IPDSharing	429	337	1.272997
Baseline Characteristics	262	186	1.408602
Results Submission Events	199	199	1.000000
Reported Adverse Events	167	138	1.210145
Documents	149	146	1.020548
Participant Flow	142	118	1.203390
2020 Outcome Measures	1	1	1.000000
Quality Control Review has not concludedReturned: March 18	1	1	1.000000

Enrollment Metrics by Phase

Measure	Early.Phase.1	N.A	Phase.1	Phase.1.Phase.2	Phase.2	Phase.2.Phase.3	Phase.3	Phase.4
Min.	4.00000	2.0000	1.00000	1.0000	1.00000	9.0000	6.0000	10.0000
1st Qu.	12.50000	26.0000	18.00000	30.0000	30.00000	50.0000	174.7500	58.0000
Median	20.00000	53.0000	30.00000	45.0000	50.00000	100.0000	350.0000	101.0000
Mean	35.77778	194.3723	39.69351	68.9191	76.33951	246.1525	572.8712	221.4706
3rd Qu.	33.00000	120.0000	49.00000	76.0000	92.75000	201.0000	576.7500	206.2500
Max.	312.00000	4000.0000	746.00000	2000.0000	862.00000	2000.0000	9349.0000	2600.0000

Trial Group Type

group_type	Group_Count
Experimental	3833
NA	504
Active Comparator	463
Other	145
No Intervention	90
Placebo Comparator	62
Sham Comparator	2

Intervention Model

intervention_model	Study_Count
Single Group Assignment	1945
Parallel Assignment	790
NA	289
Sequential Assignment	96
Crossover Assignment	33
Factorial Assignment	18

Primary Purpose

primary_purpose	Study_Count
Treatment	2904
Supportive Care	123
Prevention	60
NA	23
Other	21
Basic Science	16
Health Services Research	12
Diagnostic	10
Device Feasibility	1
Screening	1

Observational Studies

Studies by Country

Country	Study_Count
United States	143
NA	78
France	30
Italy	22
China	13
Israel	10
Korea, Republic of	9
Spain	9
Denmark	7
Russian Federation	7
Canada	6
Egypt	5
United Kingdom	5
Germany	4
Greece	4
Mexico	3
Sweden	3
United States\|Australia\|Canada	3
United States\|Puerto Rico	3
Australia	2
Belgium	2
Brazil	2
Hong Kong	2
India	2
Ireland\|United Kingdom	2
Japan	2
Taiwan	2
Turkey	2
United States\|Australia\|Canada\|New Zealand\|Puerto Rico\|Switzerland	2
United States\|Canada	2
Argentina	1
Argentina\|Brazil\|Chile\|Colombia\|Guatemala\|Mexico\|Panama	1
Austria	1
Austria\|Croatia	1
Austria\|Germany	1
Austria\|Germany\|Italy	1
Austria\|Germany\|Switzerland	1
Austria\|United States\|Brazil\|China\|Germany\|Iraq\|Italy\|Malaysia\|Netherlands	1
Belgium\|Croatia\|France\|Italy\|North Macedonia\|Slovakia\|Slovenia\|Turkey	1
Belgium\|France\|Portugal	1
Canada\|Korea, Republic of	1
Czech Republic\|France\|Germany\|Italy\|Poland\|Russian Federation\|Spain\|United Kingdom	1
Czechia	1
Denmark\|Finland\|Germany\|Hungary\|Israel\|Poland\|Russian Federation\|Saudi Arabia\|United Kingdom	1
Denmark\|Finland\|Iceland\|Lithuania\|Norway\|Sweden	1
Denmark\|Finland\|Iceland\|Norway\|Sweden	1
Denmark\|France\|Germany\|Israel\|Italy\|Netherlands\|Poland\|Russian Federation\|Spain	1
France\|Germany\|Italy\|Spain	1
Guadeloupe\|Martinique	1
Guatemala	1
Hungary	1
Indonesia	1
Italy\|Switzerland	1
Jordan	1
Serbia	1
Switzerland	1
Ukraine	1
United States\|Australia\|Canada\|Ireland\|New Zealand\|Puerto Rico\|Switzerland	1
United States\|Australia\|Canada\|New Zealand	1
United States\|Australia\|Canada\|Puerto Rico	1
United States\|Australia\|Canada\|Puerto Rico\|Switzerland	1
United States\|Austria\|Belgium\|France\|Germany\|Greece\|Iraq\|Italy\|Netherlands\|Taiwan	1
United States\|Belgium\|Canada\|Germany\|Netherlands\|United Kingdom	1
United States\|Canada\|Germany	1
United States\|Canada\|Puerto Rico\|Switzerland	1
United States\|Czech Republic\|France\|Germany\|Italy\|Poland\|Spain\|United Kingdom	1
United States\|France\|Germany\|Italy\|Netherlands\|Puerto Rico\|Russian Federation\|Spain	1
United States\|Netherlands	1
United States\|Taiwan	1

Sites per Study

Site_count	Study_Count
1	285
2	23
3	11
4	4
5	6
6	3
7	4
8	2
9	2
10	3
11	1
12	1
13	2
14	4
15	2
16	1
17	4
18	1
19	4
20	2
21	1
25	2
26	1
28	1
31	3
32	2
33	3
34	1
35	1
37	2
38	2
39	2
40	1
41	2
42	1
43	1
46	2
47	1
49	1
50	1
51	1
52	1
55	1
56	1
59	1
66	2
70	1
71	1
77	1
79	1
84	1
96	1
112	1
135	1
137	1
142	1
144	1
161	1
165	1
183	1
192	1
200	1
214	1
225	1
244	1
280	1
291	1
292	1

Number of Updates

Count of Versions	Count of Studies
1	39
2	54
3	46
4	50
5	46
6	24
7	17
8	8
9	21
10	14
11	10
12	2
13	9
14	9
15	6
16	5
17	4
18	1
20	4
21	1
22	1
23	2
24	2
25	2
27	2
28	1
30	1
33	1
34	1
37	1
38	1
41	1
42	1
44	1
45	1
47	1
62	1
63	2
66	1
68	1
71	1
73	1
78	2
81	1
82	1
83	2
88	2
97	1
105	1
112	1
118	1
122	1
124	1
126	1
164	1
165	1
185	1
224	1
239	1
253	1
267	1
285	1
297	1
341	1
364	1
391	1
453	1

Update History Change Type

Change Type	Count_of_Changes	Count_of_Studies	ratio
Study Status	7871	386	20.391192
Contacts/Locations	4376	268	16.328358
Study Description	613	148	4.141892
Recruitment Status	556	319	1.742947
Study Design	545	294	1.853741
None (earliest Version on record)	425	425	1.000000
Eligibility	415	224	1.852679
Study Identification	332	210	1.580952
Sponsor/Collaborators	281	218	1.288991
Outcome Measures	272	178	1.528090
Groups	248	120	2.066667
Interventions	248	120	2.066667
Oversight	239	202	1.183168
Conditions	238	105	2.266667
References	98	55	1.781818
IPDSharing	24	22	1.090909
Results	7	7	1.000000
Results Submission Events	7	7	1.000000
Documents	3	3	1.000000
More Information	2	2	1.000000
Baseline Characteristics	1	1	1.000000
Reported Adverse Events	1	1	1.000000

Enrollment Metrics

Measure	Observational
Min	1.0000
1st Qu	50.0000
Median	149.0000
Mean	845.7915
3rd Qu	400.0000
Max	99999.0000

Observation Model

observational_model	Study_Count
Cohort	213
Case-Only	102
Other	36
NA	27
Case-Control	24
Case Control	15
Family-Based	3
Ecologic or Community	2
Case-Crossover	1
Case Control, Natural History	1
Defined Population, Natural History	1

Time Perspective

time_perspective	Study_Count
Prospective	218
Retrospective	147
Cross-Sectional	27
NA	16
Other	15
Cross-Sectional, Retrospective	1
Longitudinal, Prospective	1

Registries

Studies by Country

Country	Study_Count
Germany	5
United States	5
France	4
NA	2
Brazil	1
Canada	1
China	1
Czechia	1
Hong Kong	1
Indonesia	1
Italy	1
Sweden	1
Turkey	1
United Kingdom	1

Sites per Study

Site_count	Study_Count
1	16
2	3
6	1
7	1
9	1
27	1
34	1
51	1
192	1

Number of Updates

Count of Versions	Count of Studies
1	10
2	2
3	2
4	5
5	2
6	2
11	1
13	1
23	1

Update History Change Type

Change Type	Count_of_Changes	Count_of_Studies	ratio
Study Status	83	16	5.187500
Contacts/Locations	34	12	2.833333
None (earliest Version on record)	26	26	1.000000
Study Design	16	12	1.333333
Recruitment Status	11	9	1.222222
Outcome Measures	9	5	1.800000
Eligibility	8	5	1.600000
References	7	2	3.500000
Study Identification	6	5	1.200000
Study Description	5	4	1.250000
Sponsor/Collaborators	4	3	1.333333
Groups	3	3	1.000000
Interventions	3	3	1.000000
IPDSharing	3	2	1.500000
Oversight	3	3	1.000000
Conditions	2	1	2.000000

Enrollment Metrics

Measure	Registries
Min	24.000
1st Qu	200.000
Median	494.000
Mean	2613.885
3rd Qu	2750.000
Max	27000.000

Registry Model

observational_model	Study_Count
Cohort	14
Other	8
Case-Only	3
Case Control	1

Time Perspective

time_perspective	Study_Count
Prospective	19
Other	4
Cross-Sectional	3

Follow-up

target_duration	Study_Count
10 Years	7
5 Years	6
1 Year	3
2 Years	3
1 Day	1
12 Months	1
15 Years	1
20 Years	1
25 Years	1
3 Years	1
4 Years	1

intervention_type	Study_Count
Drug	1672
Biological	274
Drug\|Other	183
Biological\|Drug	173
Drug\|Procedure	100
Biological\|Drug\|Other	79
Biological\|Drug\|Procedure\|Radiation	66
Biological\|Drug\|Procedure	61
Other	59
Drug\|Procedure\|Radiation	58
Drug\|placebo	48
Procedure	45
Drug\|Radiation	33
Biological\|Drug\|Other\|Procedure\|Radiation	27
Behavioral	26
Drug\|Other\|Procedure\|Radiation	26
Biological\|Drug\|Radiation	22
Biological\|Other	20
Drug\|Other\|Procedure	17
Biological\|Drug\|Other\|Procedure	13
Device	11
Biological\|Procedure	10
Combination Product	9
Dietary Supplement	9
Drug\|Genetic\|Other	9
Device\|Drug\|Procedure	7
Other\|Procedure	7
Drug\|Genetic	6
Drug\|Other\|Radiation	6
Behavioral\|Other	5
Biological\|Drug\|Genetic\|Other\|Procedure	5
Biological\|Device\|Drug	4
Dietary Supplement\|Drug	4
Dietary Supplement\|placebo	4
Drug\|Genetic\|Other\|Procedure	4
Genetic	4
Radiation	4
Biological\|Other\|Procedure	3
Biological\|Procedure\|Radiation	3
Device\|Drug	3
Biological\|Combination Product	2
Biological\|Drug\|Other\|Radiation	2
Biological\|Drug\|placebo	2
Biological\|Genetic\|Other	2
Biological\|Other\|placebo	2
Device\|Drug\|Other	2
Device\|Other	2
Diagnostic Test\|Drug\|Genetic\|Procedure\|Radiation	2
Dietary Supplement\|Other	2
Drug\|placebo\|Procedure	2
Genetic\|Other	2
Genetic\|Procedure	2
Behavioral\|Dietary Supplement\|Other	1
Behavioral\|Dietary Supplement\|Other\|Procedure	1
Behavioral\|Drug	1
Behavioral\|Drug\|Other\|Procedure	1
Behavioral\|Other\|Procedure	1
Biological\|Combination Product\|Drug	1
Biological\|Device	1
Biological\|Device\|Drug\|Other	1
Biological\|Device\|Drug\|Other\|Procedure	1
Biological\|Device\|Drug\|Procedure\|Radiation	1
Biological\|Device\|Drug\|Radiation	1
Biological\|Dietary Supplement\|Drug\|placebo	1
Biological\|Dietary Supplement\|Drug\|Procedure	1
Biological\|Drug\|Genetic\|Other	1
Biological\|Drug\|placebo\|Procedure	1
Biological\|Genetic\|Other\|Procedure	1
Biological\|placebo	1
Combination Product\|Dietary Supplement	1
Device\|Drug\|Other\|Procedure\|Radiation	1
Device\|Drug\|Procedure\|Radiation	1
Device\|Other\|Procedure	1
Diagnostic Test\|Drug	1
Dietary Supplement\|Drug\|Other	1
Drug\|Genetic\|Other\|Procedure\|Radiation	1
Drug\|Genetic\|Procedure\|Radiation	1
Drug\|Other\|placebo\|Procedure	1
Other\|placebo\|Procedure	1
Procedure\|Radiation	1

Count of Versions	Count of Studies
1	104
2	154
3	151
4	170
5	145
6	142
7	137
8	121
9	138
10	126
11	130
12	137
13	121
14	106
15	92
16	69
17	76
18	78
19	55
20	52
21	51
22	44
23	42
24	45
25	40
26	47
27	33
28	36
29	23
30	29
31	22
32	27
33	21
34	14
35	13
36	17
37	13
38	15
39	6
40	17
41	14
42	11
43	5
44	10
45	9
46	8
47	6
48	5
49	5
50	5
51	9
52	6
53	5
54	1
55	5
56	2
57	3
58	2
59	5
60	3
61	3
62	6
63	2
64	2
65	6
66	3
67	7
68	1
69	4
70	3
71	4
72	8
73	2
74	2
75	3
76	1
77	3
78	3
79	3
80	1
81	4
82	2
83	4
84	1
85	4
86	5
88	1
91	3
92	1
93	1
94	3
96	3
97	1
98	2
101	1
103	1
105	1
106	1
107	2
109	2
111	1
112	1
113	1
114	1
115	1
116	1
117	1
118	2
119	1
124	2
125	2
127	3
129	2
130	1
132	1
133	1
134	2
136	1
137	1
139	2
141	1
148	1
149	1
153	1
154	1
156	2
157	2
158	1
162	2
164	1
170	2
174	1
178	1
183	1
185	1
188	1
192	1
204	1
205	1
208	1
213	1
223	1
232	1
237	1
239	1
241	1
243	1
281	1
284	1
292	1
304	2
320	1
326	1
346	1
347	1
349	2
376	1
397	1
418	1
428	1
439	1
444	1
455	1
482	1
510	1
556	1
630	1
870	1
883	1

Site_count	Study_Count
1	285
2	23
3	11
4	4
5	6
6	3
7	4
8	2
9	2
10	3
11	1
12	1
13	2
14	4
15	2
16	1
17	4
18	1
19	4
20	2
21	1
25	2
26	1
28	1
31	3
32	2
33	3
34	1
35	1
37	2
38	2
39	2
40	1
41	2
42	1
43	1
46	2
47	1
49	1
50	1
51	1
52	1
55	1
56	1
59	1
66	2
70	1
71	1
77	1
79	1
84	1
96	1
112	1
135	1
137	1
142	1
144	1
161	1
165	1
183	1
192	1
200	1
214	1
225	1
244	1
280	1
291	1
292	1

Count of Versions	Count of Studies
1	39
2	54
3	46
4	50
5	46
6	24
7	17
8	8
9	21
10	14
11	10
12	2
13	9
14	9
15	6
16	5
17	4
18	1
20	4
21	1
22	1
23	2
24	2
25	2
27	2
28	1
30	1
33	1
34	1
37	1
38	1
41	1
42	1
44	1
45	1
47	1
62	1
63	2
66	1
68	1
71	1
73	1
78	2
81	1
82	1
83	2
88	2
97	1
105	1
112	1
118	1
122	1
124	1
126	1
164	1
165	1
185	1
224	1
239	1
253	1
267	1
285	1
297	1
341	1
364	1
391	1
453	1

Count of Versions	Count of Studies
1	104
2	154
3	151
4	170
5	145
6	142
7	137
8	121
9	138
10	126
11	130
12	137
13	121
14	106
15	92
16	69
17	76
18	78
19	55
20	52
21	51
22	44
23	42
24	45
25	40
26	47
27	33
28	36
29	23
30	29
31	22
32	27
33	21
34	14
35	13
36	17
37	13
38	15
39	6
40	17
41	14
42	11
43	5
44	10
45	9
46	8
47	6
48	5
49	5
50	5
51	9
52	6
53	5
54	1
55	5
56	2
57	3
58	2
59	5
60	3
61	3
62	6
63	2
64	2
65	6
66	3
67	7
68	1
69	4
70	3
71	4
72	8
73	2
74	2
75	3
76	1
77	3
78	3
79	3
80	1
81	4
82	2
83	4
84	1
85	4
86	5
88	1
91	3
92	1
93	1
94	3
96	3
97	1
98	2
101	1
103	1
105	1
106	1
107	2
109	2
111	1
112	1
113	1
114	1
115	1
116	1
117	1
118	2
119	1
124	2
125	2
127	3
129	2
130	1
132	1
133	1
134	2
136	1
137	1
139	2
141	1
148	1
149	1
153	1
154	1
156	2
157	2
158	1
162	2
164	1
170	2
174	1
178	1
183	1
185	1
188	1
192	1
204	1
205	1
208	1
213	1
223	1
232	1
237	1
239	1
241	1
243	1
281	1
284	1
292	1
304	2
320	1
326	1
346	1
347	1
349	2
376	1
397	1
418	1
428	1
439	1
444	1
455	1
482	1
510	1
556	1
630	1
870	1
883	1

Site_count	Study_Count
1	285
2	23
3	11
4	4
5	6
6	3
7	4
8	2
9	2
10	3
11	1
12	1
13	2
14	4
15	2
16	1
17	4
18	1
19	4
20	2
21	1
25	2
26	1
28	1
31	3
32	2
33	3
34	1
35	1
37	2
38	2
39	2
40	1
41	2
42	1
43	1
46	2
47	1
49	1
50	1
51	1
52	1
55	1
56	1
59	1
66	2
70	1
71	1
77	1
79	1
84	1
96	1
112	1
135	1
137	1
142	1
144	1
161	1
165	1
183	1
192	1
200	1
214	1
225	1
244	1
280	1
291	1
292	1

Count of Versions	Count of Studies
1	39
2	54
3	46
4	50
5	46
6	24
7	17
8	8
9	21
10	14
11	10
12	2
13	9
14	9
15	6
16	5
17	4
18	1
20	4
21	1
22	1
23	2
24	2
25	2
27	2
28	1
30	1
33	1
34	1
37	1
38	1
41	1
42	1
44	1
45	1
47	1
62	1
63	2
66	1
68	1
71	1
73	1
78	2
81	1
82	1
83	2
88	2
97	1
105	1
112	1
118	1
122	1
124	1
126	1
164	1
165	1
185	1
224	1
239	1
253	1
267	1
285	1
297	1
341	1
364	1
391	1
453	1

leukemia

Study Counts

Studies over Time

Interventional Trials

Intervention Type

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Studies by Country

Sites per Study

Phase

Number of Arms

Number of Updates

Update History Change Type

Enrollment Metrics by Phase

Trial Group Type

Intervention Model

Primary Purpose

Observational Studies

Studies by Country

Sites per Study

Number of Updates

Update History Change Type

Enrollment Metrics

Observation Model

Time Perspective

Registries

Studies by Country

Sites per Study

Number of Updates

Update History Change Type

Enrollment Metrics

Registry Model

Time Perspective

Follow-up

Count of Versions	Count of Studies
1	104
2	154
3	151
4	170
5	145
6	142
7	137
8	121
9	138
10	126
11	130
12	137
13	121
14	106
15	92
16	69
17	76
18	78
19	55
20	52
21	51
22	44
23	42
24	45
25	40
26	47
27	33
28	36
29	23
30	29
31	22
32	27
33	21
34	14
35	13
36	17
37	13
38	15
39	6
40	17
41	14
42	11
43	5
44	10
45	9
46	8
47	6
48	5
49	5
50	5
51	9
52	6
53	5
54	1
55	5
56	2
57	3
58	2
59	5
60	3
61	3
62	6
63	2
64	2
65	6
66	3
67	7
68	1
69	4
70	3
71	4
72	8
73	2
74	2
75	3
76	1
77	3
78	3
79	3
80	1
81	4
82	2
83	4
84	1
85	4
86	5
88	1
91	3
92	1
93	1
94	3
96	3
97	1
98	2
101	1
103	1
105	1
106	1
107	2
109	2
111	1
112	1
113	1
114	1
115	1
116	1
117	1
118	2
119	1
124	2
125	2
127	3
129	2
130	1
132	1
133	1
134	2
136	1
137	1
139	2
141	1
148	1
149	1
153	1
154	1
156	2
157	2
158	1
162	2
164	1
170	2
174	1
178	1
183	1
185	1
188	1
192	1
204	1
205	1
208	1
213	1
223	1
232	1
237	1
239	1
241	1
243	1
281	1
284	1
292	1
304	2
320	1
326	1
346	1
347	1
349	2
376	1
397	1
418	1
428	1
439	1
444	1
455	1
482	1
510	1
556	1
630	1
870	1
883	1

Site_count	Study_Count
1	285
2	23
3	11
4	4
5	6
6	3
7	4
8	2
9	2
10	3
11	1
12	1
13	2
14	4
15	2
16	1
17	4
18	1
19	4
20	2
21	1
25	2
26	1
28	1
31	3
32	2
33	3
34	1
35	1
37	2
38	2
39	2
40	1
41	2
42	1
43	1
46	2
47	1
49	1
50	1
51	1
52	1
55	1
56	1
59	1
66	2
70	1
71	1
77	1
79	1
84	1
96	1
112	1
135	1
137	1
142	1
144	1
161	1
165	1
183	1
192	1
200	1
214	1
225	1
244	1
280	1
291	1
292	1

Count of Versions	Count of Studies
1	39
2	54
3	46
4	50
5	46
6	24
7	17
8	8
9	21
10	14
11	10
12	2
13	9
14	9
15	6
16	5
17	4
18	1
20	4
21	1
22	1
23	2
24	2
25	2
27	2
28	1
30	1
33	1
34	1
37	1
38	1
41	1
42	1
44	1
45	1
47	1
62	1
63	2
66	1
68	1
71	1
73	1
78	2
81	1
82	1
83	2
88	2
97	1
105	1
112	1
118	1
122	1
124	1
126	1
164	1
165	1
185	1
224	1
239	1
253	1
267	1
285	1
297	1
341	1
364	1
391	1
453	1